Text

Calculation CA06451 Sre, Radiological Consequences Design Basis Calculation Using AST Rev 000
	ML053220420
Person / Time
Site:	Calvert Cliffs
Issue date:	11/03/2005
From:	; Constellation Energy Group
To:	; Office of Nuclear Reactor Regulation
References
	CA06451, Rev 000
	Download: ML053220420 (128)
	v • d • e

Enclosure (5)

CA06451 SRE Radiological Consequences Design Basis Calculation Using AST Calvert Cliffs Nuclear Power, Inc.

November 3, 2005

EN-1-100 Fonns Appendix Revision 3 ESP No.: I ES200100401 Supp No. I 000 Rev. No. 000 Page 1 of 1 FORM 19, CALCULATION COVER SHEET A. INITIATION (Control Doc Type - DCALC) Page l of 127 DCALCNo.: CA06451 Revision No.: 000 Vendor Calculation (Check one): E Yes 0 No Responsible Group: FOSU Responsible Engineer: Gerard E. Gryczkowski B. CALCULATION ENGINEERING El Civil El Instr &Controls 3 Nuc Engrg DISCIPLINE: Ox Electrical El Mechanical El Nuc Fuel Mngmt El Other: a Reliability Engrg

Title:

SEIZED ROTOR EVENT USING ALTERNATE SOURCE TERMS Unit Eli 0 2 OCOMMON Proprietary or Safeguards Calculation E YES 0 NO Comments: NA Vendor Calc No.: NA - REVISION No.: NA Vendor Name: NA Safety Class (Check one): 0 SR a AQ El NSR There are assumptions that require Verification during walkdown: AIT#: NA This calculation SUPERSEDES: NA C. REVIEW AND APPROVAL:

Responsible Engineer: Gerard E. Gryczkowski 4/01/2005 Printed IV= 0ign~apff/ Date Independent Reviewer: Ian Somnmerville 7 -1/2 -~

Printed Name and Signature Date Approval: /0 4 / e, 6etk' jS 2 //i* /&j4 Printed Name and Signature . Date IF the results or conclusions of this calculation or revision might affect a procedure or the basis of a procedure, a Change Notification Form (Form 14) shall be forwarded to the Procedure Development Unit with a summary of the calculation's purpose and results.

CA06451 Rev.OOO Page 2 of 127

2. LIST OF EFFECTIVE PAGES Page Latest Page Latest Page Latest Page Latest Page Latest Rev Rev Rev Rev Rev 001 0 002 0 003 0 004 0 005 0 006 0 007 0 008 0 009 0 010 0 011 0 012 0 013 0 014 0 015 0 016 0 017 0 018 0 019 0 020 0 021 0 022 0 023 0 024 0 025 0 026 0 027 0 028 0 029 0 030 0 031 0 032 0 033 0 034 0 035 0 036 0 037 0 038 0 039 0 040 0 041 0 042 0 043 0 044 0 045 0 046 0 047 0 048 0 049 0 050 0 051 0 052 0 053 0 054 0 055 0 056 0 057 0 058 0 059 0 060 0 061 0 062 0 063 0 064 0 065 0 066 0 067 0 068 0 069 0 070 0 071 0 072 0 073 0 074 0 075 0 076 0 077 0 078 0 079 0 080 0 081 0 082 0 083 0 084 0 085 0 086 0 087 0 088 0 089 0 090 0 091 0 092 0 093 0 094 0 095 0 096 0 097 0 098 0 099 0 100 0 101 0 102 0 103 0 104 0 105 0 106 0 107 0 108 0 109 0 110 0 111 0 112 0 113 0 114 0 115 0 116 0 117 0 118 0 119 0 120 0 121 0 122 0 123 0 124 0 125 0 126 0 127 0

CA06451 Rev.000 Page 3 of 127

3. REVIEWER COMMENTS

1. What is "the probabilistic convolution methodology"?

Response: Probabilistic Convolution Methodology (PCM) is a probabilistic rather than deterministic method of calculating DNB fuel failure for loss of flow. For more information see the Licensing Topical Report CENPD-183, which was accepted by the NRC on 5/12182.

P .6 1 A 4-4-4~ -9.I

2. Release fractions are all zero?

Response: The failed fuel fraction and the gas gap fractions are both nonzero? Your questions must be more detailed.

3. p. 11 - what is difference between raw adv and adjusted adv?

Response: Adiusted ADV X/Q values are the raw ADV X/O values divided by five to account for thermal and momentum buoyancy effects. Only raw ADV X/O values were used in this work.

L 4. p. 11 - Total SG volume normalized to STP ? Ref?

p. I1 - SG Mass Ref 32 p. 3 0 ??? (I get 275938 but what about the 125165188?

Response: The SG volume at STP is a calculated not referenced value. It is calculated from the SG mass and specific volume. I still get a SG mass of 275942 Ibm. or 125165188 gm.

5. p. 16 - Please state page for input data from Ref 05 Response: Attachment H of Ref.5 l- 6. p. 17 - Please state file name where attachment A is calculated Response: SRE.XLS(SRE)

- 7. p. 17 - Water mass = 410,000 lbs ?

(9.3842E-01

410,000 * .454 *0.000001 =?? 1.936E+02). (for Kr-85) (should equal 174.67)

Response: Mrcs=454874 Ibm and M2sz=275942 Ibm per Input Table of Masses and Volumes.

8. p. 17 - Please state page # and col label for CA06422(Ref 4) and see comments on p. 17 Response: Table I Column R for primary system iodine activities. Table 2 Column H for secondary system iodine activities. Table 4 Column 0 for primary system noble gas activities.

9. CA06422 (Ref 4) is not reviewed Response: It is reviewed and approved as of 6/22/05.

17 10 p. - hn = 546.6 ? (=535.06 - See hand calc back of hand comments)

Response: Corrected 18

11. p. dVs/dT = 52.47

0.016018 *60 = 50.42 OK why use the vf ?

Response: Since the volume of the steam generator is the amount of fluid in the SG at STP. the fluid steaming should also be in terms of fluid loss at STP. Note that RADTRAD calculates the fractional activity release rate as loss rate in cfm over volume in ft3. Note that use of mass rather than volume could have been used and results in the same answer.

12. Is the way to view the output files as follows - ?

In RADTRAD - click on "view or print output" Then click OPEN and click "All Files" then double click the first file with the right filename?

CA06451 Rev.000 Page 4 of 227 Why not print entire output as per manual?

l - Response: The above process works, as well as using NOTESPAD. or NOTEPAD. The entire file was not printed since (a) it was rather long and (b) the bulk of the output file is a listingi of the inputs in a very hard to decipher format. It would be better to view the inputs via the Graphical User Interface (GUI).

' 13. Where is the power level specified? (Sources are given in Ci/MWt)

Response: From Inputs I and 2, power for the failed fuel isotopics is Power = 2754*1.7 = 4681.8 MWt. For the TS primary and secondary activities and as described in Sections 9.2.b and 9.2.c. a power of one is entered, since the isotopics are in Curies not Ci/MWt. The power is entered into RADTRAD in the "Source Term and DCF" section on the "Nuclide Inventory" pate.

CA06451 Rev. 000 Page 5 of 127

4. TABLE OF CONTENTS

01. COVER SHEET I

02. LIST OF EFFECTIVE PAGES 2

03. REVIEWER COMMENTS 3

04. TABLE OF CONTENTS 5

05. INTRODUCTION 7

06. INPUT DATA 9

07. TECHNICAL ASSUMPTIONS 15

08. REFERENCES 16

09. METHODS OF ANALYSIS 18 09.1 RADTRAD Computations 18 09.2 Gas Gap, Primary, and Secondary Release Activities 18 09.3 8-Hour Secondary Steam Release Calculations 19 09.4 2-Hour Secondary Steam Release Calculations 20 09.5 Flashing Fraction Calculations 21

10. CALCULATIONS 24

11. DOCUMENTATION OF COMPUTER CODES 25

12. RESULTS 26

13. CONCLUSIONS 28

14. ATTACHMENTS 29 ATTACHMENT A: SEIZED ROTOR EVENT RELEASE ACTIVITIES 29 ATTACHMENT B: RCS AND SG TEMPERATURES DURING COOLDOWN FOR U2C15 31 ATTACHMENT C: INCONEL ALLOY 690 DATA 33 ATTACHMENT D: NUCLEAR INVENTORY FILE GAP 14.NIF 37 ATTACHMENT E: NUCLEAR INVENTORY FILE PRI14.NIF 40 ATTACHMENT F: NUCLEAR INVENTORY FILE SEC05.NIF 43 ATTACHMENT G: NUCLEAR INVENTORY FILE CRCB63.NIF 45 ATTACHMENT H: RELEASE FRACTION AND TIMING FILE SREFFI.RFT 56

CA06451 Rev.000 Page 6 of 127 ATTACHMENT I: RELEASE FRACTION AND TIMING FILE SREFFN.RFT 57 ATTACHMENT 3: RELEASE FRACTION AND TIMING FILE SREPRI.RFT 58 ATTACHMENT K: RELEASE FRACTION AND TIMING FILE SREPRN.RFT 59 ATTACHMENT L: RELEASE FRACTION AND TIMING FILE SRESEC.RFT 60 ATTACHMENT M: RELEASE FRACTION AND TIMING FILE SREFFA.RFT 61 ATTACHMENT N: CONVERSION FACTORS FILE FGR1 4.INP 62 ATTACHMENT 0: CONVERSION FACTORS FILE FGROS.INP 66 ATTACHMENT P: CONVERSION FACTORS FILE FGR63.INP 68 ATTACHMENT Q: SREFFI OUTPUT FILE 82 ATTACHMENT R: SREFFN OUTPUT FILE 84 ATTACHMENT S: SREPRI OUTPUT FILE 86 ATTACHMENT T: SREPRN OUTPUT FILE 88 ATTACHMENT U: SRESEC OUTPUT FILE 90 ATTACHMENT V: SREFFA OUTPUT FILE 92 ATTACHMENT W: SREFFI2 OUTPUT FILE 94 ATTACHMENT X: SREFFN2 OUTPUT FILE 96 ATTACHMENT Y: SREPRI2 OUTPUT FILE 98 ATTACHMENT Z: SREPRN2 OUTPUT FILE 100 ATTACHMENT AA: SRESEC2 OUTPUT FILE 102 ATTACHMENT AB: SREFFA2 OUTPUT FILE 104 ATTACHMENT AC: ETP 97-064R CONTROL ROOM INLEAKAGE RESULTS 106 ATTACHMENT AD: ETP 01-035R PERFLUOROCARBON TRACER GAS TESTING 122 LAST PAGE OF REPORT 127

CA06451 Rev.O00 Page 7 of 127

5. INTRODUCTION Chapter 14.16 of the Updated Final Safety Analysis Report (UFSAR) presents the licensing basis evaluation of the Seized Rotor Event (SRE). A Seized Rotor Event is defined as a complete seizure of a single Reactor Coolant Pump (RCP) shaft. The seizure is postulated to occur due to a mechanical failure or a loss of component cooling to the pump shaft seals. The most limiting SRE is an instantaneous RCP shaft seizure at hot full power (HFP). The reactor coolant flow through the core would be asymmetrically reduced to three pump flow as the result of a shaft seizure on one pump.

The primary function of the RCPs is to provide forced coolant flow through the reactor core. There are four RCPs in the RCS which are located in the Steam Generator (SG) cold legs. The RCS is a two-loop two-SG system with four cold legs. The shaft seal system for the RCPs consists of three sets of four similar, rubbing face seals mounted in a cartridge, plus a fourth rubbing face, low pressure, vapor seal mounted on top of the cartridge. Each of the four seals consists of a rotating tungsten carbide ring riding over a carbon graphite stationary face. The reactor coolant leaking into the seal cavity is forced through the seal water cooler by the auxiliary impeller where it is cooled with component cooling water. The seals are kept at approximately 1451F by maintaining a controlled flow of this cooled reactor coolant through the seal cartridge. Each pump is equipped with renewable casing wear rings, four tandem mechanical face seals, and a self-aligning, water-lubricated bearing mounted above the pump impeller. Additional shaft support is provided by the pump motor bearings. The pump motor-driver and pump shaft are connected with a rigid coupling. The pump impeller and pump shaft are bolted and pinned together to allow differential thermal expansion. In addition, a welded pump shaft impeller assembly has been approved for use in any of the reactor coolant pumps. Material of construction used for the shaft and impeller in conjunction with the design and location of the weld, alleviate the differential thermal expansion concern in the welded assembly design. The pump and motor are furnished as a unit complete with an oil lift pump, oil cooler, seal water cooler, and instrumentation. The instrumentation will alert the operators to any incipient failures in the pump motors or seals. Non-reverse rotation devices are provided on the pump motors to prevent the pump from windmilling in the reverse direction, to allow starting the pump with 90% rated voltage, and to limit backflow through a stopped pump from thereby bypassing the core.

A SRE is initiated at HFP by an instantaneous complete seizure of a single RCP shaft. With the reduction of core flow due to the loss of an RCP, the core coolant temperatures will increase. Assuming a positive moderator temperature coefficient (MTC), the core power will increase. The core average heat flux will decrease slightly due to the increasing core temperatures. The insertion of the CEAs due to a low RCS flow trip will terminate the power rise; however, a limited number of fuel pins will experience DNB for a short period of time and thus fail. The initial secondary activity together with initial primary activity and failed fuel activity released to the primary that then leaks into the secondary will escape out of the steam generators via the ADVs and condenser. Note that per the requirements of Regulatory Guide (RG) 1.183 (Ref 08), the release of fission products from the secondary system should be evaluated with the assumption of a coincident loss of offsite power (LOOP). Thus, the use of condensers can not be credited in this work.

The SRE analysis was first analyzed by Combustion Engineering (CE) in Refs. 9-10. The analysis was updated in Ref.l I for Unit I Cycle 12 parameters, resulting in 2% failed fuel. Starting with Unit I Cycle 17, a sufficient number of assemblies containing mixing vanes were present to allow the use of ABB-CE heat transfer correlation and gain operating margin with respect to DNBR. A new analysis of record was generated to utilize the ABB-CE heat transfer correlation (Ref.12). Concurrently, the new analysis of record included an increase in nominal power in anticipating of a power measurement uncertainty recapture uprate. However, the Unit 2 core will not have a sufficient number of mixing vane assemblies until Unit 2 Cycle 16. Therefore, the new analysis of record will not apply to Unit 2 until Cycle 16. Ref.12 resulted in 1.02% failed fuel, based on the probabilistic convolution methodology. Using a conservative 5% fuel failure rate and 200 gpd primary-to-secondary leakage, Ref.12 determined a 2-hour offsite thyroid dose of 12.0 REM and a 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months offsite whole body dose of 0.2 REM, which are the Analysis-of-Record (AOR) values in UFSAR 14.16 Rev.34.

CA06451 Rev.000 Page 8 of 127 The potential for DNB propagation during the seized rotor event was also evaluated. Departure from nucleate boiling propagation would result in increased offsite dose due to additional fuel failure. The minimum time in DNB

(<3.5 seconds) experienced during the seized rotor transient effectively minimizes the potential for DNB propagation and no additional fuel failure is postulated to occur.

Previously, power reactor licensees have typically used the U.S.A.E.C Technical Information Document TID-14844, "Calculation of Distance Factors for Power and Test Reactor Sites," (Ref.18) as the basis for DBA analysis source terms. TID-1 4844 is referenced in 10 CFR 100.11, the power reactor siting regulation, which contains offsite dose limits in terms of whole body and thyroid doses. In December 1999, the NRC issued a new regulation, 10 CFR 50.67, "Accident Source Term," which provided a mechanism for licensed power reactors to replace the traditional accident source term used in their DBA analyses with an alternate source term. Regulatory guidance for the implementation of these ASTs is provided in Regulatory Guide 1.183, "Alternative Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors" (Ref.08). Section 50.67 of 10 CFR requires a licensee seeking to use AST to apply for a license amendment and requires that the application contain an evaluation of the consequences of affected DBAs. As part of the implementation of the AST, the total effective dose equivalent (TEDE) acceptance criterion of 10 CFR 50.67 replaces the previous whole body and thyroid dose guidelines of 10 CFR 100.11 and 10 CFR 50, Appendix A, GDC-19 for the loss-of-coolant accident (LOCA), the main steam line break (MSLB), the steam generator tube rupture (SGTR), the seized rotor event (SRE), the fuel handling accident (FHA), and the control rod ejection accident (CREA). The NSSS response to the SRE was simulated using the CESEC computer code. The Unit I transient minimum DNBR value was calculated using the CETOP-D computer code. The Unit 2 transient minimum DNBR value was calculated using the TORC computer code.

The current work utilizes the alternate source term (AST) methodology of 10 CFR 50.67 and Regulatory Guide 1.183 to calculate offsite and control room doses for a SRE. The SRE was analyzed for both two and eight hour cooldown times to maximize site boundary and control room doses. A bounding control room inleakage value of 3500 cfm was assumed. Modification of the control room emergency ventilation system to a nominal 10000 cfm flow with a 90% filtration efficiency for elemental and organic iodine and a 99% filtration efficiency for particulate iodine was credited. Also credited was installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof. This modification limits activity ingress into the control room from either the West Road Inlet or the Turbine Building, thus limiting the atmospheric dispersion coefficient value.

The Technical Specification limit for RCS activity was reduced from 1.0 pCi/gm to 0.5 pCi/gm.

The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the design-basis SRE are detailed in the following table.

I SRE Results l EAB LPZ CR l Rem Rem Rem 8 Hour Secondary Pathway 0.0336 0.0095 0.7885 2 Hour Secondary Pathway 0.0386 0.0091 0.2294 Regulatory Limits 2.5 (RG 1.183) 2.5 (RG 1.183) 5.0 (10CFR50.67)

Note that all values are below the regulatory limits.

CA06451 Rev. O00 Page 9 of 127

6. INPUT DATA The input data to determine the exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses from a Seized Rotor Event are the following:

(01) Initial thermal power is 2754 MWt (UFSAR 3.2.1/Ref.l).

(02) The pin power peaking factor is 1.70. Per the Core Operating Limits Reports for Units I and 2, (Refs.2-3), the total integrated radial peaking factors (FrT) are less than or equal to 1.65. For conservatism, a pin power peaking factor of 1.70 will be used in this work.

(03) The isotopic half-lives (t) ,were extracted from Ref.06 and are listed in column A of Attachment A. The decay constants (A;), listed in column B of Attachment A, are readily calculated via the following algorithm:

A; = ln(2) / t; (04) The failed fuel factor of 5% is the same as that assumed in the current AOR calculation (Ref. 12).and in UFSAR 14.16. Note that the AOR (Ref.12) calculates a 1.02% failed fuel fraction, based on probabilistic convolution methodology; however, 5% is used for conservatism. This is incorporated into the SRE failed fuel iodine and noble gas release fraction and timing files SREFFI.RFT and SREFFN.RFT, listed in Attachments H and I.

(05) Per Ref.07, damaged fuel rods are assumed to release their gas gap activities consisting of the following isotopes (Attachment A Column D).

16%I-131

10% other iodines

20% Kr-85

10% other noble gases 24% alkali metals (06) Per Refs.8 and 37, the failed fuel gas gap activities are assumed to be released instantaneously and homogeneously throughout the primary system at the initiation of the accident. Per Ref.8, the primary TS activities are assumed to be homogeneously distributed throughout the primary system at the beginning of the accident. Per Ref.8, the secondary TS activities are assumed to be homogeneously distributed throughout the secondary system at the beginning of the accident. These release assumptions are incorporated into the release fraction and timing files.

Files Release Timing Iodine Noble Gas Alkali Metal Attachment Hours Release Fraction Release Fraction Fraction SREFFI.RFT 0.0001 0.0500 0.0000 0.0000 H SREFFN.RFT 0.0001 0.0000 0.0500 0.0000 I SREPRI.RFT 0.0001 1.0000 0.0000 0.0000 J SREPRN.RFT 0.0001 0.0000 1.0000 0.0000 K SRESEC.RFT 0.0001 1.0000 0.0000 0.0000 L SREFFA.RFT 0.0001 0.0000 0.0000 0.01200 M (07) The dose conversion factors (DCFs) were extracted from Refs.20-21 and inserted into input files for use by RADTRAD. This data is included in the Conversion Factor Files FGR63.INP in Attachment P for use with failed fuel isotopics, FGR14.lNP in Attachment N for use with gas gap and primary system isotopics, and FGRO5.INP in for use with secondary system isotopics. Note that the cloudshine data in the Conversion Factor Files corresponds to the FGR-12 data, while the inhaled chronic data in the Conversion Factor Files corresponds to the

CA06452 Rev.000 Page 10 of 127 worst-case effective data in FGR-1 1. The remaining data in the Conversion Factor Files is extraneous and not used by RADTRAD.

(08) Per Ref.08, iodine releases from the steam generators to the environment should be assumed to be 97%

elemental and 3% organic. Iodine released from the failed fuel is assumed to be 95% particulate, 4.85% elemental, and 0.15% organic.

(09) Masses and Volumes 1 RCS(cf) 7286.18 Total RCS and PZR volumes normalized to STP Vrcsfd) 9576 RCS volume per UFSAR T4.1 Vpzr(cf) 600 PZR volume per UFSAR T4.7 vrcs(cf/lbm) 0.022132 Ref.31 Specific Vol @ 574.5 F and 2250 psla - UFSAR T4.1 F4.9 vpzr(cfflbm) 0.02703 Ref.31 Specific Vol @ 653 F and 2250 psia - UFSAR T4.7 Mrcs(lbm) 432676.67 RCS mass: Vrcslvrcs Mpzr(lbm) 22197.56 PZR mass: Vpzrtvpzr Mtot(lbm-g) 454874.23 206327482 RCS + PZR mass: Mrcs+Mpzr vstp(cfAbm) 0.016018 Ref.31 Specific Vol @ 1 gm/cc Vtot(cf) 7286.18 Mtotvstp t STP 2 SG(cf) 4420.04 Total SG volume normalized to STP M2sg(lbm-g) 275942.00 125165188 SG mass per Ref.32 Sheet 30 - 102% Full Power Wsg( c; 4420.04 _ M2sg'vstp l} STP 3 AFW(cf) 10000.00 _ Auxiliary Feedwater Volume 4 Environment 289194 cf ControlRoomVolume_(Ref.19) 5 1Control Room 2899 f______Control Room Volume (Ref.19)

(10) Per Ref.08, the primary to secondary leakage of 200 gpd (TS 3.4.13) is assumed to continue until the primary system pressure is less than the secondary system pressure or until the temperature of the leakage is less than I 00C (212°F). The release of radioactivity is assumed to continue until shutdown cooling (SDC) is in operation and releases from the steam generators have been terminated. For the secondary system release pathway, the duration of the cooldown from HFP, defined as 574.5°F and 2250 psia per UFSAR Table 4.1 and Figure 4.9, to SDC, defined as 300°F and 270 psia per the EOPs, is limited by the TS 3.4.3 maximum cooldown rate of 100°F/hr. Two SRE accident durations are utilized. The first scenario assumes a long 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months cooldown period based on actual plant operation (See Attachment B for the Unit 2 Cycle 15 cooldown to SDC). The second scenario assumes a 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months cooldown period to maximize the two-hour EAB doses.

(11) Per Ref.08, the retention of particulate radionuclides in the steam generators is limited by the moisture carryover from the steam generators. Per Ref.34, the design moisture carryover is less than 0.05%. A value of 0.001 will be conservatively used in this work.

(12) The breathing rates are extracted from Ref.08:

Time Breathing Rate (hours) (m3/sec) 0-8 3.5E-04 8-24 1.8E-04 24-720 2.3E-04

CA06451 Rev. 000 Page 11 of 127 (13) The control room occupancy factors are extracted from Ref.08:

Time Occupancy (hours) Factor 0-24 1.0 24-96 0.6 96-720 0.4 (14) Control room inleakage: The control room inleakages for the two trains Air Conditioning Units (ACU) 11 and 12 were measured by NUCON International Inc. via sulfur hexaflouride (SF 6) tracer gas tests as documented in Refs.23-26 (Attachment AC). An additional inleakage test was performed by Brookhaven National Laboratory (BNL) via a perfluorocarbon tracer gas (PFT) test as documented in Ref.27 (Attachment AD).

ACU 11 ACU 12 SF6 Test 11/11/97 4300+/-300 cfm 3000+/-300 cfm SF6 Test 11/11/97 3600+/-600 cfm 2550+/-450 cfm SF6 Test 11/11/97 2900+/-250 cfm 2750+/-380 cfm SF6 Test 1/1 8/00 2600+/-200 cfm 3000+/-250 cfm PFT Test 5/1/02 2930+/-185 cfm 2930+/-185 cfm The latest SF6 and PFT tests show fairly good agreement, as indicated above. A conservative value of 3500 cfm will be utilized in this work.

The control room inleakage points were deduced from the PFT testing carried out by Brookhaven National Laboratory and include the Auxiliary Building West Road inlet (WR), the Turbine Building inlet (TB), Access Control 11 (ACI 1), Access Control 13 (AC 13), the Switchgear Rooms (SWGRs), and the Main Steam Isolation Valve Rooms (MSIVs). ACI I and AC1 3 will be equipped with dampers and radiation monitors, which will isolate this leakage path in case of an accident. The SWGRs are in continual recirculation mode and thus are also isolated from the environment. The MSIV rooms are also isolated from the environment, except for the Main Steam Line Break Accident which occurs in these rooms, due to the thermal buoyancy of the air in these rooms and due to the J-neck exhaust. For conservatism, all of the measured inleakage will be assumed to enter the control room from the most conservative pathway of either the West Road or Turbine Building inlets.

(15) Control room recirculation flow:

Flowrate: 10000.+/- 1000 cfm (Note that this value will be the result of a new modification.)

Initiation delay time: 20 minutes (Ref.29 conservatively assumes a 20 minute time delay for a manual start of the Control Room Emergency Ventilation System.)

Filter efficiencies: 90% for elemental and organic iodine species (Ref.28 and Technical Specification 5.5.11 allow a 95% filter efficiency for a 2" activated carbon bed depth; however, NRC Generic Letter 99-02 (Ref.30) requires plants that test their activated charcoal to the ASTM D3803-1989 standards to use a safety factor of two. This results in a maximum credited efficiency of 90% for accident analyses.)

Filter efficiencies: 99% for particulate iodine(Per Ref.28, an engineered-safety-feature air filtration system satisfying a filter penetration less than 0.05% at rated flow can be considered to warrant a 99%

removal efficiency for particulates in accident dose evaluations.)

CA06451 Rev. 000 Page 12 of 127 (16) The atmospheric dump valve (ADV)-to-site boundary, two-hour, atmospheric dispersion coefficient of 1.44E-4 sec/rn3 was calculated via the Gifford wake model extracted from UFSAR 2.3.6, as follows XYQ = 1If[A * (2ryu. + cA)] = 1.44E-4 sec/n 3 where for 1150 m exclusion area boundary distance and 5% frequency a = average wind speed = I rn/sec a;= standard deviation of the distribution in the lateral direction = 92 m (UFSAR Table 2-14) ar-= standard deviation of the distribution in the vertical direction = 24 m (UFSAR Table 2-14) c= wake factor A= cross-sectional area of structure from which material is released = 0 m (17) Atmospheric dispersion coefficients from the ADV to low population zone (2 miles)

(UFSAR Fig.2.3-3/UFSAR 14. 4.3)

Time X/Q (hours) (sec/rn3) 0-2 3.39E-05 2-24 2.20E-06 24-720 5.40E-07 Note that the 0-2 hour value was adjusted via the Gifford wake model for a vent stack release rather than a containment release.

(18) Atmospheric dispersion coefficients from the ADV to the Control Room: (Ref.19)

The initial secondary activity together with initial primary activity and failed fuel activity released to the primary that then leaks into the secondary will escape out of the steam generators via the ADVs and condenser. Note that per the requirements of Regulatory Guide (RG) 1.183 (Ref.08), the release of fission products from the secondary system should be evaluated with the assumption of a coincident loss of offsite power (LOOP). Thus, the use of condensers can not be credited in this work. The main control room inleakage points include the west road inlets, the turbine building, and Access Controls II and 13 on the Auxiliary Building roof. Installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof are credited in this work.

3 Atmospheric Dispersion Coefficents (sec/r radvl -tb radv2-tb radv1-wr radv2-wr 0-2 hr 3.70E-03 3.83E-03 1.40E-03 1.35E-03 2-8 hr 2.78E-03 3.25E-03 1.08E-03 9.39E-04 8-24hr 1.03E-03 1.32E-03 4.73E-04 3.78E-04 1-4 days 8.24E-04 9.92E-04 3.48E-04 2.52E-04 4-30 days 6.31 E-04 7.92E-04 2.44E-04 1.66E-04 The atmospheric dispersion coefficients corresponding to the Unit 2 ADV to the turbine building will be conservatively utilized in this work. Note that neither thermal buoyancy nor vertical effluent velocity are credited in this work.

(19) Additional RADTRAD Inputs for 6 release pathway cases:

(a) Failed fuel and primary iodine via the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months seconda release pathway:

Pathways: Iodine _ cfm I rcs-env 0.0-0.25 hr 200 gpd 0.10 0.001857

_ 0.25-8.0 hr 200 gpd0.01 0.000186 2 rcs-sg 0.0-0.25 hr 200 ad0.90 0.016710

= 0.25-8.0 hr 200 gpd0.99 0.018381 3 sg-env 0.0-0.5 hr 109.2 cfm 0.01 1.0920

= 0.5-8.0 hr 50.43 cfm 0.01 0.5043 4 afw-sg 0.0-0.25 hr 1.0753

CA06451 Rev.000 Page 13 of 127 0.25-0.50 hr 1.0736 0.50-8.00 hr 0.4859 5 env-cr 3500 cfm 3500

. 6 cr-env 3500 cfm 3500 _

(b) Failed fuel alkali metals via the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months secondar release pathwav:

Pathvav Alkali Metals MC cfm 1 rcs-env 0.0-0.25 hr 200 gpd 0.10 0.001 1.8567E-06 0.25-8.0 hr 200 gpd 0.01 0.001 1.8567E-07 2 rcs-sg 0.0-0.25 hr 200 gpd 1.00 0.018567 0.25-8.0 hr 200 gpd 1.00 0.018567 3 sg-env 0.0-0.5 hr 109.2 cfm 1 0.001 1.0920E-01 0.5-8.0 hr 50.43 cfm 1 0.001 5.0430E-02 4 afw-sg 0.0-8.00 hr 0.0000 5 env-cr 3500 cfm 3500 6 cr-env 3500 cfm 3500 (c) Failed fuel and primary noble gas via the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months secondary release pathway:

Pathwvfas Nobie Gas cfm I rcs-env 0-8 hrs 200 gpd 0.018567 2 rcs-sg 0-8hrs NA 3 sg-env G-8 hrs I NA 4 afw-sg 0-8 hrs NA 5 env-cr 0-720 hrs 3500 cfm 3500 6 1 cr-env 1 0-720 hrs 1 3500 cfm 1 3500 (d) Failed fuel and primary iodine via the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months seconda release pathwa y:

Pathway Iodine _ _ l cfm I rcs-env 0.0-0.25 hr 200 gpd 0.10 0.001857 I l l 0.25-2.0 hr 200 gpd 0.01 0.000186 2 rcs-sg 0.0-0.25 hr 200 gpd 0.90 0.016710 l 0.25-2.0 hr 200 gpd 0.99 0.018381 3 sg-env 0.0-0.5 hr 103.7cfm 0.01 1.0370 l 0.5-2.0 hr 103.7 cfm 0.01 1.0370 4 _ afw-sg 0.0-0.25 hr l l 1.0203 0.25-0.50 hr 1.0186 l 0.50-2.00 hr l_ l_l_1.0186 5 env-cr l _ l 3500cdm 3500 6 cr-env l 3500cdm l 3500 (e) Failed fuel alkali metals via the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months secondary release pathway:

Pathways Alkali Metal l_____l MC cfm l rcs-env 0.0-0.25 hr 200 gpd 0.10 0.001 1.8567E-06

____l 0.25-2.0 hr 200 gpd 0.01 0.001 1.8567E-07 2 lrcs-s 0.0-0.25 hr 200 gpd 1.00 0.018567

____l 0.25-2.0 hr 200 gpd 1.00 0.018567 3 sg-env 0.0-0.5 hr 103.7cfm 1 0.001 1.0370E-01 l 0.5-2.0 hr 103.7 cfm 1 0.001 1.0370E-01l

CA06451 Rev. 000 Page 14 of 127 4 afw-sg 0.0-2.00 hr l l I l 0.0000 5 env-cr __ l 3500 300 35cfm 6 cr-env _ 3500 din l l l 3500 (f) Failed fuel and primary noble gas via the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months secondary release pathway:

Pathway Noble Gas cfm I rcs-env 0-2 hrs 200 gpd 0.018567 2 rcs-s 0-2 hrs NA 3 sg-env 0-2 hrs NA 4 aw-sg 0-2 hrs NA 5 env-cr 0-720 hrs 3500 cfn 3500 6 cr-env 0-720 hrs 3500 cfmd3500

CA06451 Rev. 000 Page 15 of 127

7. TECHNICAL ASSUMPTIONS The following technical assumptions were utilized in this work:

(01) The 5% rod fuel failure is assumed to occur in the highest powered fuel rods.

(02) No credit is taken for atmospheric cleanup systems except control room filters.

(03) No credit is taken for deposition of the plume on the ground or decay of isotopes in transit to the site boundary.

(04) Buildup of daughter nuclides is taken into account as source term nuclides decay.

CA06451 Rev.000 Page 16 of 127 8.&REFERENCES (01) "Power Levels of Nuclear Power Plants", Regulatory Guide 1.49 Rev.1, 12/73.

(02) CCNPP Core Operating Limits Report for Unit 1 Cycle 17 Rev. l (03) CCNPP Core Operating Limits Report for Unit 2 Cycle 16 Rev.0 (04) "Primary and Secondary Isotopic Calculations", CA06422 (05) "Control Room Habitability Source Term Calculations", CA06358.

(06) "Chart of the Nuclides - Nuclides and Isotopes", GE Nuclear Energy, Fifteenth Edition.

(07) "Gas Gap Isotopic Fraction Calculations", CA06421.

(08) "Alternate Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors",

Regulatory Guide 1.183 (09) J.M.Bahr, et al, "Calvert Cliffs Unit 2 Cycle 3 Reload Transient Analysis at 2700 MWt", 7/31n9, Calculation

8167-RPP-00 Rev.0.

(10) S.A.Somma, "Calvert Cliffs Unit 2 Cycle 3 Seized Rotor Analysis", Calculation #8167-RPP-007, Rev.0.

(11) S.D.Leland, "Seized Rotor Transient for Calvert Cliffs Unit 1 Cycle 12", A-CCI-FE-0035, Rev.01, 1/28/94.

(12) CA03516, Calvert Cliffs Units I and 2 Seized Rotor Analysis", Calculation # A-CC-FE-0060, Rev.01.

(13) "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation",

NUREG/CR-6604, SAND98-0272 (14) "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation",

NUREG/CR-6604, SAND98-0272/1, Supplement 1.

(15) "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation",

NUREG/CR-6604, Supplement 2 (16) "RADTRAD 3.03 Installation and Verification on PCB386", CA06210 (17) "RADTRAD 3.03 Validation", CA06207 (18) "Calculation of Distance Factors for Power and Test Reactor Sites", TID-14844, 3/23/62.

(19) CA06012: CRHVAC Atmospheric Dispersion Coefficient Calculations (20) Federal Guidance Report (FGR) 11, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors," 1989 (21) Federal Guidance Report (FGR) 12, "External Exposure to Radionuclides in Air, Water, and Soil," 1993, (22) "Fuel Performance Analysis", Westinghouse Calculation CN-WFE-02-45, Rev.0

CA06451 Rev. 000 Page 17 of 127 (23) "Control Room HVAC Inleakage Test", ETP-97-064R Rev.0, 11/11/1997 (First Run)

(24) "Control Room HVAC Inleakage Test", ETP-97-064R Rev.0, 11/11/1997 (Third Run)

(25) "Control Room HVAC Inleakage Test", ETP-97-064R Rev.0, 11/11/1997 (Fourth Run)

(26) "Control Room HVAC Inleakage Test", ETP-97-064R Rev.0, 1/18/2000.

(27) "Perfluorocarbon Tracer Gas Testing", ETP-01-035R Rev.0, 5/1/2002 (28) ) Regulatory Guide 1.52 Rev.2: "Design, Testing, and Maintenance Criteria for Post Accident ESF Atmosphere Cleanup System Air Filtration and Absorption Units of LWVRs" (29) "Control Room Recirculation Filter Initiation Time Delay", NEU-95-026 (30) NRC Generic Letter 99-02: Laboratory Testing of Nuclear-Grade Activated Charcoal (31) ASME Steam Tables, 5th Edition, United Engineering Center, N.Y., N.Y.

(32) CA05725, WEC-222-781 1-A45: Parameter Listing for RSG Inputs for Calvert Cliffs Units I & 2 (33) CA03516, A-CC-FE-0060 Rev. 1, "Calvert Cliffs Units 1 and 2 Seized Rotor Analysis" (34) SP-081 1: RSG Design Specification (35) Branch Technical Position ASB 9-2: Residual Decay Energy for LWRs for Long-Term Cooling

CA06451 Rev.OOO Page 18 of 127

9. METHODS OF ANALYSIS (9.1) RADTRAD Computations The current work re-analyzes control room habitability for SRE based on the alternate source term methodology of Ref.08 and control room inleakage of 3500 cfm This was accomplished by utilizing the RADTRAD computer code (Refs.13-15).

The RADTRAD computer code calculates TEDE and thyroid doses to personnel at the site boundary, low population zone, and control room per 10 CFR 50.67 resulting from any postulated accident which releases radioactivity within the containment, spent fuel pool, or within any primary or secondary system. RADTRAD models the transport of up to 63 radionuclides from the source region, through a secondary region if any, and then to the environment and to the control room. The code includes the capability to model time-dependent activity release; time-dependent spray/filtration/deposition removal processes, piping/filter/inleakage transfer mechanisms, atmospheric dispersion; and natural decay. RADTRAD is documented and benchmarked in Refs.13-17.

Two SRE models were constructed: a two-hour SG release model and an eight-hour SG release model. Each SRE model is composed of six release components: gas gap iodine releases, gas gap noble gas releases, gas gap alkali metal releases, TS primary iodine activity releases, TS primary noble gas activity releases, and TS secondary iodine activity releases. The SRE occurs at time t=0 releasing the failed fuel gas gap iodine, noble gas, and alkali metal activities immediately and homogeneously into the primary system. The gas gap and TS primary noble gases are released at a 200 gpd rate into the steam generators and then directly through the ADVs into the environment. The gas gap and TS primary iodines are released at a 200 gpd rate into the steam generators, where a percentage is vented directly through the ADVs into the environment via flashing. The remaining iodines are added to the secondary system, which is released by steaming with a partition factor of 100 out of the ADVs. The gas gap alkali metals are released at a 200 gpd rate into the steam generators, where a percentage is released by flashing and steaming. The retention of particulate radionuclides in the steam generators is limited by the moisture carryover from the steam generators. Note that sufficient auxiliary feedwater is added to the steam generators to keep the water mass constant throughout the event. No cleanup mechanisms (spray, filtration, plateout) are assumed in the primary or secondary systems. The activity released to the environment is transported to the site boundary and to the control room via appropriate atmospheric dispersion coefficients. While time-dependent control room inleakage can be modeled by RADTRAD, it is a constant in this work. Control room filtration is credited in this work. The control room and site boundary doses are calculated based on appropriate breathing rates and occupancy factors and on FGR 11 and 12 dose conversion factors.

(9.2) Gas Gap, Primary, and Secondary Release Activities An EXCEL spreadsheet (Attachment A) was developed to calculate the activity released to the primary and secondary systems post-SRE. Three sets of isotopic activities were generated:

Gas gap iodine, noble gas, and alkali metal activities released via fuel failure

Technical Specification Primary iodine and noble gas activities

Technical Specification Secondary iodine activities (9.2.a) Gas Gap Release Activities The initial failed fuel isotopic activity in Ci/MWt contained in the gas gaps of all of the assemblies in the core for isotope 'i' is listed in Attachment A Column E and is based on the following algorithm:

Ajo = AST.

RF; where ASTI = Isotopic activity per unit power (Ci/MWT) (Ref.05 and Attachment A Column C)

RF; = Isotopic gas gap release fraction (Ref.07 and Attachment A Column D)

CA06451 Rev. 000 Page 19 of 127 The iodine and noble gas isotopic activities were inserted into the nuclear inventory file GAP14.NIF for use by RADTRAD. The file is listed in Attachment D and consist of the 14 gas-gap noble gas and iodine isotopes. The corresponding iodine and noble gas release fractions in SREFFI.RFT and SREFFN.RFT are 0.05. The alkali metal isotopic activities are contained in the base deck CRCB63.NIF is listed in Attachment G. The corresponding alkali metal release fraction in SREFFA.RFT is 0.05*0.24 = 0.012, where 0.05 is the failed fuel fraction and 0.24 is twice the non-LOCA alkali metal release fraction of Table 3 of RG 1.183. The factor of two is per the results of Ref.7, where all gas gap release fractions were conservatively doubled.

(9.2.b) Primary Specific Activities The initial primary specific activities in pCi/gm consistent with the TS 3.4.15 1.0 pCi/gm limit were extracted from Ref.4 and are listed in column F of Attachment A. These were converted to total primary isotopic source terms in Ci in Attachment A column G via the following algorithm:

Ajo = ASTi

MRCS

0-000001 where AST1 = Isotopic activity per unit mass (pCi/gm) (Ref04 and Attachment A Column F)

MRCS = Water mass in RCS (gm)

The primary iodine isotopic source terms were then halved in Attachment A column H to reflect that the TS 3.4.15 limit for primary activity will be reduced from 1.0 pCilgm to 0.5 pCi/gm.

These isotopic activities were inserted into the nuclear inventory file PRIM4NIF for use by RADTRAD. The file is listed in Attachment E and consist of the 14 primary noble gas and iodine isotopes. The activities are the total primary activities and are not per unit power. Thus a power of one should be designated when employing these files.

(9.2.c) Secondary Specific Activities The initial secondary specific activities in pCi/gm consistent with the TS 3.7.14 0.1 uCi/gm limit were extracted from Ref.4 and are listed in column I of Attachment A. These were converted to total secondary isotopic source terms in Attachment A column J via the following algorithm:

Ajo = AST1

MSG

0.00000 1 where AST, = Isotopic activity per unit mass (pCi/gm) (Ref.04)

MSG = Water mass in SG (gm)

These isotopic activities were inserted into the nuclear inventory file SECO5.NIF for use by RADTRAD. The file is listed in Attachment F and consist of the 5 iodine isotopes. The activities are the total secondary activities and are not per unit power. Thus a power of one should be designated when employing these files.

(9.3) 8-Hour Secondary Steam Release Calculations The methodology for the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months cooldown from HFP to SDC was extracted from Ref.33. The steam release from the first 1800 seconds was taken directly from a CESEC execution. The steam release from 1800 seconds to 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months is based on a simple energy balance methodology; that is, the steam released from 1800 seconds to 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months is based on the amount of steam required to remove the residual heat from the primary and secondary systems, the decay heat generated in the core, and the reactor coolant pump heat. The steam release rates in cfm calculated below are divided by the partition coefficient of 100 (RG 1.183) and entered into RADTRAD.

l Steam Release Calculations for First 1800 Seconds dt 1800 sec First 1800 sec. CESEC with no operator action from CA03516 W 204500 Ibm SG mass release, CESEC with no operator action from CA03516 dW/dt 113.6111 Ibm/sec W/dt vstp l 0.016018 l cf/Ibm Specific volume from Steam Tables D1 gm/cc (STP) per Reg Guide 1.183 dV/dt l 109.1894 l cfm dW/dt vstp * (60 sec/min)

CA06451 Rev. 000 Page 20 of 127 l _ l_ lSteam Release Calculations from 1800 Seconds to 8 Hours msg 86500 Ibm l SG secondary water mass @ 537.7F saturated from CA03516 cpsg 1.27 btu/lbm-F SG specific heat capacity @ 537.7F saturated from CA03516 mprs l 6630 Ibm PZR steam mass @ 658.6F and 2325.8 psia from CA03516 cpprs 3.46 btu/lbm-F PZR steam specific heat @ 658.6F and 2325.8 psia from CA03516 mprw 23000 Ibm PZR water mass @ 574.OF and 2325.8 psia from CA03516 cpprw 1.31 btullbm-F PZR water specific heat _ 574.OF and 2325.8 psia from CA03516 mrcs 410000 Ibm RCS water mass @ 540.3F and 2332.8 psia from CA03516 cprcs 1.22 btullbm-F RCS water specific heat @ 540.3F and 2332.8 psia from CA03516 mrcsm l 4248300 l Ibm RCS metal mass from CA03516 cprcsm 0.12 btullbm-F RCS specific heat@ 540.3F and 2332.8 psia from CA03516 dT 329 F Delta RCS temperature between 541F and 212 F dt 27000 sec Delta time between 8.0 hours0 days 0 hours 0 weeks 0 months and 0.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months Ores 14292.26 btu/sec (msg'cpsg+mprsucpprs+mprw'cpprw+mrcs*cprcs+mrcsm*cprcsm)'dT/dt Prcp 17 MW Reactor coolant pump power from UFSAR Table 14.6.1 Qrcp 12084.66 btu/sec Prcp*(3 RCPsi4 RCPs)*(947.8167 btu/sec/MW) ti 1800 sec Decay heat generated between 1800-28800 sec t2 28800 sec Decay heat generated between 1800-28800 sec Po 2754 Mwt Initial power per UFSAR 3.2.1 and RG 1.49 A 0.13 Constant from CA03516 a 0.283 Constant from CA03516 Pdec 25.14 Mwt Decay heat rate Pdec=Po*A [t2^(1 -a)t1 (1-a)]/(1-a)/(t2-t1) from CA03516 SF 1.25 CA03516 Safety Factor Qdec 29789.68 btu/sec PdecSF'(947.8167 btulsec/mw)

Qtot 56166.60 btulsec Qres+Qrcp+Qdec hg 1150.5 btulbm Enthalpy of steam In SG @ 212 F hfw 80.0 btuflbm Enthalpy of Aux Feed entering the SG (CA03516) dWsldt 52.47 Ibm/sec Steam Release Rate QtotI(hg-hfw)

Ws 1416625.98 Ibm Integrated steam release dWs/dt-(t2-tl) dVsldt 50.4256 cfm Steam Release Rate dWsdtvstp*60 (9.4) 2-Hour Secondary Steam Release Calculations The methodology for the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months cooldown from HFP to SDC is based on a simple energy balance methodology; that is, the steam released from 0 seconds to 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months is based on the amount of steam required to remove the residual heat from the primary and secondary systems, the decay heat generated in the core, and the reactor coolant pump heat. The steam release rates in cfm calculated below are divided by the partition coefficient of 100 (RG 1.183) and entered into RADTRAD.

Steam Release Calculations from 0 Seconds to 2 Hours msg 275942 Ibm SG secondary water mass @ 525.2F saturated from SP-0811 & WEC-222-7811-A45 cpsg 1.24 btullbm-F SG specific heat capacity @ 525.2F saturated from Steam Tables Qsg 77056251.6 btu SG residual heat = msg'cpsg*(525.2-300) mprs 5765 Ibm PZR steam mass @ 6536F and 2250 psia from UFSAR Tab 4.7 (900cf/0.15613 cfAbm) cpprs 3.55 btulbm-F PZR steam specific heat @ 653F and 2250 psia from Steam Tables Oprs 7224409.75 btu PZR steam residual heat = mprs'cprs-(653-300)

CAO6451 Rev. OOO Page 21 of 127 mprw 22198 Ibm PZR water mass @ 653F and 2250 psia from UFSAR Table 4.7 (600cf/0.02703cf/bm) cpprw 2.119 btuAbm-F PZR water specific heat @ 653F and 2250 psia from Steam Tables Qprw 16604259.4 btu PZR water residual heat = mprwcprw(653-300) mrcs 432677 Ibm RCS water mass (Q574.5F and 2250 psia from Input 11 cprcs 1.335 btu/lbm-F RCS water specific heat @ 574.5F and 2250 psia from Steam Tables Qrcs 158557732 btu RCS water residual heat = mrcs'cprcs-(574.5-300) mrcsm 4248300 Ibm RCS metal mass from CA03516 cprcsm 0.12 btuAbm-F RCS specific heat a_ 574.5F from CA03516 Qrcsm 139939002 btu Reactor residual heat = mrcsm-cprcsm.(574.5-300)

Qtot 399381654 btu Total residual heat = Qsg + Qprs + Qprw + Orcs + Qrcsm dt 7200 sec Delta tme between 0 hours0 days 0 hours 0 weeks 0 months and 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months Wres 55469.67 btu/sec Qtot/dt Prp17 MW Reactor coolant pump power from UFSAR Table 14.6.1 Wrcp 12084.66 btu/sec Prcp*(3 RCPs/4 RCPs)*(947.8167 btu/sec/MW) t 0 sec Decay hea generated t between 0-7200 sec t2 7200 sec Decay heat generated between 0-7200 sec Po 2754 Mwt Initial power per UFSAR 3.2.1 and RG 1.49 A 0.13 Constant from CA03516 a 0.283 Constant from CA03516 Pdec 40.44 Mwt Decay heat rate Pdec=PoWA[t2A(1.-a)t1(1-a)l(l a)/(t2-t1) from CA03516 SF 1.25 CA03516 Safety Factor Wdec 47906.83 btu/sec PdecSF*(947.8167 btu/sec/mw)

Wtot 115461.16 btu/sec Qres+Qrcp+Qdec hg 1150.5 btuAbm Enthalpy of steam In SG @212 F (conservative) hfw 80.0 btu/lbm Enthalpy of Aux Feed entering the SG (CA03516) dWs/dt 107.86 Ibm/sec Steam Release Rate Wtott(hg-hfw)

Ws 776572.051 Ibm Integrated steam release dWsldt (t2-tl) dVs/dt 103.6594 cfm Steam Release Rate dWsdtlvstp*60 vstp 0.016018 cfAbm Steam Tables @ I gm/cc (9.5) Flashing Fraction Calculations Per Regulatory Guide 1.183 Appendix E (Ref.8), upon periods of steam generator dryout, all of the primary-to-secondary leakage is assumed to flash to vapor and be released to the environment with no mitigation.

Since the steam generator tubes remain covered for the duration of the event, a portion of the primary-to-secondary leakage will flash to vapor, based on the thermodynamic conditions in the primary and secondary systems. Per RG 1.183 Appendix A, the flashing fraction, FF, should be determined using a constant enthalpy, h, process:

FF = (hn - he2) / bhg where hn is the enthalpy of the primary system liquid, hf2 is the enthalpy of the secondary system liquid, and hra is the heat of vaporization at secondary system conditions.

To determine the flashing fractions associated with a cooldown to shutdown cooling, it is necessary to know the temperature difference between the primary and secondary systems as a function of time. The following table lists the results of the EXCEL spreadsheet SRE.XLS(FlashingFraction). This spreadsheet calculates the temperature difference required to cool the primary system to 300NF over an 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months period.

CA06451 Rev. OOO Page 22 of 127 Temperature Difference between Primary and Secondary Based on Energy Balance Time Decay Heat Decay Heat RCPs Residual SG Heat Loss delta Temp Fdec Wdec Wrcp Wres WMot dT

% btu/hr btulhr btu/hr btulhr deg F 0 100 9397033560.00 43504786.53 51452125.76 9491990472.29 76.64 1 sec 7.769 730055537.28 43504786.53 51452125.76 825012449.57 6.66 25 sec 5.471 514111706.07 43504786.53 51452125.76 609068618.36 4.92 50 sec 4.852 455944068.33 43504786.53 51452125.76 550900980.62 4.45 100 sec 4.28 402193036.37 43504786.53 51452125.76 497149948.66 4.01 900 sec 2.541 238778622.76 43504786.53 51452125.76 333735535.05 2.69 1800 sec 2.0334 191079280.41 43504786.53 51452125.76 286036192.70 2.31 2700 sec 1.7792 167192021.10 43504786.53 51452125.76 262148933.39 2.12 1 hr 1.597 150070625.95 43504786.53 51452125.76 245027538.24 1.98 2 hr 1.2646 118834886.40 43504786.53 51452125.76 213791798.69 1.73 8 hr 0.8681 81575648.33 43504786.53 51452125.76 176532560.62 1.43 Fdec = Decay heat fraction from BTP ASB 9-2: Residual Decay Energy for LWRs for Long-Term Cooling Wdec Decay heat In btu/hr from BTP ASB 9-2: Residual Decay Energy for LWRs for Long-Term Cooling Wrcp = RCP power from Section 9.3 Wres Residual power from Section 9.3 Wtot = Wdec + Wrcp + Wres Wtot = 0.266

K

dT

A / t = 123849700

dT = Total SG Heat Loss In btulhr K = Alloy Inconel 690 thermal conductivity In btu-in/ft2-hr-F (93 @ 200F, 107 @ 400F. 122 @ 600F) (Attachment C) dT = Trcs - Tsg In degrees F A = heat transfer area In ft2 (2

92008 ft2 per SP-081 1 Ref.34) t = SG tube wall thickness In in (0.046 In max per SP-081 1 Ref.34)

Note that at HFP the RCS hot leg (601 0F - UFSAR Figure 4-9) is -76 0 F hotter than the SG (525.20 F - SP-08 II).

This temperature difference drops to less than 50F within 25 seconds post-trip. The magnitude of the temperature difference is verified by inspection of the RCS and SG cooldown temperatures from Unit 2 Cycle 15 displayed in Attachment B. Based on a conservative 60F temperature difference, the flashing fractions between HZP and SDC can be calculated. Note that the flash fraction remains below I% throughout the cooldown.

Flashing Fraction Based on 6 Degree F Temperature Difference Between RCS and SG during Cooldown RCS RCS SG SG I SG Flash Temperature Fluid Enthalpy Temperature Fluid Enthalpy Fluid-Gas Enthalpy Fraction 544 @ 2000 psia 540.1 538 534.2 660.6 0.0089 500 @ 1700 psia 487.6 l 494 l 480.8 l 722.1 0.0094 400 @ 1000 psia 376 l 394 l 368.6 l 831.6 0.0089 300 @ 270 psia 270.1 1 294 l 263.5 l 914.5 0.0072 The flash fraction for leakage from the RCS to the SG at HFP and from the RCS to the Refueling Water Tank (RWT) are also calculated. Note that flash fraction for leakage from the RCS to the SG at HFP is - 8.84%. Also note that the leakage from the RCS to the RWT is - 10%, which is consistent with the recommended value in RG 1.183 (Ref.8).

Flashing Fraction Based on HFP Conditions and RWT Leakage I I I I

CA06451 Rev. 000 Page 23 of 127 RCS RCS Flash Temperature Fluid Enthalpy Temperature Fluid Enthalpy Fluid-Gas Enthalpy Fraction I 574.6 @2250 psia 578.5 I SG 525.2 Sat SG 518.4 SG 679.55 0.0884 212 @DSaturation 180.2 RWT 100 RWT 68.0 RWT 1037.1 0.1082 Based on the above data, a 10% flash fraction will be assumed during the first 15 minutes after the accident, and a 1% flash fraction will be assumed for the remaining duration of the accident.

CA06451 Rev. 000 Page 24 of 127

10. CALCULATIONS The following computations were performed in this calculational package for the SRE 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months steam generator release:

Seized Rotor Event Files for 8 Hour Steam Generator Release Activity Source Failed Fuel Prim Secondary Radionuclide Component Iodine Noble Gas Alkali Metal Iodine Noble Gas Iodine Case Input Files sreffi.psf sreffn.psf sreffa.psf srepri.psf srepm.psf sresec.psf Dose Conversion Factor File f 4.inp fgrl 4.inp fgr63.inp fgrl4.inp fgrl4.inp fgrO5.inp Release Fraction/Timing File sreffi.rft sreffn.rft sreffa.rft seri.rfl srepm.rf sresec.rft Nuclear Inventory File gapl4.nif gapl4.nif crcb63.nif pril4.nif pri14.nif secO5.nif Case Output Files srgfai.oO sreffn.oO sreffa.oO srepri.oO srepm.oO sresec.oO The following computations were performed in this calculational package for the SRE 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months steam generator release:

Seized Rotor Event Files for 2 Hour Steam Generator Release l Activity Source Failed Fuel Primary Secondary Radionuclide Component Iodine Noble Gas Alkali Metal Iodine Noble Gas Iodine Case Input Files srefi2.psf sreffn2.psf sreffa2.psf srepri2.psf srepm2.psf sresec2.psf Dose Conversion Factor File fgrl4.inp fgrl4.inp fgr63.inp fgrl4.inp fgrl4.inp fgrO5.inp Release Fraction/Timing File sreffi.rft sreffn.rft sreffa.rft srepri.rft srepm.rft sresec.rft Nuclear Inventory File gapl4.nif gapl4.nif crcb63.nif pril4.nif pril4.nif secO5.nif Case Output Files sreM2.oO sreffn2.oO sreffa2.oO srepri2.oO srepm2.oO l sresec2.oO

CA06451 Rev.000 Page 25 of 127

11. DOCUMENTATION OF COMPUTER CODES This work employed the RADTRAD computer code, which was verified, benchmarked, and documented in Refs.13-17 and which models the transport of halogen and noble gas isotopes from a primary containment to a secondary containment and thence to the environment and control room. The installation of RADTRAD is detailed in Ref.16 and the validation in Ref.17.

The RADTRAD computer code can calculates TEDE and thyroid doses to personnel at the site boundary, low population zone, and control room per the alternate source term methodology 10 CFR 50.67 and Regulatory Guide 1.183 or can calculates whole body and thyroid doses to personnel at the site boundary, low population zone, and control room per the standard source term methodology of TID-14844 (Ref.18) resulting from any postulated accident which releases radioactivity within the containment, spent fuel pool, or within any primary system.

RADTRAD models the transport of radioactivity from up to 63 radioisotopes from the sprayed and unsprayed regions of a primary containment or a SFP area, through the secondary containment if any, and then to the environment and to the control room. The code includes the capability to model time-dependent activity release; containment spray, filtration, and leakage; control room filtration and inleakage; primary and secondary containment purge filters; control room intake filters; atmospheric dispersion; and natural decay. Doses are calculated for individuals residing at the site boundary or low population zone and in the control room.

Some inputs for the RADTRAD computer program were generated via an EXCEL spreadsheet.

CA06451 Rev. O00 Page 26 of 127

12. RESULTS Chapter 14.16 of the Updated Final Safety Analysis Report (UFSAR) presents the licensing basis evaluation of the Seized Rotor Event (SRE). A Seized Rotor Event is defined as a complete seizure of a single Reactor Coolant Pump (RCP) shaft. The seizure is postulated to occur due to a mechanical failure or a loss of component cooling to the pump shaft seals. The most limiting SRE is an instantaneous RCP shaft seizure at hot full power (HFP). The reactor coolant flow through the core would be asymmetrically reduced to three pump flow as the result of a shaft seizure on one pump. With the reduction of core flow due to the loss of an RCP, the core coolant temperatures will increase.

Assuming a positive moderator temperature coefficient (MTC), the core power will increase. The core average heat flux will decrease slightly due to the increasing core temperatures. The insertion of the CEAs due to a low RCS flow trip will terminate the power rise; however, a limited number of fuel pins will experience DNB for a short period of time and thus fail. The initial secondary activity together with initial primary activity and failed fuel activity released to the primary that then leaks into the secondary will escape out of the steam generators via the ADVs.

Previously, power reactor licensees have typically used TID-14844 (Ref.18) as the basis for DBA analysis source terms. TID-14844 is referenced in 10 CFR 100.11, the power reactor siting regulation, which contains offsite dose limits in terms of whole body and thyroid doses. In December 1999, the NRC issued a new regulation, 10 CFR 50.67, "Accident Source Term," which provided a mechanism for licensed power reactors to replace the traditional accident source term used in their DBA analyses with an alternate source term Regulatory guidance for the implementation of these ASTs is provided in Regulatory Guide 1.183 (Ref.08). Section 50.67 of 10 CFR requires a licensee seeking to use AST to apply for a license amendment and requires that the application contain an evaluation of the consequences of affected DBAs. As part of the implementation of the AST, the total effective dose equivalent (TEDE) acceptance criterion of 10 CFR 50.67 replaces the previous whole body and thyroid dose guidelines of 10 CFR 100.11 and 10 CFR 50, Appendix A, GDC-19.

The current work utilizes the alternate source term (AST) methodology of 10 CFR 50.67 and Regulatory Guide 1.183 to calculate offsite and control room doses for a SRE. The SRE was analyzed for both two and eight hour cooldown times to maximize site boundary and control room doses. A bounding control room inleakage value of 3500 cfm was assumed. Modification of the control room emergency ventilation system to a nominal 10000 cfm flow with a 90% filtration efficiency for elemental and organic iodine and a 99% filtration efficiency for particulate iodine was credited. Also credited was installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof. This modification limits activity ingress into the control room from either the West Road Inlet or the Turbine Building, thus limiting the atmospheric dispersion coefficient value.

The Technical Specification limit for RCS activity was reduced from 1.0 jtCi/gm to 0.5 ,tCi/gm.

The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the 8-hour design-basis SRE calculated in Attachments Q, R, S. T, U, and V are detailed in the following table.

I SRE 8-Hour Results I l EAB LPZ CR l Rem TEDE Rem TEDE Rem TEDE Failed Fuel lodines 2.0530E-02 6.1165E-03 7.2342E-01 Failed Fuel Noble Gas 1.2240E-02 3.0713E-03 2.5541 E-02 Failed Fuel Alkali Metals 3.3181 E-04 1.4705E.04 3.0747E-02 Primary Iodine 1.5301E-06 4.5997E-07 5.6682E-05 Primary Noble Gas 3.6795E-05 9.9443E-06 1.5932E-04 Secondary Iodine 3.6692E-04 9.8650E-05 8.5006E-03 Total 0.03351 0.00944 0.78842 Regulatory Limit 2.5 (RG 1.183) 1 2.5 (RG 1.183) 5 (IOCFR5O.67)

CA06451 Rev.000 Page 27 of 127 The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the 2-hour design-basis SRE calculated in Attachments W, X, Y. Z, AA, and AB are detailed in the following table.

SRE 2-Hour Results l EAB LPZ CR l Rem TEDE Rem TEDE Rem TEDE Failed Fuel lodines 2.5081E-02 5.9046E-03 2.0740E-01 Failed Fuel Noble Gas 1.2240E-02 2.8815E-03 1.2464E-02 Failed Fuel Alkali Metals 6.2717E-04 1.4765E-04 4.6745E-03 Primary Iodine 1.8747E-06 4.4134E-07 1.6152E-05 Primary Noble Gas 3.6795E-05 8.6621 E-06 5.2343E-05 Secondary Iodine 5.8049E-04 1.3666E-04 4.7855E-03 Total 0.03857 0.00908 0.22939 Regulatory Umit 2.5 (RG 1.183) 2.5 (RG 1.183) 5 (IOCFR50.67)

CA06451 Rev.OOO Page 28 of 127

13. CONCLUSIONS The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the design-basis SRE are detailed in the following table.

SRE Results EAB LPZ CR Rem Rem Rem 8 Hour Secondary Pathway 0.0336 0.0095 0.7885 2 Hour Secondary Pathway 0.0386 0.0091 0.2294 Regulatory Limits 2.5 (RG 1.183) 1 2.5 (RG 1.183) 1 5.0 (10CFR50.67)

All SRE offsite and control room doses are below the regulatory limits.

This work supports the following changes in plant operation:

This analysis supports a pin power peaking factor of 1.70.

A maximum time to shutdown cooling of 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months was assumed.

This work relies on the following modifications and new methodologies:

Modification of the control room emergency ventilation system to a nominal 10000 cfm flow with a 90%

filtration efficiency was credited.

Installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof was credited.

Alternate Source Term Methodology was employed.

The Technical Specification limit for RCS activity was reduced from 1.0 pCi/gm to 0.5 pCi/gm.

CA06451 Rev.000 Page 29 of 127

14. ATTACHMENTS ATTACHMENT A SEIZED ROTOR EVENT RELEASE ACTIVITIES Calculation of Seized Rotor Event Release Activities Halflife lambda Core Gas Gap Gas GaP

. Source Fractions Source sec 1/sec CIJMWT Cl/MWT A B C D E Kr-85 3.3830E+08 2.0489E-09 3.7180E+02 0.20 7.4360E+01 Kr-85m 1.6128E+04 4.2978E-05 7.9679E+03 0.10 7.9679E+02 Kr-87 4.5780E+03 1.5141 E-04 1.6208E+04 0.10 1.6208E+03 Kr-88 1.0224E+04 6.7796E-05 2.2658E+04 0.10 2.2658E+03 1-131 6.9466E+05 9.9783E-07 2.7562E+04 0.16 4.4099E+03 1-132 8.2800E+03 8.3713E-05 3.9464E+04 0.10 3.9464E+03 1-133 7.4880E+04 9.2568E-06 5.5715E+04 0.10 5.5715E+03 1-134 3.1560E+03 2.1963E-04 6.2858E+04 0.10 6.2858E+03 1-135 2.3796E+04 2.9129E-05 5.2964E+04 0.10 5.2964E+03 Xe-133 4.5317E+05 1.5296E-06 5.5707E+04 0.10 5.5707E+03 Xe-135 3.2724E+04 2.1182E-05 1.7708E+04 0.10 1.7708E+03 Xe-133m 1.8922E+05 3.6632E-06 1.7354E+03 0.10 1.7354E+02 Xe-135m 9.1800E+02 7.5506E-04 1.1635E+04 0.10 1.1635E+03 Xe138 8.4600E+02 8.1932E-04 4.9330E+04 0.10 4.9330E+03 Rb-86 1.6122E+06 4.2994E-07 5.9034E+01 0.24 1.4168E+01 Cs-134 6.5072E+07 1.0652E-08 7.1917E+03 0.24 1.7260E+03 Cs-1 36 1.1318E+06 6.1241 E-07 1.7111 E+03 0.24 4.1066E+02 Cs-137 9.4673E+08 7.3215E-10 4.7857E+03 0.24 1.1486E+03 I microCi/g 1 microCii/g 0.5 microCii/g 0.1 microCi/g 0.1 microCig Primary Primary Primary Secondary Secondary Source Source Source Source Source microCi/g Ci Ci microCVg Ci F G H I J Kr-85 3.8761E+01 7.9975E+03 7.9975E+03 Kr-85m 2.0344E+00 4.1975E+02 4.1975E+02 Kr-87 1.1 747E+00 2.4238E+02 2.4238E+02 Kr-88 3.6579E+00 7.5473E+02 7.5473E+02 1-131 7.7893E-01 1.6071 E+02 8.0357E+01 8.9260E-02 1.1172E+01 1-132 2.5868E-01 5.3372E+01 2.6686E+01 2.2758E-03 2.8485E-01 1-133 1.0972E+00 2.2638E+02 1.1319E+02 5.7417E-02 7.1866E+00 1-134 1.4798E-01 3.0532E+01 1.5266E+01 5.2168E-04 6.5297E-02 1-135 6.0207E-01 1.2422E+02 6.2112E+01 1.3584E-02 1.7003E+00 Xe-1 33 4.0021E+02 8.2574E+04 8.2574E+04 Xe-135 9.5607E+00 1.9726E+03 1.9726E+03

CA06451 Rev. 000 Page 30 of 127 Xe-133m 5.7016E+00 1.1764E+03 1.1764E+03 Xe-135m 1.2511 E+00 2.5814E+02 2.5814E+02 l Xe138 6.6019E-01 1.3622E+02 1.3622E+02 A Half-lives: Chart of the Nuclides Fifteenth Edition' B Decay constants: Ln(2YA(i)

C Core source CiIMWt: CA06358 D Gas Gap Fractions: CA06421 E Gas Gap Source In Ci/MWt E(i)=C(i)*D(i)

F Primary Source InmicroCi/gm: CA06422 G Primary Source In Ci for 1.0 microCigm total: CA06422 H Primary Source In Ci for 0.5 microCVgm total: CA06422 I Secondary Source in microCi!gm: CA06422 I___

J Secondary Source in CI for 0.1 microCilgm total: CA06422_______

CA06451 Rev.000 Page 31 of 127 ATTACHMENT B RCS AND SG TEMPERATURES DURING COOLDOWN FOR U2C 15 time/date T15 T01 P3991 P4008 PA911 PWR mncore TIC incore T/C SIG pres S/G pres S/G temp delta T MWth %

2/22/05 20:00 578.7441 566.4422 860.0844 860.9044 528 50.74 1566.43 50 2/22/05 20:15 566.002 554.975 866.2637 867.7706 529 37.00 1144.26 2/22/05 20:30 558.8608 549.1283 876.4542 878.4052 531 27.86 772.418 2/22/05 20:45 556.1724 547.0767 873.8704 875.7279 531 25.17 711.863 2/22/05 21:00 554.9191 546.7604 873.238 875.0824 531 23.92 612.762 2/22/05 21:15 553.6187 545.7773 875.0209 876.7194 531 22.62 583.02 2/22/05 21:30 528.0092 526.1494 826.0601 827.7929 524 4.01 0 RXtripped at 21:18 2/22/05 21:45 531.4954 529.6996 851.4368 852.9307 527 4.50 0 2/22/05 22:00 531.9566 529.9861 854.554 856.0984 528 3.96 0 2/22/05 22:15 532.7553 530.8712 861.4042 863.3385 529 3.76 0 2/22/05 22:30 537.0707 535.1683 892.9442 895.0641 533 4.07 0 2/22/05 22:45 537.0485 535.04 893.3041 894.1574 533 4.05 0 2/22/05 23:00 536.9429 535.3205 892.8889 894.4975 533 3.94 0 2/22/05 23:15 537.4091 534.8431 893.3578 894.4955 533 4.41 0 2/22/05 23:30 536.9704 535.2005 893.1202 894.6226 533 3.97 0 2/22/05 23:45 534.7727 533.3892 873.0486 874.682 530 4.77 0 started cooldown 2/23/05 0:00 507.568 506.1674 682.9695 684.3099 502 5.57 0 at 23:40 2/23/05 0:15 486.4295 485.2568 565.0845 567.0615 482 4.43 0 2/23/05 0:30 477.68 475.6797 516.7318 518.6068 473 4.68 0 2/23/05 0:45 455.5023 453.9149 411.658 413.5607 451 4.50 0 2/23/05 1:00 430.1253 428.2714 312.3168 314.3121 425 5.13 0 2/23/05 1:15 413.5529 412.3058 260.2605 262.4067 409 4.55 0 2/23/051:30 390.885 389.1119 198.0988 200.5414 387 3.88 0 2/23/05 1:45 369.2405 368.2268 150.1976 153.0631 366 3.24 0 2/23/05 2:00 352.8415 350.7658 118.4433 121.7126 349 3.84 0 22A, 22B RCPs 2/23/05 2:15 345.1859 343.6995 105.3893 106.6911 341 4.19 0 secured at 01:56 2/23/05 2:30 333.6378 331.6456 87.99626 88.99712 329 4.64 0 2/23/05 2:45 323.0352 321.4279 75.10741 76.11856 320 3.04 0 2/23/05 3:00 316.7439 315.2555 67.55364 68.04358 314 2.74 0 2/23/05 3:15 309.7081 307.7081 59.99987 60.46406 307 2.71 0 2/23/05 3:30 303.925 302.502 53.75203 54.16422 301 2.92 0 2/23/05 3:45 291.8372 290.0799 42.79893 42.7024 290 1.84 0 2123/05 4:00 283.292 281.8082 37.41241 37.11428 283 0.29 0 2/23/05 4:15 284.2902 283.0165 37.65192 37.22566 284 0.29 0 2/23/05 4:30 284.2399 283.4768 37.89143 37.33705 284 0.24 0 2/23/05 4:45 284.4097 282.8159 38.13094 37.44844 283 1.41 0 2/23/05 5:00 283.261 281.8333 38.00369 37.47907 283 0.26 0 2/23/05 5:15 282.609 281.2734 37.46102 36.94158 283 -0.39 0 2/23/05 5:30 282.2056 280.8308 36.91834 36.40408 282 0.21 0 2/23/05 5:45 281.752 280.463 36.37567 35.86658 282 -0.25 0 2/23/05 6:00 273.5653 272.2971 31.01966 30.17249 274 -0.43 0 2/23/05 6:15 260.2524 258.7529 23.95011 22.08722 262 -1.75 0

CA06451 Rev.000 Page 32 of 127 2/23/05 6:30 249.1637 247.2722 19.26105 17.22444 254 -4.84 0 _ l l 2/231056:45 243.2102 242.1935 16.21292 14.05667 248 -4.79 °0 2/23105 7:00 261.2776 252.1104 14.28907 12.09798 244 17.28 0 _ _ _

2/23105 7:15 251.0412 247.4352 13.05073 10.81788 241 10.04 0 Shutdown cooling 2/23/05 7:30 236.9769 l 234.4763 13.5385 11.23184 '242 -5.02 l 0 Initiated at 07:21 1 2/23/057:45 -241.9588 238.4225 13.12522 10.53991 241 0.96 0° l _

2/23/05 8:00 226.6613 223.1887 11.31852 8.82128 237 -10.34 0 2/23/058:15 212.6437 208.8708 8.247018 5.75316 A 229 -16.36 0 SGBlowdown secured

CA06451 Rev.000 Page 33 of 127 ATTACHMENT C INCONEL ALLOY 690 DATA

Special Metals Corporation - Products - INCONEL alloy 690 Page I of I Cc6Y~-/ eAv0o THE ALLDLY EXPjER E INCONEL alloy 690 INCONEL alloy 690 Is a high-chromium nickel alloy having excellent resistance to many corrosive aqueous media and temperature atmospheres. The alloy'shigh chromium content gives It excellent resistance to aqueous corrosion by on acids (especially nitric acid) and salts, and to sulfidation at high-temperatures. In addition to Its corrosion resistance, 690 has high strength, good metallurgical stability, and favorable fabrication characteristics.

UNS: N06690 W.Nr.: 2.4642 Technical Bulletin (P1.1, 165KB)

Available Product Forms: Pipe, tube, plate, round bar and forging stock Technical Papers Alloy Solutions to Metal Dusting Problems in the Petrochemical Industry (PDF, 1.6MB)

Performance of Commercial Alloys In Simulated Waste Incineration Environments (PDF, 1.2M The Role of Protective Scales In Enhancing Oxidation Resistance (PDF. 2.$4MB)

httD://www.snecialmetals.com/troducts/inconelallov690.htm 6/10/9.0n0s

-@ihMlALS -w-wW.specialmetals.com_

INCONEL' alloy 690 (UNS N06690/W. Nr. 2A642) is Table 1 - Umiting Chemical Composition, %, .

a high-chromium nickel alloy having excellent of INCONEL alloy 690' resistance to many corrosive aqueous media and high-

temperature atmaospleres. Tn addition to its corrosion Nickel.58.0mn.

resistance, alloy 690 has high strength, good Chromium .. . . . 27.0-31.0 metallurgical stability, and favorable fabrication Iron .. . . . 7.0-11.0 characteristics. Carbon ..... 0.05 max.

The chemical composition of INCONEL alloy 690 Silicon ..... 0.50 max.

is listed in Table 1. The substantial chromium content gives the alloy outstanding resistance to oxidizing Manganese .....

Sulfur .

0.50 max.

0.015 max.

A ,, .

chemicals and to high-temperature oxidizing gases. Copper .. 0.50 max.

The high level of nickel imparts resistance to stress-corrosion cracking in chloride-containing environments 'Amendments for nuclear applications: 28-1 Cr, 0.04 max. C, 0.10 as well as to sodium hydroxide solutions. ax. Co.

The properties of INCONEL alloy 690 are useful for various applications involving nitric or nitric/hydrofluoric acid solutions. Examples are tail-gas Physical Constants and Thermal reheaters used in nitric acid production and heating ,,o *tes coils and tanks for nitric/hydrofluoric solutions used in pickling of stainless steels and reprocessing of nuclear Table 2 gives melting range and some physical e , . . . constants at room temperature for INCONEL alloy 690.

The alloyas resistance to sulfur-contailig gases Table 3 contains values for thermal and electrical makes it an attractive material for such applications as properties over a range of temperatures Values for coal-gasification units, burners and ducts for processing specific heat were calculated; other values were sulfuric acid, furnaces for petrochemical processing, measured. Modulus of elasticity in tension, determined recuperators, incinerators, and glass' vitrification by a dynamic-method, is shown for temperatures to equipment for radioactive waste disposal. 16000 F (870 0 C) in Table 4. All measurements of In various types of high-temperature water, alloy physical properties were done on annealed specimens.

690 displays low corrosion rates . and excellent

---resistance-to-stress-corrosion-cracking:-Thus,-alloy-690 - _

is widely used for steam generator tubes, baffles, tubesheets, and hardware in nuclear power generation. Table 2 - Physical Constants Density, Ibl. n.. ....................... 0.296 Mg/ms....................... 8.19 Melting Range, *F........................ 2450-2510

.. . ....................... .1343-1377 Specific Heat, Btu/lb-QF ....................... 0.107 J/kg-C ....................... 450 Electrical Resistivity, ohm-circ m/ift ........................ 691 pn2-m-..... be... 1..14...

Permeability at 200 oersteds (15.9 kWm) ......................... 1.001 Young's Modulus, i0 3 ksi .......................... 30.6 GPa . 211 Polsson's Ratio .0.289 Publication Number SMC-079 Copyright C Special Metals Corporation, 2003 (Oct 03)

INCONEL, INCOLOY, and MONEL are trademarks of the Special Metals Corporation group of companies.

The data contained inthis publication is for informational purposes only and may be revised at any time without prior notice. The data is believed to be accurate and reliable. but Special Metals makes no representation or warranty of any kind (express or implied) and assumes no liability with respect to the accuracy or comspleteness of the information contained herein. Although the data is believed to be representative of the product, the actual characteristics or performance of the product may vary from what is shown in this publication. Nothing contained inibis publication should be construed as guaranteeing the product for a particular use or application.

r-4orY5,1 Age

-. - iAR04.5 ._ _-- _.

Table 4 - Modulus Data (Annealed)

Table 3 - Thermal and Electrical Properties

Extrapolated value.

i 6- .

4eetween 75'F (24C) and temperature shown.

bExtrapolated values.

Mechanical Properties INCONEL alloy 690 has high strength over a broad range of temperatures. Mechanical properties of the alloy vary with product form and temper. Alloy 690 is normally used in the annealed temper, and strength characteristics described below are representative of annealed material. The usual annealing temperature is approximately 19001F (1040'C). The effect of different annealing temperatures on the tensile properties of cold-worked material is shown under "Fabrication" in Figure 8.

Tensile Properties Fatigue Strength At room and elevated temperatures, INCONEL alloy 690 The results of low-cycle fatigue tests performed at room displays high yield and ultimate strengths along with good temperature are shown in Figure 2. The specimens were ductility. Table 5 lists results of room-temperature tensile tested under axial strain with fully reversed loading.

tests on annealed material. As indicated by the values, tensile properties may vary with product form and size. At high temperatures, alloy 690 retains a substantial level of tensile properties with temperatures of over 10000 F (540CC) required to produce significant declines in strength. Figure I shows the results of short-time tensile tests performed at temperatures to 1800 0 F (982CC). The curves represent average values for both cold-worked and hot-worked products in the annealed temper.

2

CA06451 Rev. 000 Page 37 of 127 ATTACHMENT D NUCLEAR INVENTORY FILE GAP14.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

0.l000E+01 Nuclides:

14 Nuclide 001:

Kr-85 1

0.3382974720E+09 0.8500E+02 7.4360E+01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

Kr-85m 1

0.1612800000E+05 0.8500E+02 7.9679E+02 Kr-85 0.2100E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 003:

Kr-87 1

0.4578000000E+04 0.8700E+02 1.6208E+03 Rb-87 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 004:

Kr-88 1

0.1022400000E+05 0.8800E+02 2.2658E+03 Rb-88 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 005:

I-131 2

0.6946560000E+06 0.1310E+03 4.4099E+03 Xe-131m 0.11OOE-01 none O.OOOOE+00

CA06451 Rev.000 Page 38 of 127 none O.OOOOE+00 Nuclide 006:

1-132 2

0.8280000000E+04 0.1320E+03 3.9464E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 007:

I-133 2

0.7488000000E+05 0.1330E+03 5.5715E+03 Xe-133m 0.2900E-01 Xe-133 0.9700E+00 none O.OOOOE+00 Nuclide 008:

I-134 2

0.3156000000E+04 0.1340E+03 6.2858E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 009:

1-135 2

0.2379600000E+05 0.1350E+03 5.2964E+03 Xe-135m 0.1500E+00 Xe-135 0.8500E+00 none O.OOOOE+00 Nuclide 010:

Xe-133 1

0.4531680000E+06 0.1330E+03 5.5707E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 011:

Xe-135 1

0.3272400000E+05 0.1350E+03 1.7708E+03 Cs-135 0.1000E+01 none 0.OOOOE+00

CA06451 Rev. 000 Page 39 of 127 none O.OOOOE+00 Nuclide 012:

Xe-133m 1

0.1892200000E+06 0.1330E+03 1.7354E+02 Xe-133 0.1000E+01 none O.OOOOE+OO none O.OOOOE+00 Nuclide 013:

Xe-135m 1

0.9180000000E+03 0.1350E+03 1.1635E+03 Xe-135 O.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 014:

Xe-138 1

0.8460000000E+03 0.1380E+03 4.9330E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

CA06451 Rev.000 Page 40 of 127 ATTACHMENT E NUCLEAR INVENTORY FILE PRII4.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

O.1000E+01 Nuclides:

14 Nuclide 001:

Kr-85 1

0.3382974720E+09 0.8500E+02 7.9975E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

Kr-85m 1

0.1612800000E+05 0.8500E+02 4.1975E+02 Kr-85 0.2100E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 003:

Kr-87 1

0.4578000000E+04 0.8700E+02 2.4238E+02 Rb-87 0.lOOOE+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 004:

Kr-88 1

0.1022400000E+05 0.8800E+02 7.5473E+02 Rb-88 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 005:

1-131 2

0.6946560000E+06 0.1310E+03 8.0357E+01 Xe-131m 0.11OOE-01 none O.OOOOE+00

CA06451 Rev.000 Page 41 of 127 none O.OOOOE+OO Nuclide 006:

I-132 2

0.8280000000E+04 0.1320E+03 2.6686E+01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 007:

1-133 2

0.7488000000E+05 0.1330E+03 1.1319E+02 Xe-133m 0.2900E-01 Xe-133 0.9700E+00 none O.OOOOE+00 Nuclide 008:

I-134 2

0.3156000000E+04 0.1340E+03 1.5266E+01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 009:

I-135 2

0.2379600000E+05 0.1350E+03 6.2112E+01 Xe-135m O.lSOOE+00 Xe-135 0.8500E+00 none O.OOOOE+00 Nuclide 010:

Xe-133 1

0.4531680000E+06 0.1330E+03 8.2574E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 011:

Xe-135 1

0.3272400000E+05 0.1350E+03 1.9726E+03 Cs-135 0.1000E+01 none O.OOOOE+00

CA06451 Rev.000 Page 42 of 127 none O.OOOOE+00 Nuclide 012:

Xe-133m 1

0.1892200000E+06 0.1330E+03 1.1764E+03 Xe-133 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 013:

Xe-135m 1

0.9180000000E+03 0.1350E+03 2.5814E+02 Xe-135 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 014:

Xe-138 1

0.8460000000E+03 0.1380E+03 1.3622E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

CA06451 Rev.OOO Page 43 of 127 ATTACHMENT F NUCLEAR INVENTORY FILE SEC05.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

0.1000E+01 Nuclides:

05 Nuclide 001:

I-131 2

0.6946560000E+06 0.1310E+03 1.1172E+01 Xe-131m 0.llOOE-01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

I-132 2

0.8280000000E+04 0.1320E+03 2.8485E-01 none O.OOOOE+00 none 0.OOOOE+00 none O.OOOOE+00 Nuclide 003:

I-133 2

0.7488000000E+05 0.1330E+03 7.1866E+00 Xe-133m 0.2900E-01 Xe-133 0.9700E+00 none O.OOOOE+00 Nuclide 004:

1-134 2

0.3156000000E+04 0.1340E+03 6.5297E-02 none O.OOOOE+00 none 0.OOOOE+00 none 0.OOOOE+00 Nuclide 005:

I-135 2

0.2379600000E+05 0.1350E+03 1.7003E+00 Xe-135m 0.lSO0E+00 Xe-135 0.8500E+00

1 CA0645 Rev.000 Page 44 of 127 none O.OOOOE+OO File End of Nuclear Inventory

CA06451 Rev.000 Page 45 of 127 ATTACHMENT G NUCLEAR INVENTORY FILE CRCB63.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

O.1000E+01 Nuclides:

63 Nuclide 001:

Co-58 7

0.6117120000E+07 0.5800E+02 8.0012E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

Co-60 7

0.1663401096E+09 0.6000E+02 9.8625E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 003:

Kr-85 1

0.3382974720E+09 0.8500E+02 3.7180E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 004:

Kr-85m 1

0.1612800000E+05 0.8500E+02 7.9679E+03 Kr-85 0.2100E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 005:

Kr-87 1

0.4578000000E+04 0.8700E+02 1.6208E+04 Rb-87 0.1000E+01 none O.OOOOE+00

CA06451 Rev.000 Page 46 of 127 none 0.OOOOE+00 Nuclide 006:

Kr-B8 1

0.1022400000E+05 0.8800E+02 2.2658E+04 Rb-88 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 007:

Rb-86 3

0.1612224000E+07 0.8600E+02 5.9034E+01 none 0.OOOOE+00 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 008:

Sr-89 5

0.4363200000E+07 0.8900E+02 3.3293E+04 none 0.OOOOE+00 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 009:

Sr-90 5

0.9189573120E+09 0.9000E+02 3.1769E+03 Y-90 0.1000E+01 none 0.OOOOE+00 none O.OOOOE+00 Nuclide 010:

Sr-91 5

0.3420000000E+05 0.9100E+02 3.8931E+04 Y-91m 0.5800E+00 Y-91 0.4200E+00 none O.OOOOE+00 Nuclide 011:

Sr-92 5

0.9756000000E+04 0.9200E+02 4.0190E+04 Y-92 0.1000E+01 none 0.OOOOE+00

CA06451 Rev.000 Page 47 of 127 none O.OOOOE+00 Nuclide 012:

Y-90 9

0.2304000000E+06 0.9000E+02 3.4567E+03 none O.OOOOE+OO none O.OOOOE+00 none O.OOOOE+00 Nuclide 013:

Y-91 9

0.505S264000E+07 0.9100E+02 4.2527E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 014:

Y-92 9

0.1274400000E+05 0.9200E+02 4.0519E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 015:

Y-93 9

0.3636000000E+05 0.9300E+02 2.9622E+04 Zr-93 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 016:

Zr-95 9

0.5527872000E+07 0.9500E+02 5.8246E+04 Nb-95m 0.7000E-02 Nb-95 0.9900E+00 none O.OOOOE+00 Nuclide 017:

Zr-97 9

0.6084000000E+05 0.9700E+02 4.9425E+04 Nb-97m 0.9500E+00 Nb-97 0.5300E-01

CA06451 Rev. 000 Page 48 of 127 none O.OOOOE+00 Nuclide 018:

Nb-95 9

0.3036960000E+07 0.9500E+02 6.0839E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 019:

Mo-99 7

0.2376000000E+06 0.9900E+02 5.0834E+04 Tc-99m 0.8800E+00 Tc-99 0.1200E+00 none O.OOOOE+00 Nuclide 020:

Tc-99m 7

0.2167200000E+05 0.9900E+02 4.5424E+04 Tc-99 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 021:

Ru-103 7

0.3393792000E+07 0.1030E+03 4.8774E+04 Rh-103m 0.1000E+01 none O.oOOOE+00 none O.OOOOE+00 Nuclide 022:

Ru-105 7

0.1598400000E+05 0.1050E+03 3.1455E+04 Rh-105 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 023:

Ru-106 7

0.3181248000E+08 0.1060E+03 1.9695E+04 Rh-106 O.1OOOE+01 none O.OOOOE+00

CA06451 Rev.000 Page 49 of 127 none O.OOOOE+00 Nuclide 024:

Rh-105 7

0.1272960000E+06 0.1050E+03 2.8507E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 025:

Sb-127 4

0.3326400000E+06 0.1270E+03 2.4299E+03 Te-127m 0.1800E+00 Te-127 0.8200E+00 none O.OOOOE+00 Nuclide 026:

Sb-129 4

0.1555200000E+05 0.1290E+03 8.7888E+03 Te-129m 0.2200E+00 Te-129 0.7700E+00 none O.OOOOE+00 Nuclide 027:

Te-127 4

0.3366000000E+05 0.1270E+03 2.4664E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 028:

Te-127m 4

0.9417600000E+07 0.1270E+03 4.6272E+02 Te-127 0.9800E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 029:

Te-129 4

0.4176000000E+04 0.1290E+03 8.4012E+03 I-129 0.1000E+01 none O.OOOOE+00

CA06451 Rev. 000 Page 50 of 127 none O.OOOOE+00 Nuclide 030:

Te-129n 4

0.2903040000E+07 0.1290E+03 1.8872E+03 Te-129 0.6500E+00 I-129 0.3500E+00 none O.OOOOE+00 Nuclide 031:

Te-131m 4

0.1080000000E+06 0.1310E+03 5.0686E+03 Te-131 0.2200E+00

}-131 0.7800E+00 none O.OOOOE+00 Nuclide 032:

Te-132 4

0.2815200000E+06 0.1320E+03 3.8391E+04 1-132 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 033:

1-131 2

0.6946560000E+06 0.1310E+03 2.7562E+04 Xe-131m 0.11OOE-01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 034:

I-132 2

0.8280000000E+04 0.1320E+03 3.9464E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 035:

I-133 2

0.7488000000E+05 0.1330E+03 5.5715E+04 Xe-133m 0.2900E-01 Xe-133 0.9700E+00

CA06451 Rev.000 Page 51 of 127 none O.OOOOE+00 Nuclide 036:

1-134 2

0.3156000000E+04 0.1340E+03 6.2858E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 037:

1-135 2

0.2379600000E+05 0.1350E+03 5.2964E+04 Xe-135m 0.1500E+00 Xe-135 0.8500E+00 none O.OOOOE+00 Nuclide 038:

Xe-133 1

0.4531680000E+06 0.1330E+03 5.5707E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 039:

Xe-135 1

0.3272400000E+05 0.1350E+03 1.7708E+04 Cs-135 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 040:

Cs-134 3

0.6507177120E+08 0.1340E+03 7.1917E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 041:

Cs-136 3

0.1131840000E+07 0.1360E+03 1.7111E+03 none O.OOOOE+00 none O.OOOOE+00

CA06451 Rev.OOO Page 52 of 127 none O.OOOOE+00 Nuclide 042:

Cs-137 3

0.9467280000E+09 0.1370E+03 4.7857E+03 Ba-137m 0.9500E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 043:

Ba-139 6

0.4962000000E+04 0.1390E+03 5.1001E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 044:

Ba-140 6

0.1100736000E+07 0.1400E+03 5.2928E+04 La-140 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 045:

La-140 9

0.1449792000E+06 0.1400E+03 5.4255E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 046:

La-141 9

0.1414800000E+05 0.1410E+03 4.6433E+04 Ce-141 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 047:

La-142 9

0.5550000000E+04 0.1420E+03 4.4898E+04 none O.OOOOE+00 none O.OOOOE+00

CA06451 Rev.000 Page 53 of 127 none O.OOOOE+00 Nuclide 048:

Ce-141 8

0.2808086400E+07 0.1410E+03 5.1883E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 049:

Ce-143 8

0.1188000000E+06 0.1430E+03 4.4327E+04 Pr-143 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 050:

Ce-144 8

0.2456352000E+08 0.1440E+03 4.2317E+04 Pr-144m 0.1800E-01 Pr-144 0.9800E+00 none O.OOOOE+00 Nuclide 051:

Pr-143 9

0.1171S84000E+07 0.1430E+03 4.6904E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 052:

Nd-147 9

0.9486720000E+06 0.1470E+03 1.9151E+04 Pm-147 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 053:

Np-239 8

0.2034720000E+06 0.2390E+03 5.5833E+05 Pu-239 0.1000E+01 none O.OOOOE+00

CA06451 Rev. 000 Page 54 of 127 none O.OOOOE+00 Nuclide 054:

Pu-238 8

0.2768863824E+10 0.2380E+03 1.7259E+02 U-234 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 055:

Pu-239 8

0.7594336440E+12 0.2390E+03 1.1469E+01 U-235 0.1000E+01 none 0.OOOOE+00 none O.OOOOE+00 Nuclide 056:

Pu-240 8

0.2062920312E+12 0.2400E+03 2.0026E+01 U-236 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 057:

Pu-241 8

0.4544294400E+09 0.2410E+03 4.9593E+03 U-237 0.2400E-04 Am-241 0.1000E+01 none O.OOOOE+00 Nuclide 058:

Am-241 9

0.1363919472E+ll 0.2410E+03 7.3183E+00 Np-237 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 059:

Cm-242 9

0.1406592000E+08 0.2420E+03 2.0078E+03 Pu-238 0.1000E+01 none O.OOOOE+00

CA06451 Rev.000 Page 55 of 127 none O.OOOOE+00 Nuclide 060:

Cm-244 9

0.571508136E+9 0.2440E+03 3.1650E+02 Pu-240 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 061:

Xe-133m 1

1.8922000000E+05 0.1330E+03 1.7354E+03 Xe-133 0.lOOOE+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 062:

Xe-135m 1

9.1800000000E+02 0.1350E+03 1.1635E+04 Xe-135 0.lOOOE+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 063:

Xe-138 1

8.4600000000E+02 0.1380E+03 4.9330E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

CA06451 Rev.000 Page 56 of 127 ATTACHMENT H RELEASE FRACTION AND TIMING FILE SREFFI.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

0.0500E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CA06451 Rev.OOO Page 57 of 127 ATTACHMENT I RELEASE FRACTION AND TIMING FILE SREFFN.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

0.0500E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CAO6451 Rev. OOO Page 58 of 127 ATTACHMENT J RELEASE FRACTION AND TIMING FILE SREPRI.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

l.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CA06451 Rev. 00 Page 59 of 127 ATTACHMENT K RELEASE FRACTION AND TIMING FILE SREPRN.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Noble Gases:

l.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Iodine:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cesium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Tellurium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Strontium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Barium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Ruthenium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cerium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Lanthanum:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Non-Radioactive Aerosols (kg):

O.OOOOE+OO O.OOOOE+00 O.OOOOE+OO O.OOOOE+OO End of Release File

CA06451 Rev.000 Page 60 of 127 ATTACHMENT L RELEASE FRACTION AND TIMING FILE SRESEC.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOO1E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

l.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CA06451 Rev. 000 Page 61 of 127 ATTACHMENT M RELEASE FRACTION AND TIMING FILE SREFFA.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 n Design Basis Accident (a lE 0.O).OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

0.0120E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

0.OOOOE+00 O.OOOOE+00 0.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CA06451 Rev.000 Page 62 of 127 A1TACHMENT N CONVERSION FACTORS FILE FGR14.INP FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 14 NUCLIDES DEFINED IN THIS FILE:

Kr-85 Kr-85m Kr-87 Kr-88 I-131 D I-132 D I-133 D I-134 1-135 D Including:Xe-135m Xe-133 Xe-135 Xe-133m Xe-135m Xe-138 CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC Kr-85 GONADS 1.170E-16 8.121E-14 1.704E-12 2.820E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00 BREAST 1.340E-16 7.891E-14 1.656E-12 2.740E-18-1.OOOE+00 0. OOOE+00 O.OOOE+00 LUNGS 1.140E-16 7.056E-14 1.481E-12 2.450E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00 RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00 BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-1.OOOE+00 O.OOOE+00 0. OOOE+00 THYROID 1.180E-16 7.459E-14 1.565E-12 2.590E-18-l.OOOE+O0 O.OOOE+O0 0. OOOE+00 REMAINDER 1.090E-16 6.941E-14 1.457E-12 2.410E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00 EFFECTIVE 1.190E-16 7.603E-14 1.596E-12 2.640E-18-l.OOOE+00 O.OOOE+00 0.OOOE+00 SKIN(FGR) 1.320E-14 2.304E-11 4 .835E-10 8.OOOE-16-l.OOOE+00 O.OOOE+00 O.OOOE+00 Kr-85m GONADS 7.310E-15 2.594E-12 3.653E-12 1.570E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-l.OOOE+00 O.OOOE+OO 0.OOOE+00 RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.OOOE+00 O.OOOE+0O 0. OOOE+00 REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1.OOOE+00 0. OOOE+O0 O.OOOE+O0 SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.OOOE+00 O.OOOE+00 0. OOOE+00 Kr-87

CA06451 Rev. OOO Page 63 of 127 GONADS 4.OOOE-14 4.962E-12 5.026E-12 7.610E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 4.500E-14 4.740E-12 4.802E-12 7.270E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 4.040E-14 4.603E-12 4.663E-12 7.060E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 4.OOOE-14 4.708E-12 4.769E-12 7.220E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 6.020E-14 6.514E-12 6.598E-12 9.990E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 4.130E-14 4.473E-12 4.531E-12 6.860E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 3.910E-14 4.590E-12 4.650E-12 7.040E-16-l.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7.320E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKINtFGR) 1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Kr-88 GONADS 9.900E-14 2.278E-11 2.655E-11 1.800E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.11OE-13 2.177E-11 2.537E-11 1.720E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS l.OlOE-13 2.139E-11 2.493E-11 1.690E-15-l.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.OOOE-13 2.190E-11 2.552E-11 1.730E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 1.390E-13 2.886E-11 3.363E-11 2.280E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.030E-13.2.012E-11 2.345E-11 1.590E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 9.790E-14 2.139E-11 2.493E-11 1.690E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.020E-13 2.202E-11 2.567E-11 1.740E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.350E-13 5.607E-11 6.534E-11 4.430E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11 BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.OOOE+00 7.880E-11 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.S70E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-1.OOOE+00 5.730E-11 8.720E-11 THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-11 BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+00 1.410E-11 2.520E-11 LUNGS 1.090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2.710E-10 2.640E-11 RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-11 BONE SUR 1.730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1.240E-11 2.190E-11 THYROID 1.120E-13 2.381E-11 2.616E-11 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-11 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-l.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-133 GONADS 2.870E-14 1.58SE-11 6.74SE-11 6.270E-16-l.OOOE+00 1.950E-11 3.630E-ll BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-l.OOOE+00 2.940E-11 4.680E-ll LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-l.OOOE+00 8.200E-10 4.530E-11 RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-l.OOOE+00 2.720E-11 4.300E-11 BONE SUR 4.870E-14 2.161E-11 9.202E-11 8.550E-16-l.OOOE+00 2.520E-11 4.070E-ll THYROID 2.930E-14 1.502E-11 6.393E-11 5.940E-16-l.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-l.OOOE+00 5.000E-11 1.550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 I.S80E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-l.OOOE+OO O.OOOE+OO O.OOOE+OO I-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-l.OOOE+00 4.250E-12 l.lOOE-ll BREAST 1.440E-13 1.145E-11 1.147E-11 2.520E-15-l.OOOE+00 6.170E-12 1.170E-ll LUNGS 1.270E-13 1.100E-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10 1.260E-11 RED MARR 1.250E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 6.080E-12 1.090E-ll

CA06451 Rev.000 Page 64 of 127 BONE SUR 1.960E-13 1.S68E-11 1.571E-11 3.450E-15-1.OOOE+00 5.310E-12 9.320E-12 THYROID 1.300E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 2.880E-10 6.210E-10 REMAINDER 1.220E-13 1.091E-11 1.093E-11 2.400E-15-1.OOOE+00 2.270E-11 1.340E-10 EFFECTIVE 1.300E-13 1.150E-11 1.152E-11 2.530E-15-1.OOOE+00 3.550E-11 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-11 4.485E-11 9.850E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO 1-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-1.OOOE+00 1.700E-11 3.610E-11 BREAST 9.143E-14 2.971E-11 5.240E-11 1.526E-15-1.OOOE+00 2.340E-11 3.850E-11 LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-1.OOOE+00 4.410E-10 3.750E-11 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.OOOE+00 2.240E-11 3.650E-11 BONE SUR 1.184E-13 3.983E-11 7.024E-11 2.046E-15-1.OOOE+00 2.010E-11 3.360E-11 THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-l.OOOE+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.OOOE+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOOE+00 3.320E-10 6.080E-10 SKIN(FGR) 1.156E-13 9.826E-11 1.733E-10 5.047E-15-l.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-133 GONADS 1.610E-1S 1.465E-12 2.052E-11 5.200E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.960E-15 1.505E-12 2.107E-11 5.340E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.320E-15 1.045E-12 1.464E-11 3.710E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.070E-15 8.791E-13 1.231E-11 3.120E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 5.130E-15 4.254E-12 5.958E-11 1.510E-16-l.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.510E-15 1.181E-12 1.653E-11 4.190E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.240E-15 1.042E-12 1.460E-11 3.700E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.560E-15 1.299E-12 1.819E-11 4.610E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 4.970E-15 1.953E-12 2.734E-11 6.930E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-135 GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.080E-14 4.829E-12 1.058E-11 2.240E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-133m GONADS 1.420E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.700E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.190E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.100E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 3.230E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.360E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.150E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.370E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-135m GONADS 2.OOOE-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 2.290E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.980E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.910E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 3.500E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 2.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.890E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 2.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev.000 Page 65 of 127 SKIN(FGR) 2.970E-14 O.OOOE+OO O.OOOE+00 O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-138 GONADS 5.590E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 6.320E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 5.660E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 5.600E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 8.460E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 5.490E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.070E-13 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev.000 Page 66 of 127 ATITACHMENT 0 CONVERSION FACTORS FILE FGRO5.INP FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and'less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 05 NUCLIDES DEFINED IN THIS FILE:

I-131 D I-132 D I-133 D I-134 D 1-135 D Including:Xe-135m CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE BHR SHINE 7DAY SHINE RATE ACUTE CHRONIC I-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11 BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.OOOE+00 7.880E-11 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.570E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-1.OOOE+00 5.730E-11 8.720E-11 THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 I-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-11 BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+00 1.410E-11 2.520E-11 LUNGS 1.090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2.710E-10 2.640E-11 RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-11 BONE SUR 1.730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1.240E-11 2.190E-11 THYROID 1.120E-13 2.381E-11 2.616E-11 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-11 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-1.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 I-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-1.OOOE+00 1.950E-11 3.630E-11 BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.OOOE+00 2.940E-11 4.680E-11 LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.OOOE+00 8.200E-10 4.530E-11 RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-1.OOOE+00 2.720E-11 4.300E-11 BONE SUR 4.870E-14 2.161E-11 9.202E-11 8.550E-16-1.OOOE+00 2.520E-11 4.070E-11 THYROID 2.930E-14 1.502E-11 6.393E-11 5.940E-16-1.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 S.610E-16-1.OOOE+00 5.000E-11 1.550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.42SE-11 5.970E-16-1.OOOE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00

CA06451 Rev. 000 Page 67 of 127 1-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 l.100E-11 BREAST 1.440E-13 1.145E-11 1.147E-11 2.520E-15-1.OOOE+00 6.170E-12 1.170E-11 LUNGS 1.270E-13 l.lOOE-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10 1.260E-l1 RED MARR 1.250E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 6.080E-12 1.090E-l1 BONE SUR 1.960E-13 1.568E-11 1.571E-11 3.450E-15-1.OOOE+00 5.310E-12 9.320E-12 THYROID 1.300E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 2.880E-10 6.210E-10 REMAINDER 1.220E-13 1.091E-11 1.093E-11 2.400E-15-l.OOOE+00 2.270E-11 1.340E-10 EFFECTIVE 1.300E-13 1.150E-11 1.152E-11 2.530E-15-l.OOOE+00 3.550E-11 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-11 4.485E-11 9.850E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-1.OOOE+00 1.700E-11 3.610E-11 BREAST 9.143E-14 2.971E-11 5.240E-11 1.S26E-15-l.OOOE+00 2.340E-11 3.850E-11 LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-1.OOOE+00 4.410E-10 3.750E-ll RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.OOOE+00 2.240E-11 3.650E-11 BONE SUR 1.184E-13 3.983E-11 7.024E-11 2.046E-1S-1.OOOE+00 2.010E-11 3.360E-11 THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-l.OOOE+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.OOOE+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOOE+00 3.320E-10 6.080E-10 SKIN(FGR) 1.156E-13 9.826E-11 1.733E-10 5.047E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev.o00 Page 68 of 127 ATTACHMENT P CONVERSION FACTORS FILE FGR63.1NP FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 63 NUCLIDES DEFINED IN THIS FILE:

Co-58 Y Co-60 Y Kr-85 Kr-85m Kr-87 Kr-88 Rb-86 D Sr-89 Y Sr-90 y Sr-91 Y Including:Y-91m Sr-92 Y Y-90 Y Y-91 Y Y-92 y Y-93 Y Zr-95 D Zr-97 Y Including:Nb-97m , Including:Nb-97 Nb-95 Y Mo-99 Y Tc-99m D Ru-103 Y Including:Rh-103m Ru-105 y Ru-106 Y Including:Rh-106 Rh-105 Y Sb-127 W Sb-129 W Te-127 W Te-127m W Te-129 W Te-129m W Including:Te-129 Te-131m W Including:Te-131 Te-132 w 1-131 D I-132 D I-133 D I-134 D I-135 D Including:Xe-135m

CA06451 Rev.000 Page 69 of 127 Xe-133 Xe-135 Cs-134 D Cs-136 D Cs-137 D Including:Ba-137m Ba-139 D Ba-140 D La-140 w La-141 D La-142 D Ce-141 Y Ce-143 Y Ce-144 Y Including:Pr-144m, Including:Pr-144 Pr-143 Y Nd-147 Y Np-239 w Pu-238 Y Pu-239 Y Pu-240 Y Pu-241 Y Am-241 w Cm-242 w Cm-244 w Xe-133m Xe-135m Xe-138 CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC Co-58 GONADS 4 .660E-14 2.867E-11 5.828E-10 9.970E-16-1.OOOE+OO 6.170E-10 1.040E-09 BREAST 5.300E-14 2.737E-11 5.565E-10 9.520E-16-1.OOOE+OO 9.370E-10 1.790E-10 LUNGS 4.640E-14 2.617E-11 5.319E-10 9.100E-16-1.OOOE+OO 1.600E-08 8.530E-11 RED MARR 4 .530E-14 2.671E-11 5.430E-10 9.290E-16-1.OOOE+OO 9.230E-10 2.600E-10 BONE SUR 7.410E-14 3.795E-11 7.716E-10 1.320E-15-1.OOOE+OO 6.930E-10 1.250E-10 THYROID 4.770E-14 2.720E-11 5.530E-10 9.460E-16-1.OOOE+OO 8.720E-10 6.310E-11 REMAINDER 4 .440E-14 2.585E-11 5.255E-10 8.990E-16-1.OOOE+OO 1.890E-09 1.580E-09 EFFECTIVE 4 .760E-14 2.732E-11 5.553E-10 9.500E-16-1.OOOE+OO 2.940E-09 8.090E-10 SKIN(FGR) 5.580E-14 3.278E-11 6.664E-10 1.140E-15-1.OOOE+OO O.OOOE+00 O.OOOE+00 Co-60 GONADS 1.230E-13 7.056E-11 1.480E-09 2.450E-15-1.OOOE+OO 4.760E-09 3.190E-09 BREAST 1.390E-13 6.739E-11 1.413E-09 2.340E-15-1.OOOE+OO 1.840E-08 1.100E-09 LUNGS 1.240E-13 6.537E-11 1.371E-09 2.270E-15-1.OOOE+OO 3.450E-07 8.770E-10 RED MARR 1.230E-13 6.710E-11 1.407E-09 2.330E-15-1.OOOE+OO 1.720E-08 1.320E-09 BONE SUE 1.78OE-13 8.956E-11 1.879E-09 3.110E-15-1.OOOE+OO 1.350E-08 9.390E-10 THYROID 1.270E-13 6.480E-11 1.359E-09 2.250E-15-1.OOOE+0O 1.620E-08 7.880E-10 REMAINDER 1.200E-13 6.508E-11 1.365E-09 2.260E-15-1.OOOE+OO 3.600E-08 4.970E-09 EFFECTIVE 1.260E-13 6.768E-11 1.419E-09 2.350E-15-1.OOOE+OO 5.910E-08 2.770E-09 SKIN(FGR) 1.450E-13 7.948E-11 1.667E-09 2.760E-15-1.OOOE+OO O.OOOE+00 O.OOOE+00 Kr-85 GONADS 1.170E-16 8.121E-14 1.704E-12 2.820E-18-1.OOOE+OO O.OOOE+00 O.OOOE+00 BREAST 1.340E-16 7.891E-14 1.656E-12 2.740E-18-1.OOOE+OO O.OOOE+00 0.OOOE+00 LUNGS 1.140E-16 7.056E-14 1.481E-12 2.450E-18-1.OOOE+OO O.OOOE+00 O.OOOE+00 RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-1.OOOE+OO 0. OOOE+00 O.OOOE+00 BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-1.OOOE+OO O.OOOE+00 O.OOOE+00

CA06451 Rev.G000 Page 70 of 127 THYROID 1.180E-16 7.459E-14 1.565E-12 2.590E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.090E-16 6.941E-14 1.457E-12 2.410E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.190E-16 7.603E-14 1.596E-12 2.640E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.320E-14 2.304E-11 4.835E-10 8.000E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Kr-85m GONADS 7.310E-15 2.594E-12 3.653E-12 1.570E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Kr-87 GONADS 4.OOOE-14 4.962E-12 5.026E-12 7.610E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 4.500E-14 4.740E-12 4.802E-12 7.270E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 4.040E-14 4.603E-12 4.663E-12 7.060E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 4.000E-14 4.708E-12 4.769E-12 7.220E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 6.020E-14 6.514E-12 6.598E-12 9.990E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 4.130E-14 4.473E-12 4.531E-12 6.860E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 3.910E-14 4.590E-12 4.650E-12 7.040E-16-l.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7.320E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Kr-88 GONADS 9.900E-14 2.278E-11 2.65SE-11 1.800E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.11OE-13 2.177E-11 2.537E-11 1.720E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.OlOE-13 2.139E-11 2.493E-11 1.690E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.OOOE-13 2.190E-11 2.552E-11 1.730E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 1.390E-13 2.886E-11 3.363E-11 2.280E-15-l.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.030E-13 2.012E-11 2.345E-11 1.590E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 9.790E-14 2.139E-11 2.493E-11 1.690E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.020E-13 2.202E-11 2.567E-11 1.740E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.350E-13 5.607E-11 6.534E-11 4.430E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Rb-86 GONADS 4.710E-15 2.788E-12 5.187E-11 9.740E-17-1.OOOE+00 1.340E-09 2.150E-09 BREAST 5.340E-15 2.662E-12 4.953E-11 9.300E-17-1.OOOE+00 1.330E-09 2.140E-09 LUNGS 4.710E-15 2.553E-12 4.750E-11 8.920E-17-1.OOOE+00 3.300E-09 2.140E-09 RED MARR 4.640E-15 2.619E-12 4.873E-11 9.150E-17-1.OOOE+00 2.320E-09 3.720E-09 BONE SUR 7.050E-15 3.635E-12 6.764E-11 1.270E-16-1.OOOE+00 4.270E-09 6.860E-09 THYROID 4.840E-15 2.599E-12 4.836E-11 9.080E-17-1.OOOE+00 1.330E-09 2.140E-09 REMAINDER 4.520E-15 2.542E-12 4.729E-11 8.880E-17-1.OOOE+00 1.380E-09 2.330E-09 EFFECTIVE 4.810E-15 2.665E-12 4.958E-11 9.310E-17-1.OOOE+00 1.790E-09 2.530E-09 SKIN(FGR) 4.850E-14 2.210E-10 4.111E-09 7.720E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Sr-89 GONADS 7.730E-17 7.155E-14 1.436E-12 2.490E-18-1.OOOE+00 7.950E-12 8.050E-12 BREAST 9.080E-17 7.212E-14 1.447E-12 2.510E-18-1.OOOE+00 7.960E-12 7.980E-12 LUNGS 7.080E-17 5.689E-14 1.142E-12 1.980E-18-1.OOOE+00 8.350E-08 7.970E-12 RED MARR 6.390E-17 5.345E-14 1.073E-12 1.860E-18-1.OOOE+00 1.070E-10 1.080E-10 BONE SUR 1.940E-16 1.560E-13 3.131E-12 5.430E-18-1.OOOE+00 1.590E-10 1.610E-10 THYROID 7.600E-17 6.063E-14 1.217E-12 2.110E-18-1.OOOE+00 7.960E-12 7.970E-12 REMAINDER 6.710E-17 5.603E-14 1.124E-12 1.950E-18-1.OOOE+00 3.970E-09 8.250E-09 EFFECTIVE 7.730E-17 6.523E-14 1.309E-12 2.270E-18-1.OOOE+00 1.120E-08 2.500E-09 SKIN(FGR) 3.690E-14 1.914E-10 3.841E-09 6.660E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev. 000 Page 71 of 127 Sr-90 GONADS 7.780E-18 9.590E-15 2.014E-13 3.330E-19-1.OOOE+00 2.690E-10 5.040E-11 BREAST 9.490E-18 1.008E-14 2.116E-13 3.500E-19-1.OOOE+00 2.690E-10 5.040E-11 LUNGS 6.440E-18 6.307E-15 1.324E-13 2.190E-19-1.OOOE+00 2.860E-06 5.040E-11 RED MARR 5.440E-18 5.558E-15 1.167E-13 1.930E-19-1.OOOE+00 3.280E-08 6.450E-09 BONE SUR 2.280E-17 2.393E-14 5.025E-13 8.310E-19-1.OOOE+00 7.090E-08 1.390E-08 THYROID 7.330E-18 7.171E-15 1.506E-13 2.490E-19-1.OOOE+00 2.690E-10 5.040E-11 REMAINDER 6.110E-18 6.422E-15 1.348E-13 2.230E-19-1.OOOE+00 5.730E-09 6.700E-09 EFFECTIVE 7.530E-18 8.179E-15 1.717E-13 2.840E-19-1.OOOE+00 3.510E-07 3.230E-09 SKIN(FGR) 9.200E-15 4.032E-12 8.465E-11 1.400E-16-1.OOOE+00 0.OOOE+O0 O.OOOE+00 Sr-91 GONADS 4.819E-14 2.155E-11 5.062E-11 1.026E-15-1.OOOE+00 5.669E-11 2.520E-10 BREAST 5.477E-14 2.059E-11 4.838E-11 9.806E-16-1.OOOE+00 1.77SE-11 3.676E-11 LUNGS 4.803E-14 1.970E-11 4.626E-11 9.376E-16-1.OOOE+00 2.170E-09 1.055E-11 RED MARR 4.691E-14 2.011E-11 4.722E-11 9.570E-16-1.OOOE+00 2.275E-11 5.659E-11 BONE SUR 7.674E-14 2.852E-11 6.709E-11 1.360E-15-1.OOOE+00 1.306E-11 2.070E-11 THYROID 4.938E-14 2.035E-11 4.782E-11 9.693E-16-1.OOOE+00 9.930E-12 1.968E-12 REMAINDER 4.610E-14 1.948E-11 4.573E-11 9.268E-16-1.OOOE+00 5.802E-10 2.557E-09 EFFECTIVE 4.924E-14 2.057E-11 4.832E-11 9.793E-16-1.OOOE+00 4.547E-10 8.455E-10 SKIN(FGR) 9.938E-14 1.748E-10 3.987E-10 8.080E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Sr-92 GONADS 6.610E-14 1.593E-11 1.830E-11 1.300E-15-1.OOOE+00 1.020E-11 8.180E-11 BREAST 7.480E-14 1.520E-11 1.74SE-11 1.240E-15-1.OOOE+00 6.490E-12 1.700E-11 LUNGS 6.670E-14 1.483E-11 1.703E-11 1.210E-15-1.OOOE+00 1.050E-09 7.220E-12 RED MARR 6.620E-14 1.520E-11 1.745E-11 1.240E-15-1.OOOE+00 6.980E-12 2.290E-11 BONE SUR 9.490E-14 2.010E-11 2.308E-11 1.640E-15-1.OOOE+00 4.360E-12 8.490E-12 THYROID 6.820E-14 1.446E-11 1.661E-11 1.180E-15-1.OOOE+00 3.920E-12 1.300E-12 REMAINDER 6.4SOE-14 1.471E-11 1.689E-11 1.200E-15-1.OOOE+00 2.900E-10 1.720E-09 EFFECTIVE 6.790E-14 1.532E-11 1.759E-11 1.250E-15-1.OOOE+00 2.180E-10 5.430E-10 SKIN(FGR) 8.56OE-14 2.280E-11 2.618E-11 1.860E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Y-90 GONADS 1.890E-16 1.586E-13 1.601E-12 5.750E-18-1.OOOE+00 5.170E-13 1.430E-14 BREAST 2.200E-16 1.578E-13 1.593E-12 5.720E-18-1.OOOE+00 5.170E-13 1.270E-14 LUNGS 1.770E-16 1.313E-13 1.326E-12 4.760E-18-l.OOOE+00 9.310E-09 1.260E-14 RED MARR 1.620E-16 1.261E-13 1.273E-12 4.570E-18-1.OOOE+00 1.520E-11 3.700E-13 BONE SUR 4.440E-16 3.228E-13 3.259E-12 1.170E-17-1.OOOE+00 1.510E-11 3.670E-13 THYROID 1.870E-16 1.385E-13 1.398E-12 5.020E-18-1.OOOE+00 5.170E-13 1.260E-14 REMAINDER 1.680E-16 1.291E-13 1.303E-12 4.680E-18-l.OOOE+00 3.870E-09 9.680E-09 EFFECTIVE 1.900E-16 1.468E-13 1.482E-12 5.320E-18-1.OOOE+00 2.280E-09 2.910E-09 SKIN(FGR) 6.240E-14 2.897E-10 2.924E-09 1.050E-14-1.OOOE+00 O.OOOE+00 O.OOOE+0O Y-91 GONADS 2.560E-16 1.756E-13 3.546E-12 6.110E-18-l.OOOE+00 8.200E-12 3.540E-12 BREAST 2.930E-16 1.713E-13 3.459E-12 5.960E-18-1.OOOE+00 8.920E-12 5.540E-13 LUNGS 2.500E-16 1.526E-13 3.082E-12 5.310E-18-1.OOOE+00 9.870E-08 2.020E-13 RED MARR 2.410E-16 1.521E-13 3.070E-12 5.290E-18-1.OOOE+00 3.190E-10 6.590E-12 BONE SUR 4.560E-16 2.903E-13 5.862E-12 l.OlOE-17-l.OOOE+00 3.180E-10 6.130E-12 THYROID 2.600E-16 1.564E-13 3.157E-12 5.440E-18-1.OOOE+00 8.500E-12 1.290E-13 REMAINDER 2.390E-16 1.509E-13 3.047E-12 5.250E-18-1.OOOE+00 4.200E-09 8.570E-09 EFFECTIVE 2.600E-16 1.650E-13 3.332E-12 5.740E-18-1.OOOE+00 1.320E-08 2.570E-09 SKIN(FGR) 3.850E-14 1.989E-10 4.01GE-09 6.920E-15-1.OOOE+00 O.OOOE+O0 O.OOOE+00 Y-92 GONADS 1.270E-14 3.855E-12 4.872E-12 2.650E-16-1.OOOE+00 2.610E-12 1.960E-11 BREAST 1.440E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+00 1.500E-12 3.550E-12 LUNGS 1.270E-14 3.535E-12 4.468E-12 2.430E-16-1.OOOE+00 1.240E-09 1.390E-12

CA06451 Rev.000 Page 72 of 127 RED MARR 1.250E-14 3.608E-12 4.560E-12 2.480E-16-1.OOOE+00 2.070E-12 4.910E-12 BONE SUR 1.950E-14 5.091E-12 6.435E-12 3.500E-16-1.OOOE+00 1.510E-12 1.750E-12 THYROID 1.300E-14 3.579E-12 4.523E-12 2.460E-16-1.OOOE+00 1.050E-12 1.770E-13 REMAINDER 1.220E-14 3.506E-12 4.431E-12 2.410E-16-1.OOOE+00 2.030E-10 1.700E-09 EFFECTIVE 1.300E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+00 2.110E-10 5.150E-10 SKIN(FGR) 1.140E-13 2.022E-10 2.556E-10 1.390E-14-1.OOOE+OO O.OOOE+OO O.OOOE+O0 Y-93 GONADS 4.670E-15 2.108E-12 4.989E-12 9.510E-17-1.OOOE+00 5.310E-12 2.200E-11 BREAST 5.300E-15 2.026E-12 4.794E-12 9.140E-17-1.OOOE+00 1.740E-12 3.130E-12 LUNGS 4.680E-15 1.937E-12 4.58SE-12 8.740E-17-1.OOOE+00 2.520E-09 8.670E-13 RED MARR 4.580E-15 1.972E-12 4.669E-12 8.900E-17-1.OOOE+00 4.040E-12 4.930E-12 BONE SUR 7.580E-15 2.948E-12 6.977E-12 1.330E-16-1.OOOE+00 3.140E-12 1.730E-12 THYROID 4.790E-15 1.908E-12 4.516E-12 8.610E-17-1.OOOE+00 9.260E-13 1.260E-13 REMAINDER 4.510E-15 1.919E-12 4.543E-12 8.660E-17-1.OOOE+00 9.250E-10 4.090E-09 EFFECTIVE 4.800E-15 2.021E-12 4.784E-12 9.120E-17-1.OOOE+00 5.820E-10 1.230E-09 SKIN(FGR) 8.500E-14 2.726E-10 6.452E-10 1.230E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Zr-95 GONADS 3.530E-14 2.182E-11 4.421E-1O 7.590E-16-1.OOOE+00 1.880E-09 8.160E-1O BREAST 4.010E-14 2.084E-11 4.223E-10 7.250E-16-1.OOOE+OO 1.910E-09 1.050E-10 LUNGS 3.510E-14 1.989E-11 4.030E-10 6.920E-16-1.OOOE+00 2.170E-09 2.340E-11 RED MARR 3.430E-14 2.030E-11 4.112E-10 7.060E-16-1.OOOE+00 1.300E-08 2.140E-10 BONE SUR 5.620E-14 2.875E-11 5.824E-10 l.OOOE-15-1.OOOE+00 1.030E-07 4.860E-10 THYROID 3.610E-14 2.076E-11 4.205E-10 7.220E-16-1.OOOE+00 1.440E-09 8.270E-12 REMAINDER 3.360E-14 1.963E-11 3.978E-10 6.830E-16-1.OOOE+00 2.280E-09 2.530E-09 EFFECTIVE 3.600E-14 2.078E-11 4.211E-10 7.230E-16-1.OOOE+00 6.390E-09 1.020E-09 SKIN(FGR) 4.500E-14 2.561E-11 5.190E-10 8.910E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Zr-97 GONADS 4.331E-14 2.179E-11 7.799E-11 9.253E-16-1.OOOE+00 1.840E-10 6.228E-10 BREAST 4.928E-14 2.083E-11 7.455E-11 8.846E-16-1.OOOE+00 4.706E-11 8.137E-1l LUNGS 4.322E-14 1.992E-11 7.127E-11 8.456E-16-1.OOOE+00 4.108E-09 1.770E-11 RED MARR 4.224E-14 2.034E-11 7.279E-11 8.634E-16-1.OOOE+00 6.376E-11 1.302E-10 BONE SUR 6.897E-14 2.881E-11 1.031E-10 1.224E-15-1.OOOE+00 3.504E-11 4.558E-11 THYROID 4.443E-14 2.061E-11 7.377E-11 8.755E-16-1.OOOE+00 2.315E-11 2.671E-12 REMAINDER 4.139E-14 1.966E-11 7.03SE-11 8.345E-16-1.OOOE+00 2.041E-09 6.990E-09 EFFECTIVE 4.432E-14 2.078E-11 7.438E-11 8.824E-16-1.OOOE+00 1.171E-09 2.283E-09 SKIN(FGR) 9.835E-14 2.281E-10 8.148E-1O 9.587E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Nb-95 GONADS 3.660E-14 2.253E-11 4.435E-10 7.850E-16-1.OOOE+00 4.320E-10 8.050E-10 BREAST 4.160E-14 2.1SOE-11 4.231E-10 7.490E-16-1.OOOE+00 4.070E-10 1.070E-10 LUNGS 3.650E-14 2.OS5E-11 4.045E-10 7.160E-16-1.OOOE+00 8.320E-09 2.740E-11 RED MARR 3.560E-14 2.101E-11 4.135E-10 7.320E-16-1.OOOE+00 4.420E-10 1.990E-10 BONE SUR 5.790E-14 2.9S7E-11 5.819E-10 1.030E-15-1.OOOE+00 5.130E-10 2.940E-10 THYROID 3.750E-14 2.144E-11 4.220E-10 7.470E-16-1.OOOE+00 3.580E-10 1.180E-11 REMAINDER 3.490E-14 2.032E-11 4.OOOE-10 7.080E-16-1.OOOE+00 1.070E-09 1.470E-09 EFFECTIVE 3.740E-14 2.147E-11 4.226E-10 7.480E-16-1.OOOE+00 1.570E-09 6.950E-10 SKIN(FGR) 4.300E-14 2.598E-11 5.112E-10 9.050E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Mo-99 GONADS 7.130E-15 4.282E-12 4.403E-11 1.550E-16-1.OOOE+00 9.510E-11 2.180E-10 BREAST 8.130E-15 4.116E-12 4.233E-11 1.490E-16-1.OOOE+00 2.750E-11 3.430E-11 LUNGS 7.060E-15 3.867E-12 3.977E-11 1.400E-16-1.OOOE+00 4.290E-09 1.510E-11 RED MARR 6.820E-15 3.923E-12 4.034E-11 1.420E-16-1.OOOE+00 5.240E-11 8.320E-11 BONE SUR 1.240E-14 6.10SE-12 6.278E-11 2.210E-16-1.OOOE+00 4.130E-11 6.320E-l1 THYROID 7.270E-15 4.033E-12 4.147E-11 1.460E-16-1.OOOE+00 1.520E-11 1.030E-11 REMAINDER 6.740E-15 3.812E-12 3.920E-11 1.380E-16-1.OOOE+00 1.740E-09 4.280E-09

CA06451 Rev.000 Page 73 of 127 EFFECTIVE 7.280E-15 4.061E-12 4.176E-11 1.470E-16-1.OOOE+00 1.070E-09 1.360E-09 SKIN(FGR) 3.140E-14 1.039E-10 1.068E-09 3.760E-15-1.OOOE+00 O.000E+00 0.000E+00 Tc-99m GONADS 5.750E-15 2.334E-12 3.877E-12 1.240E-16-l.OOOE+OO 2.770E-12 9.750E-12 BREAST 6.650E-15 2.258E-12 3.752E-12 1.200E-16-1.OOOE+OO 2. 1S0E-12 3.570E-12 LUNGS 5.490E-15 2.127E-12 3.533E-12 1.130E-16-1.OOOE+oo 2.280E-l1 3.140E-12 RED MARR 4.910E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+o0 3.360E-12 6.290E-12 BONE SUR 1.630E-14 5.383E-12 8.942E-12 2.860E-16-1.OOOE+OO 2.620E-12 4.060E-12 THYROID 5.750E-15 2.14SE-12 3.564E-12 1.140E-16-l.OOOE+OO 5.010E-ll 8.460E-l1 REMAINDER 5.150E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+OO 1.020E-1l 3.340E-ll EFFECTIVE 5.890E-15 2.277E-12 3.783E-12 1.210E-16-1.OOOE+OO 8.800E-12 1.680E-li SKIN(FGR) 7.14OE-15 2.710E-12 4.502E-12 1.440E-16-l.OOOE+OO O.OOOE+OO 0. OOOE+OO Ru-103 GONADS 2.191E-14 1.404E-11 2.783E-10 4.892E-16-l.OOOE+OO 3.070E-10 5.720E-10 BREAST 2.512E-14 1.350E-11 2.677E-10 4.705E-16-l.OOOE+OO 3.110E-10 1.200E-10 LUNGS 2.180E-14 1.273E-11 2.522E-1O 4.432E-16-1.OOOE+OO 1.561E-08 7.310E-ll RED MARR 2.100E-14 1.287E-11 2.551E-10 4.483E-16-1.OOOE+OO 3.190E-10 1.660E-10 BONE SUR 3.892E-14 1.958E-11 3.882E-10 6.823E-16-1.OOOE+OO 2.370E-10 9.631E-1l THYROID 2.241E-14 1.331E-11 2.639E-10 4.638E-16-1.OOOE+OO 2.570E-10 6.250E-il REMAINDER 2.080E-14 1.248E-11 2.472E-10 4.346E-16-l.OOOE+OO 1.250E-09 2.110E-09 EFFECTIVE 2.251E-14 1.332E-11 2.641E-10 4.642E-16-l.OOOE+OO 2.421E-09 8.271E-10 SKIN(FGR) 2.774E-14 1.785E-l1 3.543E-10 6.229E-16-l.OOOE+OO C. OOOE+OO O.OOOE+OO Ru-105 GONADS 3.720E-14 1.327E-11 1.861E-11 8.070E-16-l.OOOE+oo 1.590E-11 9.670E-l1 BREAST 4 .240E-14 1.271E-11 1.783E-1l 7.730E-16-1.OOOE+oo 6.610E-12 1.590E-1l LUNGS 3.700E-14 1.210E-11 1.697E-ll 7.360E-i6-l.OOOE+OO 5.730E-10 6.210E-12 RED MARR 3.590E-14 1.230E-il 1.725E-l1 7.480E-16-1.OOOE+OO 7.700E-12 2.350E-li BONE SUR 6.280E-14 1.809E-l1 2.537E-ll 1.lOOE-15-l.OOOE+oo 4.620E-12 8.890E-12 THYROID 3.800E-14 1.260E-11 1.766E-11 7.660E-16-1.OOOE+OO 4.150E-12 1.820E-12 REMAINDER 3.540E-14 1.189E-11 1.667E-11 7.230E-16-1.OOOE+CO 1.610E-10 8.540E-10 EFFECTIVE 3.810E-14 1.265E-11 1.773E-11 7.690E-16-1.OOOE+OO 1.230E-10 2.870E-10 SKIN(FGR) 6.730E-14 7.368E-11 1.033E-10 4.480E-15-l.OOOE+OO C. OOOE+OO O.OOOE+OO Ru-106 GONADS 1.010E-14 6.411E-12 1.34OE-10 2.230E-16-i.OOOE+oo 1.300E-09 1.640E-09 BREAST 1.160E-14 6.152E-12 1.286E-10 2.140E-i6-i.OOOE+oo 1.780E-09 1.440E-09 LUNGS 1.010E-14 5.836E-12 1.220E-10 2.030E-16-1.OOOE+OO 1.040E-06 1.420E-09 RED MARR 9.750E-15 5.893E-12 1.232E-10 2.050E-16-l.OOOE+OO 1.760E-09 1.460E-09 BONE SUR 1.720E-14 8.883E-12 1.856E-1O 3.090E-16-l.OOOE+OO 1.610E-09 1.430E-09 THYROID 1.030E-14 6.066E-12 1.268E-10 2.110E-16-l.OOOE+OO 1.720E-09 1.410E-09 REMAINDER 9.630E-15 5.721E-12 1.196E-10 1.990E-16-l.OOOE+oO 1.200E-08 2.110E-08 EFFECTIVE 1.040E-14 6.095E-12 1.274E-10 2.120E-16-i.OOOE+OO 1.290E-07 7.400E-09 SKIN(FGR) 1.090E-13 4.082E-10 8.531E-09 1.420E-14-l.OOOE+0O O.OOOE+OO C. OOOE+OO Rh-105 GONADS 3.64OE-15 2.127E-12 1.411E-11 7.980E-17-1.OOOE+00 2.110E-ll 5.800E-ll BREAST 4.160E-15 2.063E-12 1.369E-1l 7.740E-17-l.OOOE+OO 5.610E-12 8.970E-12 LUNGS 3.570E-15 1.935E-12 1.284E-l1 7.260E-17-1.OOOE+oo 9.580E-10 3.860E-12 RED MARR 3.380E-15 1.946E-12 1.291E-1l 7.300E-17-l.OOOE+OO 7.770E-12 1.470E-1l BONE SUR 7.530E-15 3.332E-12 2.210E-11 1.250E-16-1.OOOE+oo 4.460E-12 6.750E-12 THYROID 3.680E-15 1.983E-12 1.316E-11 7.440E-17-l.OOOE+OO 2.880E-12 2.910E-12 REMAINDER 3.390E-15 1.885E-12 1.250E-11 7.070E-17-1.OOOE+OO 4.530E-10 1.270E-09 EFFECTIVE 3.720E-15 2.031E-12 1.347E-11 7.620E-17-1.OOOE+OO 2.580E-10 3.990E-10 SKIN(FGR) 1.070E-14 4.691E-12 3.112E-11 1.760E-16-l.OOOE+oo O. OOOE+OO O.OOOE+OO Sb-127 GONADS 3.260E-14 1.985E-11 2.441E-10 7.100E-16-1.OOOE+00 2.520E-10 6.140E-10

CA06451 Rev.000 Page 74 of 127 BREAST 3.720E-14 1.904E-11 2.341E-10 6.810E-16-1.OOOE+00 9.120E-11 7.600E-11 LUNGS 3.240E-14 1.809E-11 2.224E-10 6.470E-16-1.OOOE+00 6.940E-09 1.570E-11 RED MARR 3.140E-14 1.834E-11 2.255E-10 6.560E-16-1.OOOE+00 1.610E-10 1.330E-10 BONE SUR 5.520E-14 2.720E-11 3.345E-10 9.730E-16-1.OOOE+00 1.340E-10 5.240E-11 THYROID 3.330E-14 1.884E-11 2.317E-10 6.740E-16-1.OOOE+00 6.150E-11 4.640E-12 REMAINDER 3.090E-14 1.775E-11 2.183E-10 6.350E-16-1.OOOE+00 2.330E-09 5.870E-09 EFFECTIVE 3.330E-14 1.890E-11 2.324E-10 6.760E-16-1.OOOE+00 1.630E-09 1.950E-09 SKIN(FGR) 5.580E-14 7.967E-11 9.799E-10 2.850E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Sb-129 GONADS 6.970E-14 2.336E-11 3.231E-11 1.440E-15-1.OOOE+00 2.150E-11 1.510E-10 BREAST 7.910E-14 2.222E-11 3.074E-11 1.370E-15-1.OOOE+00 1.280E-11 2.560E-11 LUNGS 6.980E-14 2.141E-11 2.962E-11 1.320E-15-1.OOOE+00 8.980E-10 9.390E-12 RED MARR 6.860E-14 2.190E-11 3.029E-11 1.350E-15-1.OOOE+00 1.700E-11 3.670E-11 BONE SUR 1.070E-13 3.033E-11 4.196E-11 1.870E-15-1.OOOE+00 1.460E-11 1.340E-11 THYROID 7.160E-14 2.174E-11 3.007E-11 1.340E-15-1.OOOE+00 9.720E-12 1.470E-12 REMAINDER 6.710E-14 2.125E-11 2.939E-11 1.310E-15-1.OOOE+00 1.870E-10 1.450E-09 EFFECTIVE 7.140E-14 2.238E-11 3.096E-11 1.380E-15-1.OOOE+00 1.740E-10 4.840E-10 SKIN(FGR) 1.050E-13 8.273E-11 1.144E-10 5.100E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Te-127 GONADS 2.370E-16 1.191E-13 2.661E-13 5.480E-18-1.OOOE+00 2.020E-12 4.020E-12 BREAST 2.730E-16 1.158E-13 2.588E-13 5.330E-18-1.OOOE+00 1.880E-12 3.OOOE-12 LUNGS 2.320E-16 1.060E-13 2.370E-13 4.880E-18-1.OOOE+00 4.270E-10 2.890E-12 RED MARR 2.210E-16 1.058E-13 2.365E-13 4.870E-18-1.OOOE+00 4.090E-12 6.570E-12 BONE SUR 4.650E-16 1.862E-13 4.162E-13 8.570E-18-1.000E+00 4.090E-12 6.460E-12 THYROID 2.400E-16 1.106E-13 2.472E-13 5.090E-18-1.000E+00 1.840E-12 2.860E-12 REMAINDER 2.210E-16 1.036E-13 2.316E-13 4.770E-18-1.OOOE+00 1.11OE-10 6.130E-10 EFFECTIVE 2.420E-16 1.125E-13 2.515E-13 5.180E-18-1.000E+00 8.600E-11 1.870E-10 SKIN(FGR) 1.140E-14 1.173E-11 2.622E-11 5.400E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 Te-127m GONADS 1.900E-16 4.689E-13 9.642E-12 1.630E-17-1.OOOE+00 1.100E-10 1.250E-10 BREAST 2.690E-16 5.150E-13 1.059E-11 1.790E-17-1.OOOE+00 1.100E-10 9.740E-11 LUNGS 7.620E-17 1.602E-13 3.295E-12 5.570E-18-1.OOOE+00 3.340E-08 9.620E-11 RED MARR 6.430E-17 1.249E-13 2.567E-12 4.340E-18-1.OOOE+00 5.360E-09 5.430E-09 BONE SUR 3.940E-16 9.005E-13 1.852E-11 3.130E-17-1.OOOE+00 2.040E-08 2.070E-08 THYROID 1.500E-16 2.779E-13 5.714E-12 9.660E-18-1.OOOE+00 9.660E-11 9.430E-11 REMAINDER 8.640E-17 1.999E-13 4.111E-12 6.950E-18-1.OOOE+00 1.660E-09 2.980E-09 EFFECTIVE 1.470E-16 3.251E-13 6.684E-12 1.130E-17-1.OOOE+00 5.810E-09 2.230E-09 SKIN(FGR) 8.490E-16 1.496E-12 3.076E-11 5.200E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 Te-129 GONADS 2.710E-15 3.889E-13 3.922E-13 6.510E-17-1.OOOE+00 5.050E-13 1.590E-12 BREAST 3.120E-15 3.800E-13 3.832E-13 6.360E-17-1.OOOE+00 5.390E-13 6.050E-13 LUNGS 2.640E-15 3.298E-13 3.326E-13 5.520E-17-1.OOOE+00 1.530E-10 4.910E-13 RED MARR 2.540E-15 3.298E-13 3.326E-13 5.520E-17-1.OOOE+00 6.190E-13 7.640E-13 BONE SUR 4.880E-15 5.753E-13 5.802E-13 9.630E-17-1.OOOE+00 6.220E-13 5.400E-13 THYROID 2.740E-15 3.525E-13 3.555E-13 5.900E-17-1.OOOE+00 5.090E-13 3.360E-13 REMAINDER 2.520E-15 3.262E-13 3.289E-13 5.460E-17-1.OOOE+00 7.280E-12 1.790E-10 EFFECTIVE 2.750E-15 3.590E-13 3.621E-13 6.010E-17-1.OOOE+00 2.090E-11 5.450E-11 SKIN(FGR) 3.570E-14 3.429E-11 3.458E-11 5.740E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Te-129m GONADS 3.321E-15 2.206E-12 4.799E-11 8.561E-17-1.OOOE+00 1.783E-10 2.420E-10 BREAST 3.838E-15 2.181E-12 4.739E-11 8.454E-17-1.OOOE+00 1.694E-10 1.664E-10 LUNGS 3.176E-15 1.741E-12 3.815E-11 6.808E-17-1.OOOE+00 4.040E-08 1.593E-10 RED MARR 3.071E-15 1.729E-12 3.793E-11 6.768E-17-1.OOOE+00 3.100E-09 3.500E-09 BONE SUR 5.772E-15 3.287E-12 7.147E-11 1.275E-16-1.OOOE+00 7.050E-09 7.990E-09

CA06451 Rev. 000 Page 75 of 127 THYROID 3.341E-15 1.923E-12 4.201E-11 7.495E-17-1.OOOE+00 1.563E-10 1.572E-10 REMAINDER 3.048E-15 1.746E-12 3.822E-11 6.819E-17-1.OOOE+00 3.275E-09 7.196E-09 EFFECTIVE 3.337E-15 1.974E-12 4.308E-11 7.686E-17-1.OOOE+00 6.484E-09 2.925E-09 SKIN(FGR) 3.811E-14 1.501E-10 3.360E-09 6.001E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-131m GONADS 7.292E-14 4.020E-11 2.343E-10 1.535E-15-1.OOOE+00 2.345E-10 7.415E-10 BREAST 8.286E-14 3.853E-11 2.246E-10 1.472E-15-1.OOOE+00 9.309E-11 1.361E-10 LUNGS 7.265E-14 3.657E-11 2.131E-10 1.397E-15-1.OOOE+00 2.296E-09 6.335E-11 RED MARR 7.097E-14 3.736E-11 2.178E-10 1.427E-15-1.OOOE+00 1.417E-10 2.435E-10 BONE SUR 1.174E-13 5.467E-11 3.189E-10 2.090E-15-1.OOOE+00 2.276E-10 3.248E-10 THYROID 7.471E-14 3.741E-11 2.181E-10 1.429E-15-1.OOOE+00 3.669E-08 4.383E-08 REMAINDER 6.965E-14 3.626E-11 2.113E-10 1.385E-15-1.OOOE+00 9.509E-10 3.153E-09 EFFECTIVE 7.463E-14 3.825E-11 2.229E-10 1.461E-15-1.OOOE+00 1.758E-09 2.514E-09 SKIN(FGR) 1.038E-13 1.033E-10 6.188E-10 4.056E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-132 GONADS 1.020E-14 6.812E-12 7.706E-11 2.450E-16-1.OOOE+00 4.150E-10 5.410E-10 BREAST 1.180E-14 6.756E-12 7.643E-11 2.430E-16-1.OOOE+00 3.630E-10 3.500E-10 LUNGS 9.650E-15 5.727E-12 6.479E-11 2.060E-16-1.OOOE+00 1.670E-09 3.300E-10 RED MARR 8.950E-15 5.588E-12 6.322E-11 2.010E-16-1.OOOE+00 4.270E-10 4.440E-10 BONE SUR 2.420E-14 1.273E-11 1.441E-10 4.580E-16-1.OOOE+00 7.120E-10 8.300E-10 THYROID 1.020E-14 5.978E-12 6.762E-11 2.150E-16-1.OOOE+00 6.280E-08 5.950E-08 REMAINDER 9.160E-15 5.644E-12 6.385E-11 2.030E-16-1.OOOE+00 7.890E-10 1.490E-09 EFFECTIVE 1.030E-14 6.339E-12 7.171E-11 2.280E-16-1.OOOE+00 2.550E-09 2.540E-09 SKIN(FGR) 1.390E-14 8.313E-12 9.405E-11 2.990E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO 1-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11 BREAST 2.040E-14 1.082E-11 1.730E-10 3.81OE-16-1.OOOE+00 7.880E-11 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.570E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-1.OOOE+00 5.730E-11 8.720E-11 THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-11 BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+00 1.410E-11 2.520E-11 LUNGS 1.090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2.710E-10 2.640E-11 RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-11 BONE SUR 1.730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1.240E-11 2.190E-11 THYROID 1.120E-13 2.381E-11 2.616E-11 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-11 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-1.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-1.OOOE+00 1.950E-11 3.630E-11 BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.OOOE+00 2.940E-11 4.680E-11 LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.OOOE+00 8.200E-10 4.530E-11 RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-1.OOOE+00 2.720E-11 4.300E-11 BONE SUR 4.870E-14 2.161E-11 9.202E-11 8.550E-16-1.OOOE+00 2.520E-11 4.070E-11 THYROID 2.930E-14 1.502E-11 6.393E-11 5.940E-16-1.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-1.OOOE+00 5.OOOE-11 1.550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev.000 Page 76 of 127 I-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 1.10E-li BREAST 1.440E-13 1.145E-11 1.147E-11 2.520E-15-l.OOOE+00 6.170E-12 1.170E-li LUNGS 1.270E-13 1.10E-il 1.102E-11 2.420E-15-i.OOOE+00 1.430E-10 1.260E-11 RED MARR 1.250E-13 1.127E-11 1.129E-11 2.480E-15-l.OOOE+00 6.080E-12 l.O90E-ll BONE SUR 1.960E-13 1.568E-11 1.571E-11 3.450E-15-l.OOOE+00 5.310E-12 9.320E-12 THYROID 1.300E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 2.880E-10 6.210E-10 REMAINDER 1.220E-13 i.091E-11 1.093E-11 2.400E-15-l.OOOE+00 2.270E-11 1.340E-10 EFFECTIVE 1.300E-13 1.150E-11 1.152E-11 2.530E-15-1.OOOE+00 3.550E-li 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-ll 4.485E-11 9.850E-15-l.OOOE+OO O.OOOE+CC O.OOOE+CO I-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-l.000E+00 1.700E-11 3.610E-ll BREAST 9.143E-14 2.971E-11 5.240E-11 1.526E-15-l.OOOE+00 2.34CE-11 3.850E-ll LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-l.OOOE+00 4.410E-10 3.750E-l1 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.OOOE+00 2.240E-11 3.650E-11 BONE SUR 1.184E-13 3.983E-li 7.024E-ll 2.046E-15-l.OOOE+00 2.010E-11 3.360E-ll THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-1.OOOE+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.OOOE+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOOE+00 3.320E-10 6.080E-10 SKIN(FGR) 1.156E-13 9.826E-11 1.733E-10 5.047E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-133 GONADS 1.610E-15 1.465E-12 2.052E-11 5.200E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.960E-15 1.505E-12 2.107E-11 5.3iOE-17-1.OOOE+OO O.OOOE+OO O.OOOE+CO LUNGS 1.320E-15 1.045E-12 1.464E-11 3.710E-17-l.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.070E-15 8.791E-13 1.231E-11 3.120E-17-l.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 5.130E-15 4.254E-12 5.958E-11 1.510E-16-l.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.510E-15 1.181E-12 1.653E-11 4.190E-17-l.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.240E-15 1.042E-12 1.460E-11 3.700E-17-l.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.560E-15 1.299E-12 1.819E-11 4.610E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 4.970E-15 1.953E-12 2.734E-11 6.930E-17-1.OOOE+OO O.OOOE+CO O.OOOE+OO Xe-135 GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-i.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-i.OOOE+CO O.OOOE+OO O.OOOE+OO LUNGS 1.130E-14 4.959E-12 1.086E-il 2.300E-i6-l.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-l.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.180E-14 5.023E-12 1.10E-li 2.330E-16-l.OOOE+OO O.OOOE+OO O.OOOE+OC REMAINDER 1.080E-14 4.829E-12 1.05SE-11 2.240E-16-l.OOOE+OO 0..OOE+OO O.OOOE+OO EFFECTIVE 1.l90E-14 5.217E-12 1.142E-11 2.420E-16-l.OOOE+CO O.OOOE+OO O.OOOE+OO SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-1.OOOE+0 O.OOOE+OO O.OOOE+OO Cs-134 GONADS 7.400E-14 4.607E-11 9.646E-10 1.600E-15-l.OOOE+00 1.300E-08 2.060E-08 BREAST 8.430E-14 4.406E-11 9.224E-10 1.530E-15-l.OOOE+00 1.080E-08 1.720E-08 LUNGS 7.370E-14 4.204E-11 8.802E-10 1.460E-15-1.OOOE+00 1.180E-08 1.760E-08 RED MARR 7.190E-14 4.262E-11 8.922E-10 1.480E-15-l.OOOE+00 1.180E-08 1.870E-08 BONE SUR 1.200E-13 6.105E-11 1.278E-09 2.120E-15-l.OOOE+OO l.lOOE-08 1.740E-08 THYROID 7.570E-14 4.377E-1 9.163E-10 1.520E-15-1.OOOE+OO 1.11CE-08 1.760E-08 REMAINDER 7.060E-14 4.147E-11 8.681E-10 1.440E-15-l.OOOE+00 1.390E-08 2.210E-08 EFFECTIVE 7.570E-14 4.377E-11 9.163E-10 1.520E-15-1.OOOE+00 1.250E-08 1.980E-08 SKIN(FGR) 9.450E-14 6.249E-11 1.308E-09 2.170E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Cs-136 GONADS 1.040E-13 6.223E-i1 1.102E-09 2.180E-15-1.OOOE+00 1.880E-09 3.040E-09 BREAST 1.180E-13 5.966E-11 1.056E-09 2.090E-15-1.OOOE+00 1.670E-09 2.650E-09 LUNGS 1.040E-13 5.710E-il l.OllE-O9 2.000E-15-l.OOOE+00 2.320E-09 2.620E-09

CA06451 Rev.000 Page 77 of 127 RED MARR 1.OlOE-13 5.824E-11 1.031E-09 2.040E-15-1.OOOE+00 1.860E-09 2.950E-09 BONE SUR 1.660E-13 8.422E-11 1.491E-09 2.950E-15-1.OOOE+00 1.700E-09 2.710E-09 THYROID 1.070E-13 5.852E-11 1.036E-09 2.050E-15-1.OOOE+00 1.730E-09 2.740E-09 REMAINDER 9.950E-14 5.652E-11 1.001E-09 1.980E-15-1.OOOE+00 2.190E-09 3.520E-09 EFFECTIVE 1.060E-13 5.966E-11 1.056E-09 2.090E-15-1.OOOE+00 1.980E-09 3.040E-09 SKIN(FGR) 1.250E-13 7.251E-11 1.284E-09 2.540E-1S-1.OOOE+OO O.OOOE+OO O.OOOE+0O Cs-137 GONADS 2.669E-14 1.669E-11 3.530E-10 S.840E-16-1.OOOE+00 8.760E-09 1.390E-08 BREAST 3.047E-14 1.596E-11 3.376E-10 5.585E-16-1.OOOE+00 7.840E-09 1.240E-08 LUNGS 2.649E-14 1.517E-11 3.209E-10 5.309E-16-1.OOOE+00 8.820E-09 1.270E-08 RED MARR 2.583E-14 1.542E-11 3.260E-10 5.394E-16-1.OOOE+00 8.300E-09 1.320E-08 BONE SUR 4.382E-14 2.238E-11 4.734E-10 7.832E-16-1.OOOE+00 7.940E-09 1.260E-08 THYROID 2.725E-14 1.588E-11 3.358E-10 5.556E-16-1.OOOE+00 7.930E-09 1.260E-08 REMAINDER 2.536E-14 1.490E-11 3.152E-10 S.215E-16-1.OOOE+00 9.120E-09 1.450E-08 EFFECTIVE 2.725E-14 1.585E-11 3.353E-10 S.546E-16-1.OOOE+00 8.630E-09 1.350E-08 SKIN(FGR) 4.392E-14 5.253E-11 1.11OE-09 1.836E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ba-139 GONADS 2.130E-1S 3.368E-13 3.429E-13 4.790E-17-1.OOOE+00 2.560E-12 1.560E-12 BREAST 2.450E-1S 3.297E-13 3.357E-13 4.690E-17-1.OOOE+00 2.460E-12 5.170E-13 LUNGS 2.030E-15 3.002E-13 3.057E-13 4.270E-17-1.OOOE+00 2.530E-10 3.890E-13 RED MARR 1.870E-15 2.932E-13 2.985E-13 4.170E-17-1.OOOE+00 3.410E-12 8.590E-13 BONE SUR 5.290E-15 6.841E-13 6.965E-13 9.730E-17-1.OOOE+00 2.490E-12 4.380E-13 THYROID 2.130E-1S 3.044E-13 3.100E-13 4.330E-17-1.OOOE+00 2.400E-12 2.660E-13 REMAINDER 1.920E-15 2.932E-13 2.985E-13 4.170E-17-1.OOOE+00 4.820E-11 3.570E-10 EFFECTIVE 2.170E-1S 3.227E-13 3.286E-13 4.590E-17-1.OOOE+00 4.640E-11 1.080E-10 SKIN(FGR) 6.160E-14 7.241E-11 7.373E-11 1.030E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ba-140 GONADS 8.410E-15 5.451E-12 9.607E-11 1.910E-16-1.OOOE+00 4.300E-10 9.960E-10 BREAST 9.640E-15 5.280E-12 9.305E-11 1.850E-16-1.OOOE+00 2.870E-10 1.590E-10 LUNGS 8.270E-1S 4.852E-12 8.550E-11 1.700E-16-1.OOOE+00 1.660E-09 6.630E-11 RED MARR 7.930E-1S 4.880E-12 8.601E-11 1.710E-16-1.OOOE+00 1.290E-09 4.390E-10 BONE SUR 1.550E-14 8.020E-12 1.413E-10 2.810E-16-1.OOOE+00 2.410E-09 5.530E-10 THYROID 8.530E-15 5.109E-12 9.003E-11 1.790E-16-1.OOOE+00 2.560E-10 5.250E-11 REMAINDER 7.890E-15 4.766E-12 8.399E-11 1.670E-16-1.OOOE+00 1.410E-09 7.370E-09 EFFECTIVE 8.580E-15 5.137E-12 9.053E-11 1.800E-16-1.OOOE+00 1.O1OE-09 2.560E-09 SKIN(FGR) 2.520E-14 5.565E-11 9.808E-10 1.950E-15-1.OOOE+OO O.OOOE+O0 O.OOOE+00 La-140 GONADS 1.140E-13 6.027E-11 4.425E-10 2.240E-15-1.OOOE+00 4.540E-10 1.340E-09 BREAST 1.290E-13 5.758E-11 4.228E-10 2.140E-15-1.OOOE+00 1.450E-10 1.800E-10 LUNGS 1.150E-13 5.596E-11 4.109E-10 2.080E-15-1.OOOE+00 4.210E-09 4.010E-11 RED MARR 1.140E-13 5.731E-11 4.208E-10 2.130E-15-1.OOOE+00 2.140E-10 2.810E-10 BONE SUR 1.690E-13 7.776E-11 5.709E-10 2.890E-15-1.OOOE+00 1.410E-10 9.770E-11 THYROID 1.180E-13 5.462E-11 4.010E-10 2.030E-15-l.OOOE+00 6.870E-11 6.400E-12 REMAINDER 1.11OE-13 5.569E-11 4.089E-10 2.070E-15-1.OOOE+00 2.120E-09 6.260E-09 EFFECTIVE 1.170E-13 5.812E-11 4.267E-10 2.160E-15-1.OOOE+00 1.310E-09 2.280E-09 SKIN(FGR) 1.660E-13 2.217E-10 1.628E-09 8.240E-15-1.OOOE+OO O.OOOE+00 O.OOOE+00 La-141 GONADS 2.330E-15 7.315E-13 9.675E-13 4.740E-17-1.OOOE+00 1.OlOE-11 3.770E-12 BREAST 2.640E-15 7.007E-13 9.267E-13 4.540E-17-1.OOOE+00 9.840E-12 7.070E-13 LUNGS 2.340E-1S 6.713E-13 8.879E-13 4.350E-17-1.OOOE+00 6.460E-10 2.720E-13 RED MARR 2.310E-15 6.852E-13 9.063E-13 4.440E-17-1.OOOE+00 2.930E-11 1.070E-12 BONE SUR 3.490E-15 9.923E-13 1.312E-12 6.430E-17-1.OOOE+00 1.200E-10 6.060E-13 THYROID 2.390E-15 6.590E-13 8.716E-13 4.270E-17-1.OOOE+00 9.400E-12 5.290E-14 REMAINDER 2.260E-15 6.682E-13 8.838E-13 4.330E-17-1.OOOE+00 2.280E-10 1.240E-09

CA06451 Rev.OOO Page 78 of 127 EFFECTIVE 2.390E-1S 7.007E-13 9.267E-13 4.S40E-17-1.OOOE+00 1.570E-10 3.740E-10 SKIN(FGR) 6.580E-14 1.667E-10 2.204E-10 1.080E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO La-142 GONADS 1.400E-13 1.978E-11 2.034E-11 2.540E-15-1.OOOE+00 1.660E-11 6.990E-11 BREAST 1.570E-13 1.885E-11 1.938E-11 2.420E-15-1.OOOE+00 1.130E-11 1.540E-11 LUNGS 1.420E-13 1.846E-11 1.898E-11 2.370E-15-1.OOOE+00 3.010E-10 8.400E-12 RED MARR 1.420E-13 1.900E-11 1.954E-11 2.440E-15-1.OOOE+00 1.360E-11 1.930E-11 BONE SUR 1.950E-13 2.484E-11 2.554E-11 3.190E-15-1.OOOE+OO 1.110E-11 7.400E-12 THYROID 1.450E-13 1.768E-11 1.818E-11 2.270E-15-1.OOOE+00 8.740E-12 1.160E-12 REMAINDER 1.380E-13 1.853E-11 1.906E-11 2.380E-15-1.OOOE+00 8.070E-11 5.200E-10 EFFECTIVE 1.440E-13 1.916E-11 1.970E-11 2.460E-15-1.OOOE+00 6.840E-11 1.790E-10 SKIN(FGR) 2.160E-13 9.111E-11 9.36BE-11 1.170E-14-1.OOOE+00 O.OOOE+OO O.OOOE+OO Ce-141 GONADS 3.380E-15 2.213E-12 4.332E-11 7.710E-17-1.OOOE+OO 5.540E-11 1.080E-10 BREAST 3.930E-15 2.170E-12 4.247E-11 7.S60E-17-1.OOOE+00 4.460E-11 1.110E-11 LUNGS 3.170E-15 1.951E-12 3.820E-11 6.800E-17-1.OOOE+00 1.670E-08 1.430E-12 RED MARR 2.830E-15 1.860E-12 3.641E-11 6.480E-17-1.OOOE+00 8.960E-11 3.390E-11 BONE SUR 9.410E-15 5.166E-12 1.011E-10 1.800E-16-1.OOOE+00 2.540E-10 2.300E-11 THYROID 3.350E-15 2.003E-12 3.922E-11 6.980E-17-1.OOOE+00 2.SSOE-11 1.800E-13 REMAINDER 2.980E-15 1.894E-12 3.708E-11 6.600E-17-1.OOOE+00 1.260E-09 2.500E-09 EFFECTIVE 3.430E-1S 2.118E-12 4.146E-11 7.380E-17-1.OOOE+00 2.420E-09 7.830E-10 SKIN(FGR) 1.020E-14 3.788E-12 7.416E-11 1.320E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ce-143 GONADS 1.280E-14 7.900E-12 4.958E-11 2.980E-16-1.OOOE+00 7.S30E-11 2.120E-10 BREAST 1.470E-14 7.688E-12 4.82SE-11 2.900E-16-1.OOOE+00 1.660E-11 2.320E-11 LUNGS 1.230E-14 6.893E-12 4.325E-11 2.600E-16-1.OOOE+00 3.880E-09 3.820E-12 RED MARR 1.170E-14 6.787E-12 4.259E-11 2.560E-16-1.OOOE+00 2.960E-11 5.070E-11 BONE SUR 2.520E-14 1.323E-11 8.302E-11 4.990E-16-1.OOOE+00 1.640E-11 1.610E-11 THYROID 1.280E-14 7.211E-12 4.525E-11 2.720E-16-1.OOOE+00 6.230E-12 4.350E-13 REMAINDER 1.170E-14 6.734E-12 4.226E-11 2.S40E-16-1.OOOE+00 1.420E-09 3.890E-09 EFFECTIVE 1.290E-14 7.396E-12 4.642E-11 2.790E-16-1.OOOE+00 9.160E-10 1.230E-09 SKIN(FGR) 3.960E-14 1.058E-10 6.638E-10 3.990E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ce-144 GONADS 2.725E-15 6.328E-13 1.319E-11 6.088E-17-1.OOOE+00 2.390E-10 6.987E-11 BREAST 3.129E-15 6.274E-13 1.307E-11 S.922E-17-1.OOOE+00 3.480E-10 1.223E-11 LUNGS 2.639E-15 5.228E-13 1.089E-11 S.362E-17-1.OOOE+00 7.911E-07 6.551E-12 RED MARR 2.507E-15 4.7SSE-13 9.907E-12 5.247E-17-1.OOOE+00 2.880E-09 8.923E-11 BONE SUR 5.441E-15 1.646E-12 3.429E-11 1.127E-16-1.OOOE+00 4.720E-09 1.280E-10 THYROID 2.753E-15 5.529E-13 1.152E-11 5.418E-17-1.OOOE+00 2.920E-10 5.154E-12 REMAINDER 2.534E-15 5.086E-13 1.060E-11 5.283E-17-1.OOOE+OO 1.910E-08 1.890E-08 EFFECTIVE 2.773E-15 5.909E-13 1.231E-11 5.766E-17-1.OOOE+OO 1.OlOE-07 5.711E-09 SKIN(FGR) 8.574E-14 7.648E-13 1.594E-11 1.250E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pr-143 GONADS 2.130E-17 2.264E-14 4.032E-13 7.930E-19-1.OOOE+00 4.370E-18 8.990E-18 BREAST 2.550E-17 2.330E-14 4.149E-13 8.160E-19-1.OOOE+00 2.220E-18 1.090E-18 LUNGS 1.860E-17 1.642E-14 2.923E-13 5.750E-19-1.OOOE+00 1.330E-08 1.910E-19 RED MARR 1.620E-17 1.493E-14 2.659E-13 5.230E-19-1.OOOE+00 1.480E-11 1.030E-12 BONE SUR 5.930E-17 5.454E-14 9.711E-13 1.910E-18-1.OOOE+00 1.490E-11 1.030E-12 THYROID 2.050E-17 1.802E-14 3.208E-13 6.310E-19-1.OOOE+00 1.680E-18 2.660E-20 REMAINDER 1.760E-17 1.642E-14 2.923E-13 5.750E-19-1.OOOE+00 1.970E-09 4.220E-09 EFFECTIVE 2.100E-17 2.002E-14 3.564E-13 7.010E-19-1.OOOE+00 2.190E-09 1.270E-09 SKIN(FGR) 1.760E-14 5.711E-11 1.017E-09 2.OOOE-15-1.OOOE+OO O.OOOE+00 O.OOOE+00 Nd-147 GONADS 6.130E-15 4.218E-12 7.235E-11 1.480E-16-1.OOOE+00 8.410E-11 1.790E-10

CA06451 Rev.000 Page 79 of 127 BREAST 7.120E-15 4.132E-12 7.088E-11 1.450E-16-1.OOOE+00 3.450E-11 1.870E-11 LUNGS 5.820E-15 3.648E-12 6.257E-11 1.280E-16-1.OOOE+00 1.060E-08 2.440E-12 RED MARR 5.400E-15 3.505E-12 6.013E-11 1.230E-16-1.OOOE+00 9.190E-11 5.050E-11 BONE SUR 1.320E-14 8.265E-12 1.418E-10 2.900E-16-1.OOOE+00 3.260E-10 2.220E-11 THYROID 6.120E-15 3.876E-12 6.648E-11 1.360E-16-1.OOOE+00 1.820E-11 2.640E-13 REMAINDER 5.530E-15 3.562E-12 6.111E-11 1.250E-16-1.OOOE+00 1.760E-09 3.760E-09 EFFECTIVE 6.190E-15 3.961E-12 6.795E-11 1.390E-16-1.OOOE+00 1.850E-09 1.180E-09 SKIN(FGR) 1.950E-14 3.135E-11 5.377E-10 1.100E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Np-239 GONADS 7.530E-15 4.691E-12 4.380E-11 1.710E-16-1.OOOE+00 7.450E-11 1.620E-10 BREAST 8.730E-15 4.636E-12 4.329E-11 1.690E-16-1.OOOE+00 1.630E-11 1.720E-11 LUNGS 7.180E-15 4.115E-12 3.842E-11 1.500E-16-1.OOOE+00 2.360E-09 2.400E-12 RED MARR 6.500E-15 4.005E-12 3.740E-11 1.460E-16-1.OOOE+00 2.080E-10 4.660E-11 BONE SUR 2.OOOE-14 1.OO1E-11 9.349E-11 3.650E-16-1.OOOE+00 2.030E-09 3.590E-11 THYROID 7.520E-15 4.197E-12 3.919E-11 1.530E-16-1.OOOE+00 7.620E-12 2.070E-13 REMAINDER 6.760E-15 4.005E-12 3.740E-11 1.460E-16-1.OOOE+00 9.590E-10 2.770E-09 EFFECTIVE 7.690E-15 4.471E-12 4.175E-11 1.630E-16-1.OOOE+00 6.780E-10 8.820E-10 SKIN(FGR) 1.600E-14 7.215E-12 6.737E-11 2.630E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-238 GONADS 6.560E-18 4.291E-14 9.011E-13 1.490E-18-1.OOOE+00 1.040E-05 2.330E-09 BREAST 1.270E-17 5.558E-14 1.167E-12 1.930E-18-1.OOOE+00 4.400E-10 1.800E-13 LUNGS 1.060E-18 2.267E-15 4.759E-14 7.870E-20-1.OOOE+00 3.200E-04 8.640E-14 RED MARR 1.680E-18 5.587E-15 1.173E-13 1.940E-19-1.OOOE+00 5.800E-05 1.270E-08 BONE SUR 9.300E-18 3.514E-14 7.378E-13 1.220E-18-1.OOOE+00 7.250E-04 1.580E-07 THYROID 4.010E-18 9.792E-15 2.056E-23 3.400E-19-l.OOOE+00 3.860E-10 7.990E-14 REMAINDER 1.990E-18 9.216E-15 1.935E-13 3.200E-19-1.OOOE+00 2.740E-05 2.180E-08 EFFECTIVE 4.880E-18 2.413E-14 5.068E-13 8.380E-19-1.OOOE+00 7.790E-05 1.340E-08 SKIN(FGR) 4.090E-17 2.776E-13 5.830E-12 9.640E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-239 GONADS 4.840E-18 1.768E-14 3.713E-13 6.140E-19-1.OOOE+00 1.200E-05 2.640E-09 BREAST 7.550E-18 2.238E-14 4.699E-13 7.770E-19-1.OOOE+00 3.990E-10 1.210E-13 LUNGS 2.650E-18 2.267E-15 4.760E-14 7.870E-20-1.OOOE+00 3.230E-04 7.890E-14 RED MARR 2.670E-18 3.456E-15 7.258E-14 1.200E-19-1.OOOE+00 6.570E-05 1.410E-08 BONE SUR 9.470E-18 1.673E-14 3.514E-13 5.810E-19-1.OOOE+00 8.210E-04 1.760E-07 THYROID 3.880E-18 5.126E-15 1.077E-13 1.780E-19-1.OOOE+00 3.750E-10 7.500E-14 REMAINDER 2.860E-18 4.838E-15 1.016E-13 1.680E-19-1.OOOE+00 3.020E-05 2.120E-08 EFFECTIVE 4.240E-18 1.057E-14 2.220E-13 3.670E-19-1.OOOE+00 8.330E-05 1.400E-08 SKIN(FGR) 1.860E-17 1.057E-13 2.220E-12 3.670E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-240 GONADS 6.360E-18 4.118E-14 8.649E-13 1.430E-18-1.OOOE+00 1.200E-05 2.640E-09 BREAST 1.230E-17 5.328E-14 1.119E-12 1.850E-18-1.OOOE+00 4.330E-1O 1.730E-13 LUNGS 1.090E-18 2.249E-15 4.723E-14 7.810E-20-1.OOOE+00 3.230E-04 8.220E-14 RED MARR 1.650E-18 5.386E-15 1.131E-13 1.870E-19-1.OOOE+00 6.570E-05 1.410E-08 BONE SUR 9.260E-18 3.398E-14 7.137E-13 1.180E-18-1.OOOE+00 8.210E-04 1.760E-07 THYROID 3.920E-18 9.446E-15 1.984E-13 3.280E-19-1.OOOE+00 3.760E-1O 7.510E-14 REMAINDER 1.960E-18 8.870E-15 1.863E-13 3.080E-19-1.OOOE+00 3.020E-05 2.130E-08 EFFECTIVE 4.750E-18 2.313E-14 4.857E-13 8.030E-19-1.OOOE+00 8.330E-05 1.400E-08 SKIN(FGR) 3.920E-17 2.644E-13 5.552E-12 9.180E-18-l.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-241 GONADS 7.190E-20 6.653E-17 1.396E-15 2.310E-21-1.OOOE+00 2.760E-07 5.660E-11 BREAST 8.670E-20 7.229E-17 1.S17E-15 2.510E-21-1.OOOE+00 2.140E-11 2.790E-15 LUNGS 6.480E-20 4.090E-17 8.584E-16 1.420E-21-1.OOOE+00 3.180E-06 4.480E-15 RED MARR 5.630E-20 4.003E-17 8.403E-16 1.390E-21-1.OOOE+00 1.430E-06 2.780E-10 BONE SUR 2.190E-19 1.385E-16 2.908E-15 4.810E-21-1.OOOE+00 1.780E-05 3.480E-09

CA06451 Rev.000 Page 80 of 127 THYROID 6.980E-20 4.522E-17 9.491E-16 1.570E-21-1.OOOE+00 9.150E-12 1.OlOE-15 REMAINDER 6.090E-20 4.291E-17 9.007E-16 1.490E-21-1.OOOE+00 6.020E-07 1.850E-10 EFFECTIVE 7.250E-20 5.558E-17 1.167E-15 1.930E-21-1.OOOE+00 1.340E-06 2.070E-10 SKIN(FGR) 1.170E-19 2.033E-16 4.268E-15 7.060E-21-1.OOOE+OO O.OOOE+OO O.OOOE+OO Am-241 GONADS 8.580E-16 9.360E-13 1.966E-11 3.250E-17-1.OOOE+00 3.250E-05 2.700E-07 BREAST 1.070E-15 1.014E-12 2.129E-11 3.520E-17-1.OOOE+00 2.670E-09 2.620E-11 LUNGS 6.740E-16 5.789E-13 1.216E-11 2.010E-17-l.OOOE+00 1.840E-05 3.360E-11 RED MARR 5.210E-16 4.838E-13 1.016E-11 1.680E-17-1.OOOE+00 1.740E-04 1.450E-06 BONE SUR 2.870E-15 2.678E-12 5.625E-11 9.300E-17-1.OOOE+00 2.170E-03 1.810E-05 THYROID 7.830E-16 6.36SE-13 1.337E-11 2.210E-17-1.OOOE+00 1.600E-09 1.320E-11 REMAINDER 6.340E-16 5.933E-13 1.246E-11 2.060E-17-1.OOOE+00 7.820E-05 6.660E-07 EFFECTIVE 8.180E-16 7.920E-13 1.663E-11 2.750E-17-1.OOOE+00 1.200E-04 9.840E-07 SKIN(FGR) 1.280E-15 2.396E-12 5.032E-11 8.320E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO Cm-242 GONADS 7.830E-18 4.893E-14 1.013E-12 1.700E-18-1.OOOE+00 5.700E-07 5.200E-09 BREAST 1.480E-17 6.159E-14 1.275E-12 2.140E-18-1.OOOE+00 9.440E-10 8.950E-12 LUNGS 1.130E-18 3.022E-15 6.257E-14 1.050E-19-1.OOOE+00 1.550E-05 8.840E-12 RED MARR 1.890E-18 6.562E-15 1.359E-13 2.280E-l9-1.OOOE+00 3.900E-06 3.570E-08 BONE SUR 1.060E-17 4.231E-14 8.759E-13 1.470E-18-1.OOOE+00 4.870E-05 4.460E-07 THYROID 4.910E-18 1.261E-14 2.610E-13 4.380E-19-1.OOOE+00 9.410E-10 8.820E-12 REMAINDER 2.270E-18 1.079E-14 2.235E-13 3.750E-19-1.OOOE+00 2.450E-06 4.020E-08 EFFECTIVE S.690E-18 2.751E-14 5.697E-13 9.560E-19-1.OOOE+00 4.670E-06 3.100E-08 SKIN(FGR) 4.290E-17 2.700E-13 5.589E-12 9.380E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Cm-244 GONADS 6.900E-18 4.522E-14 9.492E-13 1.570E-18-1.OOOE+00 1.590E-05 1.330E-07 BREAST 1.330E-17 5.702E-14 1.197E-12 1.980E-18-1.OOOE+00 1.040E-09 8.820E-12 LUNGS 7.080E-19 2.592E-15 5.441E-14 9.OOOE-20-1.OOOE+00 1.930E-05 8.810E-12 RED MARR 1.460E-18 5.875E-15 1.233E-13 2.040E-19-1.OOOE+00 9.380E-05 7.820E-07 BONE SUR 8.820E-18 3.859E-14 8.101E-13 1.340E-18-1.OOOE+00 1.170E-03 9.770E-06 THYROID 4.190E-18 1.146E-14 2.406E-13 3.980E-19-1.OOOE+OO 1.OlOE-09 8.440E-12 REMAINDER 1.810E-18 9.821E-15 2.062E-13 3.410E-19-1.OOOE+00 4.780E-05 4.150E-07 EFFECTIVE 4.910E-18 2.529E-14 5.308E-13 8.780E-19-1.OOOE+00 6.700E-05 5.450E-07 SKIN(FGR) 3.910E-17 2.506E-13 5.260E-12 8.700E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-133m GONADS 1.420E-15 O.OOOE+oo O.OOOE+OO O.OOOE+OO-1.OOOE+oO O.OOOE+OO O.OOOE+oo BREAST 1.700E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.190E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.100E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 3.230E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1;OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.360E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.150E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.370E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-135m GONADS 2.OOOE-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 2.290E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.980E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.910E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+00 O.OOOE+OO O.OOOE+OO BONE SUR 3.500E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+00 O.OOOE+OO O.OOOE+OO THYROID 2.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.890E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 2.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 2.970E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev. 000 Page 81 of 127 Xe-138 GONADS 5.590E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 6.320E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 5.660E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 5.600E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 8.460E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOOE+00 O.OOOE+OO O.OOOE+OO THYROID 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 5.490E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-l.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.070E-13 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06451 Rev.OOO Page 82 of 127 ATTACHMENT Q SREFFI OUTPUT FILE

8#88######################################u########################

Cumulative Dose Summary

8###88####8################### ###############################8###88 8#######

eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 2.7314E-01 9.4484E-03 6.4302E-02 2.2243E-03 6.1552E-01 1.9354E-02 0.333 2.8559E-01 9.8762E-03 6.7233E-02 2.3250E-03 1.0146E+00 3.1892E-02 0.500 3.1372E-01 1.0838E-02 7.3855E-02 2.5516E-03 1.7091E+00 5.3694E-02 0.800 3.5931E-01 1.2386E-02 8.4587E-02 2.9159E-03 2.5897E+00 8.1306E-02 1.100 4.1117E-01 1.4132E-02 9.6796E-02 3.3269E-03 3.2181E+00 1.0098E-01 1.400 4.6925E-01 1.6073E-02 1.1047E-01 3.7838E-03 3.7503E+00 1.1762E-01 1.700 5.3349E-01 1.8206E-02 1.2559E-01 4.2860E-03 4.2615E+00 1.3359E-01 2.000 6.0385E-01 2.0530E-02 1.4216E-01 4.8332E-03 4.7877E+00 1.5001E-01 2.300 6.0385E-01 2.0530E-02 1.4332E-01 4.8716E-03 5.3202E+00 1.6661E-01 2.600 6.0385E-01 2.0530E-02 1.4458E-01 4.9128E-03 5.8570E+00 1.8333E-01 2.900 6.0385E-01 2.0530E-02 1.4593E-01 4.9569E-03 6.4167E+00 2.0076E-01 3.200 6.0385E-01 2.0530E-02 1.4737E-01 5.0038E-03 7.0083E+00 2.1916E-01 3.500 6.0385E-01 2.0530E-02 1.4890E-01 5.0534E-03 7.6359E+00 2.3868E-01 3.800 6.038SE-Ol 2.0530E-02 1.5052E-01 5.1058E-03 8.3014E+00 2.5936E-01 4.100 6.0385E-01 2.0530E-02 1.5223E-01 5.1610E-03 9.0054E+00 2.8122E-01 4.400 6.0385E-01 2.0530E-02 1.5402E-01 5.2188E-03 9.7482E+00 3.0429E-01 4.700 6.0385E-01 2.0530E-02 1.5590E-01 5.2793E-03 1.0530E+01 3.2854E-01 5.000 6.0385E-01 2.0530E-02 1.5787E-01 5.3425E-03 1.1350E+01 3.5398E-01 5.300 6.0385E-01 2.0530E-02 1.5992E-01 5.4084E-03 1.2208E+01 3.8059E-01 5.600 6.0385E-01 2.053OE-02 1.6206E-01 5.4769E-03 1.3104E+01 4 .0837E-01 5.900 6.0385E-01 2.0530E-02 1.6428E-01 5.5479E-03 1.4038E+01 4.3732E-01 6.200 6.0385E-01 2.0530E-02 1.6659E-01 5.6216E-03 1. 5010E+01 4.6741E-01 6.500 6.0385E-01 2.0530E-02 1.6897E-01 5.6978E-03 1.6018E+01 4 .9864E-01 6.800 6.0385E-01 2.0530E-02 1.7144E-01 5.7765E-03 1.7064E+01 5.3101E-01 7.100 6.0385E-01 2.0530E-02 1.7399E-01 5.8578E-03 1.8146E+01 5.6450E-01 7.400 6.0385E-01 2.0530E-02 1.7662E-01 5.9415E-03 1.9264E+01 5.9910E-01 7.700 6.0385E-01 2.0530E-02 1.7934E-01 6.0278E-03 2.0419E+01 6.3482E-01 8.000 6.038SE-Ol 2.0530E-02 1.8213E-01 6.1165E-03 2.1609E+01 6.7163E-01 8.300 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.2473E+01 6.9833E-01 8.600 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.2891E+01 7.1126E-01 8.900 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3094E+01 7.1752E-01 9.200 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3192E+01 7.2056E-01 9.500 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3239E+01 7.2203E-01 9.800 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3262E+01 7.2275E-01 10.100 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3274E+01 7.2309E-01 10.400 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3279E+01 7.2326E-01 24.000 6.038SE-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3284E+01 7.2342E-01 96.000 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3284E+01 7.2342E-01 720.000 6.0385E-01 2.0530E-02 1.8213E-01 6.1165E-03 2.3284E+01 7.2342E-01 888#88###

1. 1. 8##8888## ##8888ff888###########88888#8ff8s###TwoHourDose Worst Two-Hour Doses

CA06451 Rev.OOO Page 83 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.6961E-03 6.0385E-01 2.0530E-02

CA06451 Rev.OOO Page 84 of 127 ATTACHMENT R SREFFN OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 3.4869E-03 O.OOOOE+00 8.2087E-04 O.OOOOE+00 5.75278-04 0.500 O.OOOOE+00 4.7747E-03 O.OOOOE+00 1.1240E-03 O.OOOOE+00 1.1063E-03 0.800 O.OOOOE+00 6.7046E-03 O.OOOOE+00 1.5784E-03 O.OOOOE+00 2.2497E-03 1.100 O.OOOOE+00 8.3254E-03 O.OOOOE+00 1.9599E-03 O.OOOOE+00 3.5279E-03 1.400 O.OOOOE+00 9.7560E-03 O.OOOOE+00 2.2967E-03 O.OOOOE+00 4.8811E-03 1.700 0.0000E+00 1.1O51E-02 O.OOOOE+00 2.6017E-03 O.OOOOE+00 6.2700E-03 2.000 O.OOOOE+00 1.2240E-02 O.oOOOE+00 2.8815E-03 O.OOOOE+00 7.6647E-03 2.300 O.OOOOE+00 1.2240E-02 0.OOOOE+00 2.8982E-03 O.OOOOE+00 9.0158E-03 2.600 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9138E-03 O.OOOOE+00 1.0292E-02 2.900 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9282E-03 O.OOOOE+00 1.1495E-02 3.200 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9416E-03 O.OOOOE+00 1.2628E-02 3.500 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9542E-03 O.OOOOE+00 1.3695E-02 3.800 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9659E-03 O.OOOOE+00 1.4698E-02 4.100 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9768E-03 O.OOOOE+00 1.5641E-02 4.400 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9870E-03 O.OOOOE+00 1.6527E-02 4.700 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.9966E-03 O.OOOOE+00 1.7361E-02 5.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0056E-03 O.OOOOE+00 1.8146E-02 5.300 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0141E-03 O.OOOOE+00 1.8884E-02 5.600 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0220E-03 O.OOOOE+00 1.9580E-02 5.900 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0295E-03 O.OOOOE+00 2.0236E-02 6.200 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0365E-03 O.OOOOE+00 2.0854E-02 6.500 O.OOOOE+00 1.2240E-02 O.ooOOE+00 3.0432E-03 O.OOOOE+00 2.1438E-02 6.800 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0494E-03 O.OOOOE+00 2.1989E-02 7.100 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0553E-03 O.OOOOE+00 2.2511E-02 7.400 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0609E-03 O.OOOOE+00 2.3005E-02 7.700 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0662E-03 O.OOOOE+00 2.3472E-02 8.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.3916E-02 8.300 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.4295E-02 8.600 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.4584E-02 8.900 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.4805E-02 9.200 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.4975E-02 9.500 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.'5104E-02 9.800 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.5204E-02 10.100 O.OOOOE+00 1.2240E-02 O.ooOOE+00 3.0713E-03 O.OOOOE+00 2.5281E-02 10.400 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.5339E-02 24.000 O.OOOOE+00 1.2240E-02 0.0000E+00 3.0713E-03 O.OOOOE+00 2.5541E-02 96.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.5541E-02 720.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 3.0713E-03 O.OOOOE+00 2.5541E-02 Worst Two-Hour Doses

1. ffiii#####################################fiifiifiifiifiifi################fiifiifi#############ifi

CA06451 Rev. OOO Page 85 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.2240E-02 O.OOOOE+00 1.2240E-02

CA06451 Rev.OOO Page 86 of 127 ATTACHMENT S SREPRI OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 2.1387E-05 6.9436E-07 5.0349E-06 1.6346E-07 4.8199E-05 1.5002E-06 0.333 2.2362E-05 7.2597E-07 5.2645E-06 1.7091E-07 7.9459E-05 2.4729E-06 0.500 2.4566E-05 7.9735E-07 5.7833E-06 1.8771E-07 1.3387E-04 4.1655E-06 0.800 2.8139E-05 9.1286E-07 6.6244E-06 2.1490E-07 2.0288E-04 6.3118E-06 1.100 3.2205E-05 1.0441E-06 7.5817E-06 2.4579E-07 2.5216E-04 7.8435E-06 1.400 3.6761E-05 1.1908E-06 8.6542E-06 2.8033E-07 2.9390E-04 9.1405E-06 1.700 4.1802E-05 1.3528E-06 9.8410E-06 3.1848E-07 3.3401E-04 1.0386E-05 2.000 4.7325E-05 1.5301E-06 1.1141E-05 3.6021E-07 3.7531E-04 1.1668E-05 2.300 4.7325E-05 1.5301E-06 1.1233E-05 3.6314E-07 4.1713E-04 1.2966E-05 2.600 4.7325E-05 1.5301E-06 1.1332E-05 3.6631E-07 4.5928E-04 1.4274E-05 2.900 4.7325E-05 1.5301E-06 1.1438E-05 3.6970E-07 5.0325E-04 1.5637E-05 3.200 4.7325E-05 1.5301E-06 1.1551E-05 3.7331E-07 5.4973E-04 1.7079E-05 3.500 4.7325E-05 1.5301E-06 1.1671E-05 3.7715E-07 5.9906E-04 1.8607E-05 3.800 4.7325E-05 1.5301E-06 1.1798E-05 3.8120E-07 6.5137E-04 2.0228E-05 4.100 4.7325E-05 1.5301E-06 1.1933E-05 3.8548E-07 7.0671E-04 2.1943E-05 4.400 4.7325E-05 1.5301E-06 1.2074E-05 3.8996E-07 7.6512E-04 2.3752E-05 4.700 4.7325E-05 1.5301E-06 1.2222E-05 3.9467E-07 8.2658E-04 2.5654E-05 5.000 4.7325E-05 1.5301E-06 1.2376E-05 3.9958E-07 8.9107E-04 2.7651E-05 5.300 4.7325E-05 1.5301E-06 1.2538E-05 4.0470E-07 9.5858E-04 2.9740E-05 5.600 4.7325E-05 1.5301E-06 1.2706E-05 4.1003E-07 1.0291E-03 3.1921E-05 5.900 4.7325E-05 1.5301E-06 1.2880E-05 4.1557E-07 1.1026E-03 3.4195E-05 6.200 4.7325E-05 1.5301E-06 1.3062E-05 4.2131E-07 1.1790E-03 3.6558E-05 6.500 4.7325E-05 1.5301E-06 1.3250E-05 4.2726E-07 1.2584E-03 3.9012E-05 6.800 4.7325E-05 1.5301E-06 1.3444E-05 4.3340E-07 1.3406E-03 4.1556E-05 7.100 4.7325E-05 1.5301E-06 1.3645E-05 4.3975E-07 1.4258E-03 4.4188E-05 7.400 4.7325E-05 1.5301E-06 1.3852E-05 4.4630E-07 1.5138E-03 4.6908E-05 7.700 4.7325E-05 1.5301E-06 1.4065E-05 4.5304E-07 1.6047E-03 4.9715E-05 8.000 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.6984E-03 5.2610E-05 8.300 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.7663E-03 5.4709E-05 8.600 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.7993E-03 5.5726E-05 8.900 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8152E-03 5.6219E-05 9.200 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8230E-03 5.6457E-05 9.500 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8267E-03 5.6573E-05 9.800 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8285E-03 5.6629E-05 10.100 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8294E-03 5.6656E-05 10.400 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8298E-03 5.6670E-05 24.000 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8302E-03 5.6682E-05 96.000 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8302E-03 5.6682E-05 720.000 4.7325E-05 1.5301E-06 1.4285E-05 4.5997E-07 1.8302E-03 5.6682E-05

1. 1. 1. 1. ############-o#####r##########

Worst Two-Hour Doses

CA06451 Rev.OOO Page 87 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 6.2125E-08 4.7325E-05 1.5301E-06

CA06451 Rev.OOO Page 88 of 127 ATTACHMENT T SREPRN OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 6.8281E-06 O.OOOOE+00 1.6075E-06 O.OOOOE+00 1.1967E-06 0.500 O.OOOOE+00 1.0087E-05 O.OOOOE+00 2.3746E-06 O.OOOOE+00 2.5448E-06 0.800 O.OOOOE+00 1.5768E-05 O.OOOOE+00 3.7121E-06 O.OOOOE+00 5.9264E-06 1.100 0.0000E+00 2.1253E-05 O.OOOOE+00 5.0033E-06 O.OOOOE+00 1.0260E-05 1.400 O.OOOOE+00 2.6574E-05 O.OOOOE+00 6.2559E-06 O.OOOOE+00 1.5297E-05 1.700 O.OOOOE+00 3.1750E-05 O.OOOOE+00 7.4744E-06 O.OOOOE+00 2.0849E-05 2.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 2.6772E-05 2.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.7373E-06 O.OOOOE+00 3.2836E-05 2.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.8109E-06 O.OOOOE+00 3.887SE-05 2.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.8829E-06 O.OOOOE+00 4.4873E-05 3.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.9534E-06 O.OOOOE+00 5.0818E-05 3.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.0225E-06 O.OOOOE+00 5.6703E-05 3.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.0904E-06 O.OOOOE+00 6.2524E-05 4.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.1571E-06 O.OOOOE+00 6.8276E-05 4.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.2227E-06 O.OOOOE+00 7.3960E-05 4.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.2873E-06 O.OOOOE+00 7.9575E-05 5.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.3509E-06 O.OOOOE+00 8.5122E-05 5.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.4135E-06 O.OOOOE+00 9.0603E-05 5.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.4754E-06 O.OOOOE+00 9.6020E-05 5.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.5364E-06 O.OOOOE+00 1.0137E-04 6.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.5966E-06 O.OOOOE+00 1.0667E-04 6.500 0.OOOOE+00 3.6795E-05 0.OOOOE+00 9.6561E-06 O.OOOOE+00 1.1190E-04 6.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.7150E-06 O.OOOOE+00 1.1708E-04 7.100 O.OOOOE+00 3.679SE-05 O.OOOOE+00 9.7732E-06 O.OOOOE+00 1.2221E-04 7.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.8308E-06 O.OOOOE+00 1.2729E-04 7.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.8878E-06 O.OOOOE+00 1.3232E-04 8.000 0.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.3730E-04 8.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.4174E-04 8.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.4528E-04 8.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.4810E-04 9.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5035E-04 9.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5215E-04 9.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5359E-04 10.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5473E-04 10.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5565E-04 24.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5932E-04 96.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5932E-04 720.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5932E-04 Worst Two-Hour Doses

1. f#ffffff ####fff#########f################fffff###ff#####ff##

1. 1. 1. 1. ff

CA06451 Rev.000 Page 89 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 3.6795E-05 O.OOOOE+00 3.6795E-05

CA06451 Rev. 000 Page 90 of 127 ATTACHMENT U SRESEC OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 3.3296E-03 1.0371E-04 7.8385E-04 2.4416E-05 9.8724E-03 3.0318E-04 0.500 4.9862E-03 1.5530E-04 1.1738E-03 3.6560E-05 2.0033E-02 6.1517E-04 0.800 6.3577E-03 1.9799E-04 1.4967E-03 4.6611E-05 3.6995E-02 1.1360E-03 1.100 7.7235E-03 2.4050E-04 1.8183E-03 5.6619E-05 5.0860E-02 1.5617E-03 1.400 9.0839E-03 2.8283E-04 2.1385E-03 6.6582E-05 6.3200E-02 1.9405E-03 1.700 1.0439E-02 3.2497E-04 2.4574E-03 7.6503E-05 7.4778E-02 2.2959E-03 2.000 1.1788E-02 3.6692E-04 2.7751E-03 8.6380E-05 8.5965E-02 2.6392E-03 2.300 1.1788E-02 3.6692E-04 2.7956E-03 8.7018E-05 9.6474E-02 2.9617E-03 2.600 1.1788E-02 3.6692E-04 2.8161E-03 8.7654E-05 1.0626E-01 3.2620E-03 2.900 1.1788E-02 3.6692E-04 2.8364E-03 8.8287E-05 1.1568E-01 3.5510E-03 3.200 1.1788E-02 3.6692E-04 2.8567E-03 8.8917E-05 1.2490E-01 3.8338E-03 3.50D 1.1788E-02 3.6692E-04 2.8769E-03 8.9544E-05 1.3400E-01 4.1131E-03 3.800 1.1788E-02 3.6692E-04 2.8970E-03 9.0169E-05 1.4303E-01 4.3901E-03 4.100 1.1788E-02 3.6692E-04 2.9171E-03 9.0791E-05 1.5201E-01 4.6654E-03 4.400 1.1788E-02 3.6692E-04 2.9370E-03 9.1411E-05 1.6094E-01 4.9394E-03 4.700 1.1788E-02 3.6692E-04 2.9569E-03 9.2028E-05 1.6983E-01 5.2121E-03 5.000 1.1788E-02 3.6692E-04 2.9767E-03 9.2642E-05 1.7868E-01 5.4836E-03 5.300 1.1788E-02 3.6692E-04 2.9964E-03 9.3254E-05 1.8750E-01 5.7540E-03 5.600 1.1788E-02 3.6692E-04 3.0161E-03 9.3864E-05 1.9628E-01 6.0233E-03 5.900 1.1788E-02 3.6692E-04 3.0357E-03 9.4471E-05 2.0503E-01 6.2915E-03 6.200 1.1788E-02 3.6692E-04 3.0552E-03 9.5075E-05 2.1375E-01 6.5586E-03 6.500 1.1788E-02 3.6692E-04 3.0746E-03 9.5677E-05 2.2243E-01 6.8247E-03 6.800 1.1788E-02 3.6692E-04 3.0939E-03 9.6276E-05 2.3107E-01 7.0897E-03 7.100 1.1788E-02 3.6692E-04 3.1132E-03 9.6873E-05 2.3968E-01 7.3536E-03 7.400 1.1786E-02 3.6692E-04 3.1324E-03 9.7468E-05 2.4826E-01 7.6165E-03 7.700 1.1788E-02 3.6692E-04 3.1515E-03 9.8060E-05 2.5681E-01 7.8784E-03 8.000 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.6532E-01 8.1392E-03 8.300 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7139E-01 8.3254E-03 8.600 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7434E-01 8.4156E-03 8.900 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7577E-01 8.4594E-03 9.200 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7646E-01 8.4806E-03 9.500 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7679E-01 8.4909E-03 9.800 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7696E-01 8.4959E-03 10.100 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7704E-01 8.4983E-03 10.400 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7707E-01 8.4995E-03 24.000 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7711E-01 8.5006E-03 96.000 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7711E-01 8.5006E-03 720.000 1.1788E-02 3.6692E-04 3.1705E-03 9.8650E-05 2.7711E-01 8.5006E-03 Worst Two-Hour Doses if i if i i f f if if i if # #i# i #f if fHi i##f if #f i i#i #f f#i i #f f#i #i f##f#i if#i ###

f f i i f if i i i#i i#f f i i f if i f i f f i

CA06451 Rev. 000 Page 91 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 5.3181E-06 1.1788E-02 3.6692E-04

CA06451 Rev.OOO Page 92 of 127 ATTACHMENT V SREFFA OUTPUT FILE

1. 1. 1. 1. ff88ff################################ff##################

Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 1.3349E-05 1.5152E-05 3.1425E-06 3.5670E-06 2.4913E-05 2.7804E-05 0.333 2.0127E-05 2.2845E-05 4.7382E-06 5.3782E-06 4.9641E-05 5.5402E-05 0.500 3.9366E-05 4.4683E-05 9.2673E-06 1.0519E-05 1.2314E-04 1.3743E-04 0.800 9.3046E-05 1.0561E-04 2.1905E-05 2.4863E-05 3.4958E-04 3.9014E-04 1.100 1.7122E-04 1.9434E-04 4.0307E-05 4.5752E-05 7.2657E-04 8.1088E-04 1.400 2.7386E-04 3.1085E-04 6.4472E-05 7.3180E-05 1.2719E-03 1.4195E-03 1.700 4.0097E-04 4.5513E-04 9.4396E-05 1.0715E-04 1.9938E-03 2.2252E-03 2.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 2.8959E-03 3.2320E-03 2.300 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 3.5915E-03 4.0082E-03 2.600 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 3.9127E-03 4.3667E-03 2.900 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.0611E-03 4.5324E-03 3.200 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1297E-03 4.6088E-03 3.500 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1613E-03 4.6442E-03 3.800 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1759E-03 4.6605E-03 4.100 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1827E-03 4.6680E-03 4.400 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1858E-03 4.6715E-03 4.700 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1872E-03 4.6731E-03 5.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1879E-03 4.6739E-03 5.300 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1882E-03 4.6742E-03 5.600 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1884E-03 4.6744E-03 5.900 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1884E-03 4.6744E-03 6.200 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 6.500 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 6.800 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 7.100 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 7.400 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 7.700 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 8.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 8.300 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 8.600 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 8.900 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 9.200 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 9.500 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 9.800 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 10.100 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 10.400 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 24.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 96.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 720.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4765E-04 4.1885E-03 4.6745E-03 Worst Two-Hour Doses

CA06451 Rev.OOO Page 93 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.1186E-05 5.5254E-04 6.2717E-04

CA06451 Rev.000 Page 94 of 127 ATfACHMENT W SREFFI2 OUTPUT FILE Cumulative Dose Summary ff#fff#ffiiififif ifif#iff# iffif#i i

eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 2.7291E-0l 9.4407E-03 6.4249E-02 2.2225E-03 6.1515E-Ol 1.9342E-02 0.333 2.8519E-01 9.8624E-03 6.7138E-02 2.3218E-03 1.0138E+00 3.1866E-02 0.500 3.1280E-01 1.0807E-02 7.3639E-02 2.5441E-03 1.7066E+00 5.3616E-02 0.800 3 .7269E-0l 1.2840E-02 8.7736E-02 3.0227E-03 2.6150E+00 8.2100E-02 1.100 4 .4553E-01 1.5292E-02 1.0489E-01 3.6000E-03 3.3313E+00 1.0453E-01 1.400 5.3119E-01 1.8154E-02 1.2505E-01 4.2738E-03 4.0077E+00 1.2568E-01 1.700 6.2952E-0l 2.1420E-02 1.4820E-0l 5.0425E-03 4.7173E+00 1.4784E-01 2.000 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 5.4948E+00 1.7210E-01 2.300 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.0792E+00 1.9032E-01 2.600 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.3621E+00 1.9913E-01 2.900 7.4038E-0l 2.5081E-02 1.7430E-01 5.9046E-03 6.4991E+00 2.0340E-01 3.200 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.5654E+00 2.0546E-01 3.500 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.5975E+00 2.0646E-01 3.800 7.4038E-01 2 .5081E-02 1.7430E-01 5.9046E-03 6.6131E+00 2.0694E-01 4.100 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6206E+00 2.0718E-01 4.400 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6242E+00 2.0729E-01 4.700 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.6260E+00 2.0735E-01 5.000 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6268E+00 2.0737E-01 5.300 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6273E+00 2.0739E-01 5.600 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.6275E+00 2.0739E-01 5.900 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 6.200 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 6.500 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.6276E+00 2.0740E-01 6.800 7.403BE-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 7.100 7.403BE-0l 2.5081E-02 1.7430E-01 S.9046E-03 6.6276E+00 2.0740E-01 7.400 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 7.700 7.4038E-01 2.5081E-02 1.7430E-01 S.9046E-03 6.6276E+00 2.0740E-01 8.000 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 8.300 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 8.600 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.6276E+00 2.0740E-01 8.900 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 9.200 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.6276E+00 2.0740E-01 9.500 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-0l 9.800 7.4038E-0l 2.SO81E-02 1. 7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 10.100 7.4038E-01 2.5081E-02 1.7430E-0l 5.9046E-03 6.6276E+00 2.0740E-01 10.400 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 24.000 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 96.000 7.4038E-01 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-01 720.000 7.4038E-0l 2.5081E-02 1.7430E-01 5.9046E-03 6.6276E+00 2.0740E-0l Worst Two-Hour Doses

CA06451 Rev.OOQ Page 95 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.9987E-03 7.4038E-01 2.5081E-02

CA06451 Rev.OOO Page 96 of 127 ATTACHMENT X SREFFN2 OUTPUT FILE uifif###ifuififif###ifi#ifif#n#n#n##########Cumu#la#tiveDose#Summary Cumulative Dose Summary

1. 1. 1. 1. u###########i ifnun##############n#######n#n#n#### nn########

f###############

eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+OO O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 3.4869E-03 O.OOOOE+00 8.2087E-04 O.OOOOE+00 5.7527E-04 0.500 O.OOOOE+00 4.7747E-03 O.OOOOE+00 1.1240E-03 O.OOOOE+00 1.1063E-03 0.800 O.OOOOE+00 6.7046E-03 O.OOOOE+00 1.5784E-03 O.OOOOE+00 2.2497E-03 1.100 O.OOOOE+OO 8.3254E-03 O.OOOOE+00 1.9599E-03 O.OOOOE+00 3.5279E-03 1.400 O.OOOOE+00 9.7560E-03 O.OOOOE+00 2.2967E-03 O.OOOOE+00 4.8811E-03 1.700 O.OOOOE+00 1.1051E-02 O.OOOOE+00 2.6017E-03 O.OOOOE+00 6.2700E-03 2.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 7.6647E-03 2.300 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 0.0000E+00 8.8679E-03 2.600 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 9.7648E-03 2.900 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.0435E-02 3.200 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 0.OOOOE+00 1.0937E-02 3.500 O.OOOOE+00 1.2240E-02 O.OOOOE+OO 2.8815E-03 O.OOOOE+00 1.1313E-02 3.800 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.1596E-02 4.100 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.1808E-02 4.400 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.1968E-02 4.700 O.OOOOE+00 1.2240E-02 0.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2089E-02 5.000 O.OOOOE+00 1.2240E-02 O.OOOOE+OO 2.8815E-03 O.OOOOE+00 1.2179E-02 5.300 O.OOOOE+00 1.2240E-02 0.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2248E-02 5.600 O.OOOOE+00 1.2240E-02 O.OOOOE+OO 2.8815E-03 O.OOOOE+00 1.2300E-02 5.900 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2339E-02 6.200 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2369E-02 6.500 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2391E-02 6.800 O.OOOOE+00 1.2240E-02 O.OOOOE+OO 2.8815E-03 O.OOOOE+00 1.2409E-02 7.100 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2422E-02 7.400 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2432E-02 7.700 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2439E-02 8.000 O.OOOOE+00 1.2240E-02 O.OOOOE+OO 2.8815E-03 O.OOOOE+00 1.2445E-02 8.300 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2449E-02 8.600 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2453E-02 8.900 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2455E-02 9.200 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2457E-02 9.500 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2459E-02 9.800 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2460E-02 10.100 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2461E-02 10.400 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2461E-02 24.000 O.OOOOE+00 1.2240E-02 O.OOOOE+OO 2.8815E-03 O.OOOOE+00 1.2464E-02 96.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2464E-02 720.000 O.OOOOE+00 1.2240E-02 O.OOOOE+00 2.8815E-03 O.OOOOE+00 1.2464E-02

1. 1. n#n######n########n#####n#############n###################n######

Worst Two-Hour Doses n#n###n#n##n#n##nn#nn#n#######n##n#if#nn#n######n############u######n#n##########n uu

CA06451 Rev.000 Page 97 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.2240E-02 o.OOOOE+0O 2.2240E-02

CA06451 Rev.OOO Page 98 of 127 A1TACHMENT Y SREPR12 OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 2.1370E-05 6.9378E-07 5.0308E-06 1.6333E-07 4.8171E-05 1.4993E-06 0.333 2.2331E-05 7.2495E-07 5.2571E-06 1.7067E-07 7.9394E-05 2.4709E-06 0.500 2.4494E-05 7.9502E-07 5.7664E-06 1.8716E-07 1.3367E-04 4.1594E-06 0.800 2.9188E-05 9.4676E-07 6.8712E-06 2.2288E-07 2.0487E-04 6.3735E-06 1.100 3.4899E-05 1.1310E-06 8.2159E-06 2.6627E-07 2.6103E-04 8.1193E-06 1.400 4 .1618E-05 1.3474E-06 9.7976E-06 3.1720E-07 3.1409E-04 9.7677E-06 1.700 4.9334E-05 1.5954E-06 1.1614E-05 3.7559E-07 3.6976E-04 1.1497E-05 2.000 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 4.3080E-04 1.3392E-05 2.300 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 4.7668E-04 1.4816E-05 2.600 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 4.9890E-04 1.5505E-05 2.900 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.0966E-04 1.5839E-05 3.200 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1487E-04 1.6000E-05 3.500 5.8036E-05 1.8747E-06 1.3663E-05 4 .4134E-07 5.1739E-04 1.6078E-05 3.800 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1861E-04 1.6116E-05 4.100 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1920E-04 1.613SE-05 4.400 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1949E-04 1.6144E-05 4.700 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1963E-04 1.6148E-05 5.000 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1970E-04 1.6150E-05 5.300 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1973E-04 1.6151E-05 5.600 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.197SE-04 1.6152E-05 5.900 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1975E-04 1.6152E-05 6.200 5.8036E-05 1.8747E-06 1.3663E-05 4 .4134E-07 5.1976E-04 1. 6152E-05 6.500 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-05 6.800 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-05 7.100 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 S.1976E-04 1.6152E-05 7.400 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 S.1976E-04 1.6152E-05 7.700 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 .5.1976E-04 1.6152E-05 8.000 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-05 8.300 5.8036E-05 2.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-05 8.600 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-05 8.900 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 S.1976E-04 1.6152E-OS 9.200 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 S.1976E-04 1.61S2E-OS 9.500 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 S.1976E-04 1.6152E-OS 9.800 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-OS 10.100 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 S.1976E-04 1.6152E-OS 10.400 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-0S 24.000 5.8036E-05 1.8747E-06 1.3663E-05 4.4134E-07 5.1976E-04 1.6152E-05 96.000 5.8036E-05 1.8747E-06 1.3663E-05 4 .4134E-07 S.1976E-04 1.6152E-05 720.000 5.8036E-05 1.8747E-06 1.3663E-05 4 .4134E-07 5.1976E-04 1.6152E-05

1. 1. 1. 1. T### Hu##################################

Worst Two-Hour Doses

CA06451 Rev.OOO Page 99 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 7.4822E-08 5.8036E-05 1.8747E-06

CA06451 Rev.O00 Page 100 of 127 ATTACHMENT Z SREPRN2 OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 0.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 6.8281E-06 O.OOOOE+00 1.6075E-06 O.OOOOE+0O 1.1967E-06 0.500 O.OOOOE+00 1.0087E-OS O.OOOOE+00 2.3746E-06 O.OOOOE+00 2.5448E-06 0.800 O.OOOOE+00 1.5768E-05 O.OOOOE+00 3.7121E-06 O.OOOOE+00 5.9264E-06 1.100 O.OOOOE+00 2.1253E-05 O.OOOOE+00 5.0033E-06 O.OOOOE+00 1.0260E-05 1.400 O.OOOOE+00 2.6574E-0S O.OOOOE+00 6.2559E-06 O.OOOOE+00 1.5297E-05 1.700 O.OOOOE+00 3.1750E-OS O.OOOOE+00 7.4744E-06 O.OOOOE+00 2.0849E-OS 2.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 2.6772E-05 2.300 O.OOOOE+00 3.6795E-0S O.OOOOE+00 8.6621E-06 O.OOOOE+00 3.2167E-05 2.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 3.6408E-05 2.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 3.9747E-05 3.200 O.OOOOE+00 3.6795E-OS O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.2377E-05 3.500 O.OOOOE+00 3.6795E-05 O.OOOOE+OO 8.6621E-06 O.OOOOE+00 4.4452E-05 3.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.6090E-05 4.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.7385E-05 4.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+0O 4.8409E-05 4.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.9219E-05 5.000 O.OOOOE+00 3.6795E-Os O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.9861E-05 5.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.0370E-05 5.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.0774E-05 5.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1094E-05 6.200 O.OOOOE+00 3.6795E-05 O.OOOOE+0O 8.6621E-06 O.OOOOE+00 5.1349E-05 6.500 O.OOOOE+00 3.6795SE-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1551E-OS 6.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1712E-05 7.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1840E-05 7.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1942E-05 7.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2023E-05 8.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2087E-05 8.300 O.OOOOE+OO 3.6795E-OS O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2139E-05 8.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2180E-05 8.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+0O 5.2213E-05 9.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2239E-OS 9.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2259E-0S 9.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2276E-05 10.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2289E-05 10.400 O.OOOOE+OO 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2300E-05 24.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 S.2343E-05 96.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2343E-OS 720.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2343E-05 Worst Two-Hour Doses

1. 1. 1. 1. fififififf###

1. ## fi

fi

1. fii

1. fi#fi fiffi

1. fi

1. fi#fiiiii

1. ####ifi fiifi#i#if###########

ii iif#i#######f

CA06451 Rev. 000 Page 101 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 3.6795E-05 o.OOOOE+00 3.6795E-05

CA06451 Rev. 000 Page 102 of 127 ATTACHMENT AA SRESEC2 OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 3.1623E-03 9.8502E-05 7.4447E-04 2.3189E-05 9.3760E-03 2.8793E-04 0.500 4.7359E-03 1.4750E-04 1.1149E-03 3.4725E-05 1.9026E-02 5.8426E-04 0.800 7.5541E-03 2.3524E-04 1.7784E-03 5.5379E-05 3.8598E-02 1.1852E-03 1.100 1.0355E-02 3.2240E-04 2.4377E-03 7.5898E-05 5.9664E-02 1.8320E-03 1.400 1.3138E-02 4.0899E-04 3.0929E-03 9.6284E-05 8.1384E-02 2.4987E-03 1.700 1.5904E-02 4.9502E-04 3.7440E-03 1.1654E-04 1.0335E-0O 3.1729E-03 2.000 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.2536E-01 3.8485E-03 2.300 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.4109E-01 4.3313E-03 2.600 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.4872E-01 4.5653E-03 2.900 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5241E-01 4.6787E-03 3.200 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5421E-01 4.7337E-03 3.500 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5508E-01 4.7604E-03 3.800 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5550E-01 4.7733E-03 4.100 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5570E-01 4.7796E-03 4.400 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5580E-01 4.7826E-03 4.700 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5585E-01 4.7841E-03 5.000 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5587E-01 4.7848E-03 5.300 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5588E-01 4.7852E-03 5.600 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7853E-03 5.900 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7854E-03 6.200 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7854E-03 6.500 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 6.800 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 7.100 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 7.400 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 7.700 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 8.000 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 8.300 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 8.600 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 8.900 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 9.200 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 9.500 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 9.800 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 10.100 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 10.400 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 24.000 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 96.000 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 720.000 1.8652E-02 5.8049E-04 4.3911E-03 1.3666E-04 1.5589E-01 4.7855E-03 Worst Two-Hour Doses ft# i i i i i i i iififf#####################f

1. 1. 1. 1. i f f fi i i i iif#########iififif########K##ff ii

CA064551 Rev.000 Page 103 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 8.3439E-06 1.8652E-02 5.8049E-04

CA06451 Rev. 000 Page 104 of 127 ATTACHMENT AB SREFFA2 OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.tOOOOE+00 O.OOOOE+00 0O.OOOOE+00 0.250 1.3349E-05 1.5152E-05 3.1425E-06 3.'5670E-06 2.4913E-05 22.7804E-05 0.333 2.0127E-05 2.2845E-05 4.7382E-06 5.1 3782E-06 4.9641E-05 ! 5.5402E-05 0.500 3.9366E-05 4.4683E-05 9.2673E-06 )519E-05 1.2314E-04 3 .3743E-04 0.800 9.3046E-05 1.0561E-04 2.1905E-05 2.4 1863E-05 3.4958E-04 33.9014E-04 1.100 1.7122E-04 1.9434E-04 4.0307E-05 4.! 5752E-05 7.2657E-04 88.1088E-04 1.400 2.7386E-04 3.1085E-04 6.4472E-05 3180E-05 1.2719E-03 1 .4195E-03 1.700 4.0097E-04 4.5513E-04 9.4396E-05 0715E-04 1.9938E-03 22.2252E-03 2.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 2.8959E-03 33.2320E-03 2.300 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 3.5915E-03 44.0082E-03 2.600 5.5254E-04 6.2717E-04 1.3008E-04 4765E-04 3.9127E-03 44.3667E-03 2.900 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 4.0611E-03 44.5324E-03 1.'

3.200 5.5254E-04 6 .2717E-04 1.3008E-04 1.4 1765E-04 4.1297E-03 44.6088E-03 3.500 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1613E-03 44.6442E-03 3.800 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 4.1759E-03 44.6605E-03 4.100 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 4.1827E-03 44.6680E-03 4.400 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 4.1858E-03 44.6715E-03 4.700 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 4.1872E-03 44.6731E-03 5.000 5.5254E-04 6.2717E-04 1.3008E-04 1.4 1765E-04 4.1879E-03 44.6739E-03 5.300 5.5254E-04 6.2717E-04 1.3008E-04 1.4 4765E-04 4.1882E-03 44.6742E-03 1.4 5.600 5.5254E-04 6.2717E-04 1.3008E-04 1.4 4765E-04 4.1884E-03 44.6744E-03 1.4 5.900 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1884E-03 44.6744E-03 1.4 6.200 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 6.500 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 6.800 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 7.100 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 7.400 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 7.700 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 8.000 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 8.300 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 8.600 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 8.900 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 9.200 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 9.500 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 9.800 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 10.100 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 10.400 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 1.4 24.000 5.5254E-04 6.2717E-04 1.3008E-04 4765E-04 4.1885E-03 44.6745E-03 1.4 96.000 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.674SE-03 720.000 5.5254E-04 6.2717E-04 1.3008E-04 1765E-04 4.1885E-03 44.6745E-03 Worst Two-Hour Doses

CA06451 Rev.000 Page 105 of 127 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.118GE-05 5.5254E-04 6.2717E-04

CA06451 Rev.000 Page 106 of 127 ATTACHMENT AC ETP-97-064R CONTROL ROOM INLEAKAGE RESULTS

lull

COTrr)'jIFTn C406Yvr,;.D

-. 001 W itpa ° ..

a7 CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE V'A UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION 0 Effective Date /// 7 Safety Related X Non-Safety Related ._:

Writer: D.T. McElheny Sponsor V. P. Spunar C0NT~R0!JJ Copy.

S.

cfochr,

- &vo FT-86 (Rev. 1 10/97) - ACUS1U Attachment 2

Page 37 of 40

NUCON lnternotional, Inc.

_ . .. . y

. I e ~Decay Ilest Data EN - LA Estiffltdd duration oftest: ';' hqggs Beginng cQncentration (0C- -19.o pb Ending concentration (C(O)): 2 7ppb Time at start of test:' .. . inie "ze ro" for decay test was at 01:15 hours on 18 Nov 97.

Time at end of test . . f 2hoi irs on 19 Nov 97 Sample time intervals: I.5 minirte -. excent for last samtile Timne I Sample Concentration Time/Conc. TimdConc. Time[Cone. Time/Conc.

01:15/ 19.0 I 01:301 14.8 . _

/1 I

01:451 12.1 02:00/ 8.3 _ i / . .I

02 151 6.7*.

. //

/

02:30/ 5.1 . / /

03:12/ 2.7 (A) Air Change Rate (f/xnin) (Q) Inleakage Flow Rate (CFM) 0.0170 4300 95% Confidence Limit 95% Confidence Interval (A)= 0.0170 :_,QQQI2, 4000 <Q<' 4600 -

Comments: Decav sagfples taken at a sampIe port on the dischage of #1 I return fan. All sample . .... _

concentrations in the PPb Tanae.

MbOdM ),K ':4;e z / Iea Tesf personnel signahlre(s) and date: NUCON International Inc.

C4o6C/f/ Atv f' 5 e_ * /

,,T-86 (Rev. 1 10197) ACU#12 Attachment 2 Page 37 of 40

" 'NUCON International, Inc.

rv Decay 2stData Estimated duration o:f test: - 1.4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months Beginning concentral :Ion (Ct):. 40.5 'ub Ending concentratior L(C(O)): 14.2 Pyb Time at start of test Time "zero" for decay test was at 23:16 hours on 19 Nov 97.

Time at end of test: - Y,46-hours-&2 Nov 97 Sa~mple tmeilntervaLs: 15 minute Time / Sample Concentration Time/Conc. Time/Conc. Time/Conc. Time/Conc.

23:16/ 40.5 / / I, 23:31/ 35.2 /1

. I 23:46/ 21.2 /

I 00:01/ 26.7 I /

00:16/ 20.3 . -. / f I 00:31 / 16.7 ./

00:46/ 14.2 (A) Air Change Rate (1/min) (Q) Inleakage Flow Rate (CF1 0.011g . 3000 95% Confidence Limit 95% Confidence Interval (A) -OJOU Qf.QQ12_ _ -29Q0 <Q< 3300 Comments: Decay Fambles taken at a sample Port on the discharge of #12 retu fn, These samples were taken in c6oiiunction with samples taken in CAS and on both CSR return ducts.

The decay sample taken at 23:46 hou= as disregarded due to a faulty gas sample bag-Test persounel signa e(s) and date: CON International Inc.

I C4oryrl Awe

/e5p //0 CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION 0 Effective Date /1/ /777' Safety Related X Non-Safety Related Writer: D.T. McElheny Sponsor: V. P. Spunar i

~44A / 6 A CeoGy~5/ /t oL A e-e1//

NUCON International, Inc. b 7 TELEPHONE: (614) 848-5710

OUTSIDE OHIO: 19800-992-5192 P.O. BOX 29151 7000 HUNTLEY ROAD FAX: (614) 431-0858 COLUMBUS, OHIO 43229 U.S.A.

K' 6A Control Room Inleakage Test Report performed for:

Baltimore Gas and Electric Company Calvert Cliffs Nuclear Power Station 1850 Calvert Cliffs Pk~w.

Lusby, Maryland 20657 P.O. No. 16582 20 April 1998 Distribution:

BG&E:

Dale McElheny (1)

NUCON:

12BG847 rVIF (1)

Field Test (1)

QA . (1)

Marketing (1)

NUCON 12BG847 /02

GCv6es'/ 1ZYO FT-86 (Rev. 1 10/97) ACU#11 Trip 2 Inidal CharacterizationTest Attachment 2 Page 37 of 40 Demayft Estimated duration of test: 120 minutes Beginning concentration (Ct): 25.0 ppb Ending concentration (C(O)): 4.1 ppb Time at start of test: Time "zero" for decay test was at 22:03 hrs. on 10 Feb 98 Time at end of test: 00:03 hrs. on 11 Feb 98 Sample time intervals: 20 minutes apart Time / Sample Concentration Time/Conc. Tinie/Conc. TinielConc. Time/Conc.

22:03 /25.0 l / /

22:23 / 17.9 /. /

22:43 / 11.9 :/ /

23:03 / 9.7 /*. /

/ l 23:23/9.0 l / /

23:43 /5.7

/

00:03 / 4.1 /

(A) Air Change Rate ( /min) (Q) Inleakage Flow Rate (CFM) 0.0143 3,600

-95% Confidence Limit . I95% Confidence-Interval-

(A) = 0.0143 -: 0.0025 3000 <Q< d3W X zlAeq:

Comments: Decay samples taken at a samRle port on the discharae of #11 return fan. All sample concentrations in the npb range.

I Ae- ,.ap6it0 .

0 / C< s-A 77V&

AL?6 Ho

./

Test personnel signature(s) and date: NUCON International Inc.

C-Og(csj/ AW'

°4Ee J}3 FT-86 (Rev. 1 10/97) ACU#12 Trip 2 InitialCharacterizafionTest Attachment 2 Page 37 of 40 Decay Test Data Estimated duration c)ftest: 120 minutes Beginning concentrn tion (Ct): 47 ppb Ending concentratio: n (C(O)): 12.6 ppb Time at start of test: Time "zero" for decay test was at 02:05 hrs. on 11 Feb 98 Time at end of test: 04:05 hrs. on 11 Feb 98 Sample time interval..Is:. 20 minutes anart Time / Sample Concentration Time/Conc. Time/Conc. Time/Cone. Tiine/Conc.

02:05 / 47.0 02:25/ 33.2 / / -/

02:45 /27.4 l /

03:05 / 24.8 */ /

/

03:25 / 21.4

/ / /

03:45/ 16.1

/ /

04:05 / 12.6 (A) Air Change Rate ( 1/min) (Q) Inleakage Flow Rate (CFM) 0.0101 2550

- 95% Confidence Limit - - - 95% ConfidenceInterval (A)= 0.0101 fI- 0.0018 2100<Q< 3000 Comments: Decay samples taken at a sample port on the discharge of #f12 return fan. All sample concentrations in the ppb range.

Test personnel signature(s) and date: NUCON International Inc.

I . . . . . C6S7 Aird CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION 0 Effective Date //1/1/11 7 Safety Related X Non-Safety Related cotr Writer: D.T.McElheny Sponsor: V. P. Spunar

Approve,

kt /. c ase-,. 4, CA&6Y7/ /er.O 7

Pesy /1 TELEPHONE: (614) 846-5710 NUCON International, Inc. OUTSIDE OHIO: 1-800-992-5192 K'1 P.O. BOX 29151 7000 HUNTLEY ROAD COLUMBUS, OHIO 43229 U.S.A.

FAX: (614) 431-0858 EJ04 Control Room Inleakage Test Report performed for:

Baltimore Gas and Electric Company Calvert Cliffs Nuclear Power Station 1850 Calvert Cliffs Pkwy.

Lusby, Maryland

-20657 PO. No. 16582 20 April 1998 Distribution:

BG&E:

Dale McElheny (1)

NUCON:

12BG847 MIF (1)

Field Test (1)

QA (1)

Marketing (1)

NUCON 1.2BG847 /02

.FT-86 (Rev. 1 10/97) A CU #11 Trip 2 Test WITemPorarv ModIr(cationIn-place Attachment 2 Page 37 of 40 Decay Test Data Estimated duration c)ftest: 120 minutes Beginning concentrzition (Ct): 37.5 ppb*

Ending concentratio: n (C(O)): 9.2 ppb Time at start of test: Time "zero" for decay test was at 01:15 hrs on 12 Feb 98 Time at end of test: 03:15 hrs on 12 Feb 98 Sample time interva: Is: 20 minutes apart Time / Sample Concentration Time/Conc. Time/Conc. Time/Conc. Time/Conc.

1:15 /37.5 1:35 /28.1 I * . I I/

1:55 / 24.7 /

2:15 / 19.3

/ I 2:35 /15.7

I I /

2:55 /11.7

/

3:15 / 9.2 /

(A) Air Change Rate (min') (Q) Inleakage Flow Rate.(CFM) 0.0115 2.900 95% Confidence Limit 95% Confidence Interval (A)= 0.0115 4 .0010 2650 <Q < 3150 Comments: Decay samples taken at a sample port on the discharge of #11 return fan. All sample concentrations in the pyb range.

Test personnel signature(s) and date: NUCON International Inc.

OCc,6v- gejo FT-86 (Rev. 1 10/97) ACU#12 Trio 2 Test wITemporary Modification In-place Attachment 2 Page 37 of 40 Decay Test Data Estimated duration c)ftest: 120 minutes Beginning concentraation (Ct): 37.5 ppb Ending concentratio. Fn (C(O)): 9.2 Vpb Time at start of test: Time "zero" for decay test was at 21:25 hrs. on 11 Feb 98 Time at end of test: 23:25hrs.on 11Feb98 Sample time interva]Is: 20 minutes anart Time / Sample Concentration Time/Conc. Time/Conc. Time/Couc. Time/Conc.

21:25 /37.6

/

21:45 / 30.2

.22:05 /25.2 i/ I.

22:25 / 22.7

/

22:45 / 15.5 I ; I /

23:05 / 13.4 I I

23:25 / 10.5 I (A) Air Change Rate (1/min) (Q) Inleakage Flow Rate (CFMI) 0.0109 2.750 95% Confidence Limit 95% Confidence Interval (A) = 0.0109 + .0015 2370 <Q< 3130-Comments: Decay samples taken at a sample port on the discharge of #12 return fan. All samnle concentrations in the ppb range.

Test personnel signature(s) and date: NUCON International Inc.

Cho6yrl A4 V Pdg *//m CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE qy ENGINEERING TEST PROCEDURE 1A UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION I Effective Date i/l &/°o Safety Related X Non-Safety Related CONTROLLED COPY Writer; D. T. McElheny Sponsor: T. R. Lupold Approved /-- I /Da-a

/~ ~ TELEPHONE: (614) 846-5710 NUCON International, Inc. TOLL FREE: 1-800-992-5192 FAX: (614) 431-0858 P.O. BOX 29151 7000 HUNTLEY ROAD WEB SITE, wwncnn5o COLUMBUS, OHIO 43229 U.S.A. WEB SITE: www.nucon-Int.com Control Room Inleakage Test Report performed for:

Baltimore Gas and Electric Company Calvert Cliffs Nuclear Power Station 1850 Calvert Cliffs Pkwy.

Lusby, Maryland 20657 P.O. No. 16582 3 March 2000

~: I Distribution:

BG&E:

Dale McElheny (1)

NUCON:

12BG658 MF (1)

Field Test (1)

QA (1)

Marketing (1)

NUCON 12BG658 /01

Got$*/ dego FT-86 (Rev. 1 10/97) BG&F. ETP-A7--64R-REVt - Attachment-2 Page 37 of 40 Decay Test Data Estimated duration c)f test: 180 minutes Beginning concentrELtion (Ct): 51.4 ppb Ending concentratio' n (C(O)): 13.2 ppb Time at start of test: Time "zero" for decay test was at 01:05 hrs. on 26 Jan 00 Time at end of test: 04:05 hrs. on 26 Jan 00 Sample time interva Is: 15 minutes anart Time / Sample Concentration Time/Conc. Time/Con.c

Time/Cone. Time/Cone.

/

120/23.8

/

30/ 51.4 135121.0

/

451 47.6 150A17.8 60141.9 165/16.4 /

,/

75/ 33.0 180113.2

/- / /

90/ 30.7 105/ 29.3 / /

(A) Air Change Rate ( I/min) (Q) Inleakage Flow Rate (CFM) 0.00896 - 2600 95% Confidence Limit 95 % Confidence Interval (A) = 0.00896 :h 0.00065 2400 < Q < 2800 Comments: Decay samples taken at a sample port on the discharge of f12 return fan. All sample concentrations in the ppb range.

Test personnel signature(s) and date: NUCON International Inc.

A4

ET-86 (Rev. 1 10/97) BG&E ETP-97-064R-RFVI A-ttach-men't2 Page 37 of 40 Decay Test Data Estimated duration of test: 180 minutes

Beginning concentration (Ct): 59.2 pb i() 15 minutes into test Ending concentration (C(O)): 8.8 ppb Q, 195 minutes into test Time at start of test: Time "zero" for decay test was at 23:35 hrs. on 26 Jan00 Time at end of test: 03:00 hrs. on 27 Jan 00 Sample time intervals: 15 minutes apart to 105 minutes then () 140. 165, and 195 minutes Time / Sample Concentration Time/Conc. Time/Conc. Time/Cone. Time/Conc.

15/59.2 ,165/13.8 l l

30/52.5 195/8.8 /

45/42.8 /

/ /

60/40.2 75/36.1 /

_105 /26.2 I

/

1401 17.4 (A) Air Change Rate ( 1/min) (Q) Inleakage Flow Rate (CFM) 0.0103 3000 95% Confidence Limit 95 % Confidence Interval (A)= 0.0103 i 0.00085 2750 < Q < 3250 Comments: Decay samples taken at a sample port on the discharge of X11 return fan. All sample concentrations in the pub range.

IG-I

'/ - 3 Test personnel signature(s) and date: NUCON International Inc.

CA06451 Rev. 000 Page 122 of 127 ATTACHMENT AD ETP 01-035R PERFLUOROCARBON TRACER GAS TESTING

tef6(lrl/ &gk'o i 1/2-3 CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE UNIT 0 ETP 01-035R PERFLUOROCARBON TRACER GAS TESTING REVISION 0 . m I

Effective Date Safety Related x Non-Safety Related Writer: D. T. McElheny Sponsor: M.A Junge Approved A,t t ,,01 i~ i I Dat-e-o Date

JUL 29 '02 03 37PM BNL DRS/ECD 426 ; P. 114 .

A-41 TRACER' diC$NOLOGY CENTER .' .

BROOKHAVEN NATIONAL A ORA TORY.

: . ~FACSI LE :., r;.;>@*,

,;,.-Z

- * . .. .. :>. :4)ATE.. JUIY :29, 2.O2 TO: . John E. Wynn Jr. . ..

~Y i _g !.

AUX $Systexns zngr umt Calvert Cliffs Nuclear Power Plant.

Lusby, M 20657 FAX-NO: (410) 495 - 4727 MSSAGE:

John, I'm on vacation this week but wanted to send you the. finAl results but without my final assessmenti. Remarkably, total inleakage was 2930 ! 185 cftS. Other flows, incfin, were:

Zone From/To' :CR Inleakaje .% of tota . C Outlcage: Yo o o 0acsido' :.275 k -185.. 91:66J 4

.2 AB . 436 I57.* . .15... -: ,36 24 8:... 13 .

.:3 TB ' .46'+..661:72.. 1 6 ,. s9;§5.,. 2 ......

4 MSEv" 272+.134 . .9 . . 44*.33 2 5.* A1*-IR* .. .li74 2. . 3: :: I 6 . AC.13 ** 8v7:t 38 * *3 . 11i: 0

.7 .SWGRs . 8184 .114 28 . ,21.4i, Io More next week. I'1;put a copy inrthe mail also.

Total no. of pages including this cover page:

From. Ruissell N. Dietz- liead ! 'ep .*e ,(60 . 3 . 4 28 Tracer Tbchnolog Center. :: .:;',:',Fasx (6 .1) 3 S7 :...

Atmospheric Sciences Divis'ion. Con'inati) 3443275

BrookhavenNational Laboratory 3/4';mui1: :dietz~n1.gov Bldg 815E . I Secretary: Barbaral Roland Upton, NY 11973-5000* Secretary's cmail: rolaiidibnl.gov

..I

JLL 29 '02 '03:37PM BNL' DAS/ECD 426 , -*y6ei tvg 33 -- AX3. S .7.: 36:28 O7 -- 19 PROJECT: CALVERT CLIFFS START: 09:00 fO8-O6-i9o0): BNL CODE: 'CALlAO HOUSE:CALVERT CLIFVS -STOP: 1O0:0 (06-:18-i.9O2) . ANALYZED: 06-27-1902

* ** RATES

OVERALL iNFILTRATI0N RATE - %515978A. L o692.'I(t-.3/h) rf>zRALL AIR EXCHANGE RATE 1. 461..j G. 251(I/)

O ZONE SOURCE RATE EXFILTRATION .. -;--NFILTE ATIN----'

N LOCATION ^25C QT' @T RATE 5. RATE SD ACH . s15 M (nL/m) (nL/Jha (m 31h) (m3/h) /h)

.1G . . Z663 .0. 1 44812 3l7C>.: - S4..8 379.6 0 .0.04 2 AB3 3858.0 4. 973219 . 30896. 3 110486."' -3270765 11645.0 O..68S0 'O0.2 44 3.TB' 7o3870.0 .12 %3399361A411130: .88819. 1 4i9373.a8 '90345.6 1.482 .0

.328 4 MSIVs %458.0 4 189594 22087.4 10568.3 5694.9 . 8281.4 4.658 '6.77 Sl No.ll AC %2150..0 1 132691' 30819.8 3244.1'5 32226.2. 3348.5 19.042 2.1 96 6 No.13 AC 6.4 30 12620 14492 .4 1194.7 . :8912:'2 1907.4 ' 2.460 0.541 7 SWGR:P 9.2 10 6435 3381.7 10458.4 16598.8' 1527.7 2.346 0.246 ZONE-ZONE RATE . SI) (m 3/h) ZONE-ZONE A g S (67/.)9 1.- 2 622.2 421.7 2.* '741.3 267.9 1 1018-1'

704-6 3 1 79.. 292.2 2.

1_-4 .74.5 .5671. ... .. 9. *..227.-:2

32. 10 69 '5. '64; 22-'3 2_.4'1 2870.3 .14603.4 237 ' .67'. -3 1 '

145264 3

4557" ..

2 - 4 30.1 869.4 6-4 '237 86s 7

.2-3 -74:104*4%1a4 5 I'*1.6`5- 3 0.. . ... .3: ~3~ 138 7. 4 48. . :

2 -6< '4.2 .2179 :.* *.". '*..Y: 314.4. 243:'

2- 622 27 7 - . 5114 5564

-4 .*17034:4a %11524't3 .4 .3- . 144 132 3-5. .163.4 1-15';6 .. . *'807.0 235.2

'3 -.8 8416.2 19652~ 6 -3 1002.9 424.6 3 - 7 215.4 1033.1. 7 -3 :1267.1.2 Y%11138.9

4. -'5 '80.1 35.b 5., 4 133.1 86.7

-6 12.7 :5 6 4 755.3 506.8

,7 30.9 '191 7 4 -541'.5 547.'4 5 - '6 60.8 11.3 '6 - 5 125.9 120.7 5 -7 .22.3 .7.0 . '7 -5' " 2 7. 6 62.7 6 - 7 91.1 20.99 7 - 5 : r7. 214.7

'- -TOTAL-FLOW -IN 0t:U kONE: JATE g SD (m3/h) 'ACI g SD(/h) ZONEE RATE .SD (#nt3/h) ACH gSDt/h-)

I fi49.73 4 310. 0.586' 0.047' ' .2 35l1ii.:%12483 9 0.73O- 0.282:

53%4377~r.937.: '1.547 p.3340 -318&69 %11083.4.' . 18,966 9.

11529. 2.22 . , .0."386 5 326347.6 3389.9 1.291 2.2236 . .f '17439 5 1095J .. 814' 7 17547.1 1595.5 2.480 0;957 :

j TIP! AS:..iL . '.. M

' 'S. :,I.

'-t' . .. . . '

I' ptPDCH1 ' C PDCB' ' Pt-P1 .S ocPDI iP+CH 9490 Pt.PDi 8A47 'a 0.43 4.466 q 0.173 2.352 Q 0:111 0.186 q 0.078 0;396 e 0.014 0.101 q 0.005 0.106 g '0 009

458110 P~cP 0.151 < 0.oas 27.815 q *g.7QI G.114'q 0.065 0.103 < 0.090 0.046 g 0.026 0.009 q 0.004 0.0oa < Q

,283000 PDc8 *0.021 :t,{gANA'L*--

'g*8!' 0.013 0.219 y 0.049 7.184 n~1.632 0.008 s 0.001 0.009 q 0.001 Q.002 q 0.001 0.011 q 0 1oo223 T-?CU 0.043 o 0.011 0.1%6 s 0.026 5.846 'q 2.452 8.184 s 3.895 0.033 .q..0.009 0.025 q 0.011 0.000 ¢ .0 1692 ~BU 0.00D9 s .0.001 0.D17 g 0.003 0.06? q 0.021 '0.016 ¢ .0.005 4.085 Q 0.389 0.003 2 p.003 0.000 Q 0

2<622 ocPDOH 0.020 q 0.001 0.1.29 g 0.010 3.754 Q 0.2S9 .0.010 e 0.001 . .019q~0.002 0.725 v 0.035 .0.006 20

.15 iPPCI .0.023 q 0.031 G.888 g 0.14S 0.l35 § 0.054 0.Ql9 t Q.005:' a.000 a 0.0Q1 0.004 g 0.001 .0.867 g 0 aJU~t . .

JL29 '02 03: 38PM E3NL DRS/ECD 426 COtjC~qTPATI1O?~tPL/L)

CAMS PtPDCH FMC FMC T-P7M P0 WM~c .IPPOB WMDC xtPDCB OM* 2-Pld 477.47 .3.899 2.68B 0.83V *07' b.095 :0.083 . 0.000 &273 1.95.

.131:D1 ______________

819 81 442 2.249 .3 9 .07' 0.096 - 0.:000 9A63..34 .22 12400 9.277 4.010 2.428 0.80 G 5. 0'.109.0.O ;0.000 0.,964 ~ .88 V24 .. ' . ...

12321. 5.090 4.691* 2.82.5 *0 4 I :106O..9 D.0J09 *O.0000 MM34 9 .61 0.238...

12055 8.689 4.290 2.432 0.804 .393 0.104 0,122 "~0.000 10.829 S.S ~.24 12631 8.324 1.340 2.500 0.777 0.379 0.101 0.123 *0.000 3.588 . .875 *:23 10187 MM 8.6 .382 2.321 0.758 0.45 0.107. 0.103'. 0.000 9.774 6540.23 12057 .8.446 4.59 2.370 0.978' 0.389 0.101 0.105. 0.000 10.017 8.3 'O.304 109 .98 4.410 2.454 0.712. .0.394 0.096 006 000 9.5 829 0.1 06.2.,219 0.721 0.383 *0,09,1 0.100 0.000 9.20 S8 4 0.,221.

IAS.0,MU 0.777 0.39 0.100. 0.105 0.000 9.3924 8380 0.237 1 20 7.12& 8.6&3 2.295 0.657 0.804 0.102 0.089 0.000 B.413' 7.441 0.198.DEIXTED L 2268 6.923 4.160 2.46Y 0.644 0.520 0.110 0.087 0.00 8.174 7.227 0.194 DPETIED 2138 7.55 4.335 2.589 0.698 0.558 0.118 0.096 0.000 8.920 7:'898 011 IMMDEED I 3644 *. 3.86 . 2.495 3.554 0.826 0.184 0.145 0.052 0.000 4'003' 3.510 :0.094 DEMLETE 12390 .0.204 [0.415 15.834 0.020 0.015 0.002 0.007 0.000 0:187 0.164 6.OSDLETD 1 12036 5.449 3.128 7.235 0.502 0.276 0.06[ 0065 .0.000 6.274' 5.527 .0. 149 DEL!TID UJO111~94 54 M 5 .67 ~ '14 .62 .0 W7 '0 A DELETED 12O 1.03 V. . 8 OU 0.76. 0.1 . 01 L0.25 1.H0 .0g. DELETED 4779 0.0311 0.098 2.728 0.014 1.359 0.490 0005 . 0.000 0.459 0.400 .0.005 DELEED 4627 3.552 2.287 1.971 0.323 1.448 0.122- .0.043' 0.00 8.844 3.458 *0.092 DETRUM 12497 2.791 1.837 1.829 0.249' 1.879 .0.106 0.034 0.000 3.014 2:'637 0.070 DELEED 12183 0.030 11.417 0.020. 0.002 0.009' 0.001 0.008 0.000 0.000 0.000 ,.0.000 DELET 12063 0.025 10.242 0.141 0.001 0.014 0.002 0:007:. 0.000

. 0.000 0.000 0.000 DELETE 12393 0.025 1.611 1:556 0.098 1.488. 0.338- 0.005 0.000 ." 0.330 0.289 1.028TY'LPTED

.12009 0;072 16.480 0.089 04078' ..035 0.011. 0.014 .0.00 0.000 'O0908 Z.:;21~.

12264 0.4 35.832 0.214 0.202 0.057 0.018* 0.008* :0.000 0Q. 00 c.56.

127 .17 4.64 0244 0.257 0.080 0.00$ -0.008 OAR00 0.000 0.000 .0.07

12297 *.0.528 14.879 1.821 'O.6.2 -O.'36 0.119~ 0.009' U0.000 0,641 o:s0 ',56 0:"2OEPELETD

'12191. 0:.163 16.484 .1.16 0.3 *05B O1 008.00 00 .2 . 0.18~REE 12379. 0.335 30.172 0.222 0.061 'O088 0.012. 40.5.. 0.000 0.408 0:357 .- '1-12012 1.489 20.586 0.519 O.7' .0~9 0.00 0;:018 0.000 1.56!1 AX62. '0:049"DRLEED 12244 0-112 25.193 .16 0061 0.069 0.003 0.003 0.0 012 10.007 12155 0 107 26.430 0.094 VD.044 0.031 0.ON'. 0.00,1 0.000 0.181 0.159 0.0125 12384 0.507 0.312 4.404 0.044 0.923 0.253' 0.011~ 0,000 0.688 0.600 .'0.012 DUSETED 11218 4.313 2.583 1.058 0.367 0.203. 0.049 O.'067 'MOO 4.586 4.026 0.107 DRIXIED

'551 0.058 3.165 0.464 0.092 0.219 0.070. 0008 0.000 0.124 0.109 0.02 DELETEIY

50 0019 0.A91 7.035 0.005. 0.009 0.0 0:0 H0 g.02 0.022 0.002 12402 0.020 (1.17 7.297 0.008 0.010 0.0 0. 90 0 .26~ 0.023 0.002-12337 0.014 0.156 6.492 0.004 9.009 .0.002 .0.004 0.000 0.0120 0.018 0~02' 12417 0.017 0.23S 9.217 0.007 0.009- 0..003. -0,00B 0.000 0,024' 0.0272 .0.002 124265 0.0ON 0.205 8.888 0.008> '0.01V. 0.003' 0.05 .0,000 0.0S8 2~0.034 0. 03:..

12488 -.

0.062 0.881 15.438 0 0097 :0.'09 *0.004 0 D .00' A~ . 0:04. A& 003DELTED.

12383 0,015 0.195 8.342 ~0:005 0.007 0.001 .0.011 0.000 0.021 0.019 -0.02:-'-

12203 0.055 0.320 10.741 0.0.005 :0.009 0 '003 0. 04 000- 0:056 .0.050 b: 3.oa:, .

124118 0.013 0.29 981 0.006:. 0.O 9 Mo0.0 01*05 0.000 0.019s 0017 A 20.00 12288 UK03 0.82 12712 .03 0.008~ 0.002. 0.011 *0.000 0.,035 0.031 V0:041MMED.* ..

U 10 .21 0.05.0.OM 4 .07 0.0-:A0 .125 0.1Q 7U07 . 0 :128I 4:01 0.00 0.021 0.185 0.'006. 0.000 0.O1 0.0.54 0004 1202 0.016 _1.1290.2311 002 00.03g~0:005 ON 078 0.00 0.034 0 0 000 12307 0.029 0.051 0.080 0.010 4.300 0.004 .0.3 0.000 0.0419 05 .0 12300 0.031 0.820 0.09 0.019 0.008 0.004 0.005 0.000 0.04 .01 0.0 7155 0.019 0.123 .0.11 0.022 0.007 0.00.5 0.392 0.000 0.015 0.034 0.001' 61202 0.017 0.194 0.178 0.0227 0.008 0.005- 0.389 0.000 0.037 0.033 0.001 7750 0.024 0.712 0.08 0.013 0.007 0.0043 0.332 0.000 0.044 0.039 0.004

- 10831 0.031 0.13 0.085 9.0705 O.00 0.03 0.33a 0,000 00P43 0.035 0.005 J1.: PDCB THCP PECH oc?DCfI pfPDCH MPDCH P7CR C0!mic11Els FILE 0.74 0.74 0.68. 106 ~5~.& 0.71 60177

~~~~~~ ~~~~NOTES**** **** ***** ***.

~LI1 gas volIumes are reported at 21.5 C. and I atm.. .. . .

!he standard deviation in.th' -source strength has beafl aetl.at'- 4 X.

standard deviation in the volume measurement han-.been set at 5 %

.overal.)1 norma.lized condit~ion ntunber C/1.) 0 .42E9

(D IN= I 13

onai condition nurnber's are: .

ONE 2. -5 7

'ondition Number 1 OB 3 iO1 7 1 .379 .124E8 1 . 05 . I 24 1.-044

JUL Z9 '02 03:39PM BNL: DRS/ECD 426 -P.414 47,-/ 4rD FLW-BATIOS S!.D. NY.

?ILTRURVXILT RN 1 I 0.147 0.1142 iR 2 . IUSM 0.0455 if 31 0.0363 - .

H 4 0.258 0.3540 1.045 0.0108

?9 6 0.615 0.1209 1 7 t.90a 15.1200 MXORAL 212- 1 -C.83R 0.4851 3f1- ! *1.285 0.9277 4 4- 1 0.0969 5! 5- 1 . 0.069 0.0093 6/ 6- 1 0.029 0.0209 7,t7- 1 0.026 0.0122

19.143* 62,9947 0.082 to.1957 5/ S 2 - ' 0.036 0.0273 6/ 6- 2 0.,036' 0.0723 7/ 7- 2 0.903 0.7688

-V 4- 3 89.6471 5/5- 3 0.,203 0.1401 6/6- 3 *.392 3.1448

.7I- 3 O.0174

-.4 0.45

.0.017 0.2269 6,t rS 4 .0.017 0.0085 7! 7- 4. -0.057 0:0552 0.483 0.4655 el :- 5 1.8474 71 7-.6 12.Y15 396.7011 DAD D1TXIO1 OF PDCH 1s lost 2 IS c uXk -TAN 25.

DARD MIlATIDI OF pPDM IR ZOE 3 IS &REAM TBEA 25 z INADAR DEIVATIO0 07 p .YJJI ZOH 4 IsCATIR Ti. 25 X XAD DEVIAION OF ptPDCH 1I M0E 7.IS CXUM TM 25%

kDAR DEVIATIN OF PMC? INIM 2 IS GWT11 TA 25 S WDARD DRIATIO1 OF PDCB IN20K3 2 IS GRZATER ITA 25 X b1DAED DVIATION OF ?tCE INZONE 4 IS MTEH TM 25 X

)WARD EVIATIM Of . PDC IN SOME 5 IS GREM TM 25 X MAD DEVONIATION Or DB IN ZM 7 IS GOATER E7K 25 1 MDARD DIVIATION OF T-1T INZOE 2 IS THAN 25 %

MXA ANDARD .DIATfDN OF7-PTCH IN 0i 4 IS GkXE IVAN 25 X ANDARD DIATIOS Of I-PTCB INI OR 519S RATER THIN 25 X ADAXDDDMiA 0 -PfCH IP ZONE 2 ISGUXA M 25 X MAID DVIATION OF PMCH INZONE 4 IS GATiR TN 25 2 VNDE DIVIATIO OF ocDM IN ZOIE 2 IS GRATER TM 25 a AMDMiD DEVIATION 07 0C7DCN INZONE 3 It CWTER TEAN 25 I ANDARD DEVIAT10 OF ocWM 1 ZONE 4 IS MIIR TMtP 25-X IDARD DRUIMI OFocPDCH IN 20H! 5 IS GEATER MN 25 X A11DARD DRIAMIN OF iFFCM IF ZONY 2 1S GRIATER TPN 2 IDDEVIATION OFIMDC INZONE 3 IS CMlE UN 25 X

..,dAf DEVIAT160 OF iPCCH INZONE 5 IS GREAIER TUAN 25 X

ML053220420

Text

Title:

Navigation menu

Search